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                                           ABSTRACT  
 
Several lines of evidence link Alzheimer’s disease (AD) to atherosclerosis (CVD), 
including that elevated low density lipoprotein (LDL)-cholesterol is a common risk 
factor.  Development of genomic instability could also link the two diseases.  
Previous fluorescence in situ hybridization (FISH) analyses revealed a clonal 
expansion of aneuploid smooth muscle cells underlying atherosclerotic plaques.  
Likewise, cellular and mouse models of AD revealed tau-dependent mitotic 
defects and subsequent aneuploidy partly resulting from amyloid-beta (Aβ) 
interference with microtubule (MT) stability, and specific MT motors function. 
Moreover, AD patients develop aneuploid/hyperploid cells in brain and peripheral 
tissues, implicating similar mechanism that may lead to apoptosis and 
neurodegeneration.  
This dissertation tested the hypothesis that elevated lipoproteins and 
cholesterol may contribute to genomic instability in AD and CVD and showed 
that: (1) treatment with oxidized LDL (OX-LDL), LDL and water soluble 
cholesterol, but not high density lipoprotein (HDL), induced chromosome mis-
segregation, including trisomy and tetrasomy 12, 21, and  7 in  human epithelial 
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cells (h-TERT-HME1), primary aortic smooth muscle cells, fibroblasts, mouse 
splenocytes and neural precursors; (2) LDL-induced aneuploidy may depend on  
a functional  LDL receptor (LDLR), but not amyloid precursor protein (APP) gene; 
(3) fibroblasts and brain cells of patient with the mutation in the Niemann-Pick C1 
gene (NPC1) characterized by  impaired  intracellular cholesterol trafficking and 
changed intracellular cholesterol distribution harbored  trisomy 21 cells; (4) young 
wild-type mice fed high and low cholesterol diets developed aneuploidy in spleen 
but not in brain cells within 12 weeks; (5) like with the studies on Aβ-induced 
aneuploidy, calcium (Ca2+) chelation reduced OX-LDL and LDL-mediated 
chromosomal instability; and (6) altering plasma membrane fluidity with ethanol 
attenuated  OX-LDL and LDL-induced aneuploidy.   
These results suggest a novel biological mechanism by which disrupted 
cholesterol homeostasis may promote both atherosclerosis and AD by inducing 
chromosome mis-segregation and development of aneuploid cells.  
Understanding the cause and consequence of chromosomal instability as a 
common pathological trait in AD and CVD may be beneficial to designing 
therapies relevant for both diseases. 
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     CHAPTER ONE 
              INTRODUCTION1 
 
The accurate transmission of genetic material from a mother cell to the daughters 
requires not only a faithful replication of the genome, but also a precise 
segregation of chromosomes during the cell division.  To accomplish this 
remarkable process, the cell has to disentangle replicated DNA molecules and 
pull them accurately to the opposite poles of the mitotic spindle before 
completing cytokinesis (Figure 1).  In eukaryotic, including mammalian cells, the 
cohesion between sister chromatids, a duplicated set of chromosomes, is 
sustained long after DNA replication, which allows for successful completion of 
mitosis (M).  During the M phase of the cell cycle, microtubules (MT), highly 
dynamic protein polymers of the mitotic spindle, attach the kinetochores of the 
sisters chromatids to opposite spindle poles and drive chromosome movement 
and traction (reviewed in Morgan, 2007).  A tightly controlled interaction between 
activating and inhibiting factors of the cell cycle assures chromosomal stability 
and integrity (Draviam et al., 2004), whereas dysregulation of the genes that 
                                                          
1 Portions of the results in this chapter have been published (Granic et al., 2010) and are utilized with the permission from 
the publisher. The contributions of the authors are: A. Granic, experimental designs and implementation, data collection 
and analysis, and manuscript preparation; J. Padmanabhan, important scientific insights for the manuscript, M. Norden, 
mice genotyping and assistance with the surgical procedures, and H. Potter experimental designs and manuscript 
preparation. 
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Figure 1. Metaphase to Anaphase Transition in hTERT-HME1 Cells  
Immortalized human epithelial cells were stained for mitotic spindle (α-tubulin, red), centrosomes/spindle 
poles (γ-tubulin; green) and nuclear DNA (DAPI, blue) to visualize the transition through the M phase of the 
cell cycle. Granic and Potter, unpublished data.  
 
govern the spindle checkpoints (Bharadwaj and Yu, 2004; Kinzler and Voglstein, 
1997) and DNA repair result in various genomic alternations, including  
mutations, chromosomal rearrangements, deletions, inversions and aneuploidy 
(Draviam et al., 2004; Rao et al., 2009).  Despite numerous cytogenetic 
pathways that ought to preserve this fundamental principle of life, spontaneous 
and induced chromosome mis-segregation happens frequently in humans during 
normal and pathological conditions (Cimini et al., 1999; Rasnik, 2000; Peterson 
et al., 2008; Rao et al., 2009; Rehen et al., 2005; Shi et al., 2000; Wojda et al., 
2007). 
Aneuploidy, a numerical abnormality of chromosomes compared to the 
normal genome (King and Stansfiled, 1990) arises as a consequence of mitotic 
errors (Kops et al., 2005; Rao et al., 2009) and has been linked to (1)  
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tumorigenesis of solid tumors (Boveri 1929; reviewed in Duesberg and Rasnik, 
2000; Jefford and Irminger-Finger, 2006; Ried 2009); (2) spontaneous abortions 
and embryonic lethality (Lebedev et al., 2004; Ljunger et al., 2011); (3) etiology of 
genetic diseases with abnormal phenotype such as Down syndrome (DS) 
(reviewed in Hassold and Sherman, 2000; Nižetić, 2008); (4) aging (Aviv et al., 
2001; Carere et al., 1999; Faggioli et al., 2011; Ly et al., 2000; Vijg and Dolle, 
2007); (5) atherogenesis (Matturri et al., 1997; 2001); (6) neurogenesis (Peterson 
et al., 2008; Rehen et al., 2005; Yang et al., 2003); and (7) neurodegeneration 
and dementia (Arendt et al., 2010; Potter, 2004).  Mitotic division of an aneuploid 
cell is believed to be an evolutionary experiment resulting in cellular diversity and 
constant genomic redistribution (Rasnick, 2000), but also a phenomenon 
characterizing or contributing to the disease process. 
This chapter will focus on genomic instability and chromosomal 
aneuploidy in normal and diseased human brain, the functional consequence and 
relevance thereof, the theoretical foundation for the role of altered gene dosage 
and abnormal cell cycle in dementia of the Alzheimer’s type, cancer, and 
cardiovascular disease (CVD). 
 
GENOMIC INSTABILITY IN NORMAL HUMAN BRAIN 
 
Ever since the numbers of human chromosomes have been determined (2n = 46; 
Tjio and Levan, 1956), numerous molecular cytogenetic studies reported 
genomic imbalance and the presence of euploid and aneuploid cells (i.e., 
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mosaicism) in various pathogenic and nonpathogenic human conditions.  The 
cells from normal tissues have been assumed to contain identical genomes in 
which aging, environmental and endogenously-induced insults may compromise 
the accuracy of mitotic machinery, initiating or causing the diseased state (Aviv et 
al., 2001; Beetstra et al., 2005; Benassi-Evans and Fenech, 2011; Mukherjee 
and Thomas, 1997; Ried, 2009).  In addition, higher cellular proliferation rates of 
renewable tissues in a complex human organism during embryogenesis 
(Biancotti et al., 2010; Mantzouratou and Delhanty, 2011), neurogenesis (Yurov 
et al., 2005; 2007; Westra et al., 2008), tissue development  and cell 
differentiation put at risk tightly regulated mitotic checkpoints, often resulting in 
chromosome mis-segregation and aneuploidy (i.e., aneugenesis) (Draviam et al., 
2004).  Primary neurons in the normal human brain have been traditionally 
viewed as post-mitotic and in G0 (Obrenovich et al., 2003), and thus genetically 
stable.  However, with advancements in cytogenetic techniques (Figure 2) from 
the classic karyotype analysis of colcemid-arrested cells at metaphase (Barnicot 
and Huxley, 1961) to more sophisticated examination of dividing and post-mitotic 
cells via fluorescent DNA probes to target a part of a chromosome in interphase 
cells (i.e., fluorescent in situ hybridization, FISH; Pinkel et al., 1986) or different 
chromosome paints to visualize one or all  chromosomes in dividing cells (i.e., 
spectral karyotyping, SKY; Schröck et al., 1996; Speicher et al., 1996), the 
mosaic nature of developing and adult normal mammalian, including human 
brain has been identified (Rehen 2001; 2005; Peterson et al., 2008; Yurov et al., 
2005; 2007). 
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Figure 2. Examples of Cytogenetic Methods for Analysis of Chromosome 
Complements in Metaphase and Interphase Cells  
Chromosomes in dividing cells can be visualized and analyzed via colcemid-arrested metaphase spread (left 
panel), FISH with fluorescent DNA probe (middle panel), and chromosome paint (right panel). Granic and 
Potter, unpublished data.  
 
Mosaic Nature of Neurogenesis 
 
For almost a century, a central dogma in neuroscience (Ramon y Cajal, 1913; 
Rakic, 1985) viewed neurogenesis as a process confined to the embryonic stage 
of mammalian development, and only recently a series of studies in various 
animal models and human brain samples confirmed that new neurons are indeed 
being born in distinct regions of the adult brain throughout life (reviewed in 
Christie and Cameron, 2006; Gross, 2000; Kempermann and Gage, 2000; Ming 
and Song, 2005; Zhao et al., 2008).  Adult neurogenesis, a continuous 
generation of functional neurons in the dentate gyrus, olfactory bulb and 
neocortex from the neural precursor cells (NPCs) occurs via mitosis (Eriksson et 
al., 1998; Christi and Cameron, 2006) adding thousands of new neurons to the 
brain per day (Cameron and McKey, 2001; Hastings et al., 2000), which become 
an integral part of existing neuronal circuits (Carleton et al., 2003; Kingsbury et 
al., 2005; Van Praag et al., 2002).  
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Methodological limitations of the techniques used to identify neurogenesis (e.g. 
incorporation of the synthetic thymidine into mitotically active cells indicates DNA 
synthesis and not necessarily cell division, and neuronal-specific markers cross-
react with other brain cells or do not detect all types of neurons) (Cristie and 
Cameron, 2006; Ming and Song, 2005; Rakic, 2002) suggest that the renewal of 
the brain tissue may be happening at higher rates and in other brain regions than 
has been reported.  In addition, several modulators of adult neurogenesis have 
been recognized (Ming and Song, 2005).  Unfavorable conditions such as 
exposure to acute and chronic stress and aging may decrease (Kuhn et al., 
1996; Gould and Tanapat, 1999; Jin et al., 2003), whereas environmental 
complexity (Brown et al., 2003) and learning of hippocampal-dependent tasks, 
may increase the proliferation of neuronal cells in the dentate gyrus (Gould et al., 
1999; Leuner et al., 2004).  Accumulated evidence has shown that chronic 
neurodegenerative diseases (e.g., Huntington’s and Alzheimer’s disease; Curtis 
et al., 2003; Jin et al., 2004) and brain injury (Magavi et al., 2000) trigger a 
significant increase in neuronal marker-positive cells, suggesting an induction of 
brain’s self-repair mechanism under pathologic stimuli.  
Advanced cytogenetic analyses by FISH and SKY have provided new 
insights into the nature of the developing and adult mammalian brain.  Numerous 
chromosomal aberrations in the embryonic cerebral cortex, postnatal ventricular 
zone (VZ) and other adult cortical regions of normal mouse and human brains 
were observed among neuronal stem cells, NPCs and mature neurons (e.g., 
Kaushal et al., 2003; Kingsbury et al., 2006; Peterson et al., 2008; Rehen et al., 
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2001; 2005; Yang et al., 2003; Yurov et al., 2005; 2007; Westra et al., 2008), 
which were functionally active and had been incorporated into the present 
neuronal circuitry (Kingsbury et al., 2005).  Up to 33% metaphases cultured from 
mouse embryonic neural cells exhibited both loss and gain of autosomal and sex 
chromosomes (Rehen et al., 2001), and about one-third of postnatal NPCs that 
give rise to neurons and glia were aneuploid for more than one chromosome 
(Kaushal., et al., 2003).  Analyzing mitotic defects in prenatal cortical 
hemispheres by co-immunolabeling for histone H3 to detect chromosomes and 
for vimentin, a cytoplasmic marker of NPC, Yang et al. (2003) identified 4.6% of 
NPCs with lagging chromosomes, 3.2% with multipolar cell division events, and 
various aneuploidies by SKY.  The rate of aneuploidy per mouse chromosome in 
developing brain may be estimated as high as 1.65% assuming that every 
chromosome has an equal chance to be gained or lost (Faggioli et al., 2011).  
Similarly, application of multicolor interphase FISH with DNA probes for the 
chromosomes exhibiting a frequent mosaic autosomal aneuploidy in humans 
(i.e., chromosome 13, 18, and 21; Iourov et al., 2006) on isolated fetal brain 
nuclei revealed between 30-35% of aneuploidy or estimated aneuploidy rate of 
1.25-1.45% per chromosome (Yurov et al., 2005; 2007).  Taken together, the 
data indicates that genetic mosaicism or co-existence of euploid and aneuploid 
cells is a universal feature of the developing mammalian brain.   
 Several hypotheses have been put forth to explain the susceptibility of the 
central nervous system (CNS) to genomic instability, aneuploidy generation (i.e., 
aneugenesis) and the phenotypic benefits thereof (Dierssen et al., 2009).  
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Extreme brain complexity manifested by cellular diversity, lateral asymmetry, 
regional interconnection of specialized microdomains, functional and structural 
plasticity, and enhanced responsiveness to environmental stimuli and cues make 
the brain more sensitive to genomic variations (Gericke, 2008) compared to other 
organs.  Chromosome mis-segregation in neural precursors and consequent 
genetic mosaicism could be a mechanism for biological variability and diversity in 
neurons contributing to the functional complexity of the brain and differences in 
intellectual abilities, personality, and psychiatric diseases in humans (Muotri and 
Gage, 2006).  Neuronal genomic heterogeneity as a universal organizational and 
functional property of developing and adult brain may play a role in the late-onset 
neurodegenerative diseases if the level of aneuploidy exceeds a physiologically 
sustainable threshold and the mechanisms of aneuploidy clearance fail (Arendt 
et al., 2009; Potter, 2004).  Increased apoptosis of aneuploid neuroblasts during 
cortical development (Rehen et al., 2001) suggests an inherent susceptibility to 
the cell death and/or decreased proliferative potential (Blaschke et al., 1996; Kai 
et al., 2009; Williams et al., 2008).  
 Advancements in neuroscience in the past couple of decades challenged 
two scientific dogmas: (1) the adult brain is not capable of renewal, and (2) 
normal neural cells possess identical genomes.  However, complete 
understanding of the mechanism, extent, regional distribution and the role of both 
neurogenesis and aneugenesis under normal and pathological conditions in 
developing and mature human brain remains to be explored.  
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Mechanism of Aneuploidy Generation  
 
Numerous tightly regulated processes and checkpoints throughout mitosis should 
ensure equal chromosome segregation and accurate separation of synthetized 
genetic material into two daughter cells (reviewed in Morgan, 2007).  Molecular 
biology and cytogenetic studies using mostly human cancer cells revealed  
 
 
 
Figure 3. Mechanisms of Aneuploidy Generation 
During the separation of sister chromatids, several pathways may lead to gain or loss of chromosomes such 
as: (1) dysregulation in the spindle assembly checkpoints (SAC) genes in which one daughter cell gets both 
chromosome copies after cell division; (2) improper attachment of microtubules and kinetochores to spindle 
poles (e.g., one kinetochore attached to both spindle poles); (3) incorrect cleavage of cohesin; (4) multiple 
spindle poles leading to asymmetric cell segregation; and (5) lagging chromosomes left after anaphase may 
result in one or both daughter cells to be hypoploid.    
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several pathways that lead to aneugenesis: (1) dysregulation of spindle assembly 
checkpoint (SAC) genes; (2) improper cross-linking of microtubules and 
kinetochores; (3) sister chromatid cohesion defects; (4) supernumerary  
centrosomes; and (5) incomplete cytokinesis (Chi and Jeang, 2007; Gisselsson, 
2011; King, 2008; Yang et al., 2003).  These mechanisms of neoplastic 
aneuploidy generation and persistence of chromosomal instability in tumors may 
also explain chromosomal aberrations in the normal CNS (schematically 
presented in Figure 3).  
The SAC is a surveillance system responsible for delaying the separation 
of the sister chromatids and progression into the anaphase until all chromosomes 
are properly oriented across the mitotic plate and attached on the mitotic spindle 
via kinetochores (Ito and Matsumoto, 2010; Straight, 1997).  Dysfunction and 
epigenetic modification of the signaling within the SAC (e.g., in the Mad and Bub 
protein family) can result in a mother cell with mis-aligned or unattached 
chromosomes proceeding with chromosome segregation towards opposite 
spindle poles, producing a daughter cell with both chromosome copies.  
Furthermore, inhibition of mitotic spindle motors such as kinesins, a group of 
proteins that aid connecting antiparallel MT and segregation of spindle poles 
resulted in massive aneuploidy in cultured cells (Borysov et al., 2011).   
Proper cleavage of cohesin, a complex of four proteins that holds 
duplicated DNA molecules together from the S phase through the metaphase is 
the central event in chromosome segregation (Nasmyth, 2001; Uhlmann, 2003).  
Experimental evidence in cellular and animal models has indicated that both 
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defects in expression of cohesin (Barbero, 2011) and cohesin protease separase 
leads to mitotic errors, aneuploidy and tumor formation (Meyer et al., 2009; 
Mukherjee et al., 2011; Zhang et al., 2008).  
Additionally, erroneous number of spindle poles due to centrosome 
replication defect (Godinho et al., 2009) may separate chromosomes to several 
nuclei or give rise to asymmetric segregation and generation of laggards (Falck 
et al., 2002; Norppa and Falck, 2003), which are chromosomes left at the mitotic 
plate after anaphase and frequently captured into the micronuclei (Figure 3).    
Studies on human neoplastic tumors have shown that despite bipolar 
mitosis and accurate metaphase-anaphase transition, cytokinesis failure in 
combination with spindle multipolarity may generate clones with high levels of 
aneuploidy evident as trisomies and tetrasomies of multiple chromosomes, which 
continue to propagate in similar fashion (Gisselsson et al., 2010), allowing for 
long-term clonogenic survival of aneuploid cells (Gisselsson, 2011).   
Chromosome gain and chromosome loss observed in human tissues 
under normal and pathologic conditions may also arise through bipolar mitotic 
nondisjunction in which chromosomes fail to separate, and both sister chromatids 
move to one of the daughter cells (Kirsch-Volders et al., 2002; Torosantucci et 
al., 2002; Weaver et al., 2006), resulting in trisomic and monosomic progeny.   
Lastly, correct disassembly of both membrane layers, the nuclear pore 
complexes and the nuclear lamina of the nuclear envelope (NE) at the onset of 
mitosis requires the concerted action of duplicated centrosomes, microtubules 
and mitotic motors (i.e., dynein complexes) to generate tension and 
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fragmentation of the NE (Burke and Ellenberg, 2002; Foisner, 2002; Gönczy,. 
2002, Salina et al., 2003).  Changes in the composition and dynamics of the 
nuclear envelope prior to the M phase may affect the dismantling process of the 
NE and its dynein-mediated attachment to MT and centrosomes, consequently 
influencing the release and arrangement of the chromosomes.   
In summary, several mechanisms may lead to the formation of trisomic 
and monosomic cells during mitosis such as anaphase lagging, multipolar 
centrosomes, sister chromatid nondisjunction (Yang et al., 2003), as well as  
other pathways commonly observed in cancer cells, which allow for stable 
propagation and persistence of aneuploid karyotype (Gisselsson, 2011).  
 
Aneuploidy in Developing and Aging Brain  
 
As mentioned previously, mitotic division of neuroblasts in embryonic human 
brain is characterized by chromosomal instability in which nondisjunction is the 
essential mechanisms of aneuploidy formation (Peterson et al., 2008; Yang et al., 
2003; Yurov et al., 2005).  The invention of interphase FISH with DNA probes 
(i.e., centromeric, locus-specific, and translocation) or chromosome paints 
combined with immunocytochemistry allowed for analysis of low-level mosaicism 
in non-dividing cells, and refuted the idea that mature neurons must possess 
identical genomes to be functionally active.  Studies utilizing various FISH 
approaches on isolated nuclei from normal adult brains revealed aneuploidy for 
chromosome 1, 13, 21, 18, X and Y at a total aneuploidy rate of 2.3% (Yurov et 
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al, 2005), and 4% of monosomy and trisomy 21 (nondisjunction) in neurons and 
glia which varied within the cell types and age of an individual (Rehen et al., 
2005).   
In a more comprehensive study of aneuploidy incidence in normal brain 
tissue, Iourov et al (2009) used interphase chromosome-specific multicolor 
banding (Iourov et al., 2007) and multicolor FISH (mFISH) for chromosomes 1, 7, 
11, 13, 14, 17, 18, 21, X and Y, and determined the average rate of aneuploidy 
per chromosome as 0.5% and total aneuploidy as 10%, but noted wide variations 
between the chromosomes and individuals.  Constitutive or basal aneuploidy, 
including trisomy 21 in normal human brains increased with advancing age 
(Rehen et al., 2005; Yurov et al., 2007; Iourov et al., 2009), suggesting that 
chromosomal instability may account not only for intrinsic genomic diversity but 
also for susceptibility to aging and disease.   
FISH analysis of the neurons prepared from several brain regions (i.e., 
cerebral cortex, hippocampus, and cerebellum) of normal human brains (aged 
40-75) using the probes for chromosomes 1, 3, 6, 7, 8, 9 and 11 identified about 
40% of total aneuploidy and 20% of loss of heterozygosity (LOH) and allelic 
instability events in isolated subgroups of neurons (Pack et al., 2005).  The 
authors speculated that constitutive neuronal aneuploidy may be necessary for 
some neurons to preserve differentiated state and interconnectivity under 
changing environmental conditions (Pack et al., 2005).   
Furthermore, FISH analysis of non-telencephalic brain cells such as 
cerebellar neurons and glia of both adult mice and humans with DNA probes for 
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mouse chromosome X and 16, and human chromosome 6 and 21 revealed 
chromosome gains and losses at the level of 1% per chromosome in both cell 
populations (Westra et al. 2008).  This study reported that mosaic aneuploidy in 
both developing and adult cerebellum of mice and humans arises at a lower rate 
than in, for example in cerebral cortex (~20% verses ~33%), suggesting that 
aneuploid NPCs not only survive into adulthood as an integral part of brain 
circuits, but that the level of genomic variation may be region specific and 
contribute to overall CNS diversity.   
Combining retrograde immunocytochemistry with the neuronal tracer 
FluoroGold in vivo with immunolabeling to identify mature neurons in tissue 
sections and FISH probes for chromosomes X and Y, Kingsbury et al. (2005) 
showed that aneuploid neurons in the adult mouse brain possess axonal 
connections, demonstrate functional activity, and are likely to be present in all 
brain regions, and probably contain mis-segregated autosomal chromosomes.   
Another study compared a slide-based cytometry (SBC) and PCR 
amplification of alu-repeats with chromogenic in situ hybridization (CISH) for 
chromosome 17 to quantify the DNA content of a single neuron on a fixed brain 
slice (Mosch et al., 2007).  About 12% of adult neurons isolated from the brains 
without any known neurological or psychiatric disease (mean age ~72 years) had 
hyperploid DNA content (here defined as more than diploid [2n] and less than 
tetraploid [4n] karyotype), and included a subpopulation of cells expressing cyclin 
B1, an early M phase marker (Darzynkiewicz, 1996).  In addition, between 6-7% 
brain cells showed three hybridization spots for chromosome 17 and about 0.4-
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0.7% cyclin B1-negative neurons were tetraploid, representing constitutional 
tetraploidy.  
Taken together, the results from all the studies suggest that: (1) the brain 
genome is not constant—mosaic aneuploidy is a constitutive complement of the 
developing and mature mammalian brain; (2) aneuploid neurons are functionally 
active and incorporate into brain circuits; (3) aneuploidy levels may vary between 
brain regions and change through the developmental stages; (4) basal 
aneuploidy may be needed for brain diversification, cellular heterogeneity and 
complexity of gene expression; (5) aberrant mitosis of neuroblasts in the 
ventricular zone may not be the sole source of aneuploid neurons; and (6) overall 
aneuploidy prevalence and incidence in human brain remains to be determined.  
To date, comprehensive cytogenetic studies of chromosomal variations in normal 
human brain compared to other somatic tissues throughout life are lacking, but it 
is generally postulated that even a low level of aneuploidy may significantly 
contribute to neuronal diversity, brain function and structure, and susceptibility to 
aging, psychopathological and neurodegenerative conditions (Arendt. et al., 
2009; 2010; Muotri and Gage, 2006; Potter, 2004; Rehen et al., 2001).  
 
Consequence of Genomic Instability in CNS 
 
Gain or loss of at least one chromosome is associated with increased or 
decreased expression of many genes in cancer cells (e.g., Sellmann et al., 2010) 
and yeast strains (e.g., Pavelka et al., 2010), and exert a profound change at the 
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transcriptome and proteome level, altering cell physiology and function (Torres et 
al., 2007).  Similarly, analysis of gene expression of aneuploid NPCs born in the 
postnatal subventricular zone and olfactory bulb revealed loss of heterozygosity 
and altered gene expression in cells missing one copy of chromosome 15 
(Kaushal et al., 2003).  Some aneuploid neurons survive into adulthood (Rehen 
et al., 2001), escape ‘apoptotic pruning’ (Blaschke et al., 1996; Kai et al., 2009; 
Harrison et al., 2000), and function aside mostly euploid cells (Kingsbury et al., 
2005).  This suggests that a mosaic brain network may produce a unique 
variation in gene dosage and consequent gene expression profile with both 
beneficial and detrimental consequences as observed in cancer cells (Shelzer 
and Amon, 2011; Weaver et al., 2007;) and genetic diseases (Dowjat et al., 
2007; Gardiner et al., 2010).  For example, Down syndrome (DS), a full trisomy 
of chromosome 21 (HSA 21) is a genetic condition that provides some insights 
into how constitutive aneuploidy (a change in one chromosome copy number) 
may lead to altered gene expression, brain dysfunction and degeneration 
(discussed below).  
It is unclear how much aneuploidy a single brain cell can sustain under 
normal developmental conditions (Kingsbury et al., 2006; Arendt at al., 2009), 
and what overall ‘aneuploidy burden’ would prompt the susceptibility to disease 
and consequent neurodegeneration.  It has been suggested that the neural 
aneugenesis beyond the basal levels may represent an early or contributing 
event in the brain disease process (Arendt et al., 2009; Potter, 2004), triggered 
either by unfavorable genetic polymorphism and/or environmental stimulus.  
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GENOMIC INSTABILITY IN DISEASED BRAIN 
 
Recent cytogenetic studies have revealed an increase in genomic instability in 
several human brain diseases compared to normal aging and development, 
including Alzheimer’s disease (AD) (Arendt et al., 2010; Mosch et al., 2007; 
Iourov et al., 2009; reviewed in Kingsbury et al., 2006; Thomas and Fenech, 
2007), mosaic variegated aneuploidy (MVA) (Matsuura et al., 2000), 
schizophrenia (Yurov et al., 2008), autism (Yurov et al., 2007b), ataxia-
telangiectesia (AT) (Iourov et al., 2009; Iourov et al., 2009b), and frontotemporal 
dementia (FTD) (Granic and Potter, unpublished data; Rossi et al., 2008).  All 
aforementioned diseases share chromosome mis-segregation and cell cycle 
defects as an underlying pathological trait that may be associated with a gene 
mutation, environmental insults or gene-phenotype interaction leading to brain 
dysfunction and/or neuronal death. 
 
Aneuploidy in Alzheimer’s Disease (AD)  
Hypotheses of AD Neuropathology  
Alzheimer’s disease is a multifactorial neurodegenerative disorder characterized 
by the aberrant accumulation of two misfolded proteins—extracellular amyloid 
beta (Aβ), a main constituent of senile plaques, and intracellular 
hyperphosphorylated tau protein (p-tau) assembled into neurofibrillary tangles 
(NFTs) (reviewed in Selkoe 2004; Querfurth and LaFerla 2011).  Both early 
diagnosis and successful treatment of AD will be greatly aided by a complete 
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understanding of initiators of pathological processes that lead to formation of 
neurotoxic proteins, inflammation, oxidative damage, impaired calcium 
homeostasis, and neurodegeneration. 
Over the past decades several hypotheses have been developed to 
explain complex and heterogeneous nature of AD pathogenesis, which may not 
be mutually exclusive.  For example, a central hypothesis of AD, the Amyloid 
Cascade Hypothesis, postulates that the imbalance between Aβ production, 
aggregation and clearance from the brain is the major driver of the disease 
process leading to synaptic loss, formation of senile plaques, inflammation, 
oxidative stress, neurodegeneration, and dementia (Blennow et al., 2006; Hardy 
2006; Potter et al, 2001).  A highly neurotoxic isoform of the Aβ protein, Aβ42, is 
produced by consecutive action of two cleaving enzymes, β- (BACE-1) and γ-
secretase, from a larger transmembrane protein, the amyloid precursor protein 
(APP) (Haass and Selkoe, 1993; Wolfe, 2003) within cholesterol-rich membrane 
domains (Wahrle et al., 2002).  A crucial step in AD pathogenesis is 
oligomerization or polymerization of Aβ peptide driven by inflammatory proteins 
(Potter et al., 2001; Hardy, 2006), coupled with Aβ-mediated phosphorylation of 
tau that causes destabilization of microtubules (Small and Duff, 2008).  In 
addition, intracellular Aβ accumulates in diseased neurons and contributes to 
disease progression by affecting the function of mitochondria, calcium ion 
channels and synapses (La Ferla et al., 2007).  NFTs clustering within the 
neurons cause disruption in neuronal signaling, synaptic failure, and impaired 
nutrient trafficking through the cell body and axons, and ultimately lead to 
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neuronal death (Alonso et al., 2006).  Because of their branched cell structure 
and large surface, neurons are especially sensitive to depletion of oxygen and 
nutrients, and impaired transport of key molecules and organelles essential for 
the cell survival and communication (Mattson and Magnus, 2006; Stokin and 
Goldstein, 2006).   
 The Vascular Hypothesis of AD (de la Torre and Mussivand, 1993) posits 
that cardiovascular risk factors (CRF) play a substantial role in AD pathogenesis, 
especially in the pre-clinical phase, by lowering cerebral blood flow (CBF) to a 
critical point where the high metabolic demand of the brain for oxygen, glucose 
and other nutrients cannot be sustained, leading to chronic cerebral brain 
hypoperfusion (CBH) and a neuronal energy crisis (de la Torre, 2004).  Reduced 
ATP synthesis and depletion in affected neurons may promote oxidative stress, 
dysfunction in ion pumps, neurotransmitter failure, abnormal APP metabolism 
and increased production of Aβ, and microtubule damage (reviewed in de la 
Torre, 2010).  While CBH can be present in cognitively intact older adults 
decades before the appearance of first clinical symptoms and classic AD 
markers (Vermeer et al., 2003), a combination of unfavorable vascular factors 
(e.g., hypertension, hypercholesterolemia and atherosclerosis) and vascular-
related susceptibility genes (e.g., apolipoprotein (APOE) ε4 allele) can 
exacerbate the disturbance in the cerebrovascular environment and weaken 
brain hemodynamic function (Bell and Zlokovic, 2009; de la Torre, 2004).   
 The mechanisms that could lead to impaired cerebral perfusion in AD 
include: (1) atherosclerotic changes in small and large vessel walls of both 
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central and peripheral vascular systems (e.g., Hofman et al., 1997; Beach, et al., 
2007); (2) anatomical defects and atrophy of cerebral arterioles and capillaries 
resulting in reduced microvascular density and injury to brain endothelium 
(Farkas and Luiten, 2001; Grammas et al., 2002); (3) microvascular lesions; (4) 
loss of cholinergic innervations in brain blood vessels (Farks and Luiten, 2001); 
and (5) development of cerebral amyloid angiopathy (CAA) and Aβ deposits in 
the smooth muscle cell (SMC) layers of cerebral microartheries (Olichney et al., 
1995), causing damage to the neurovascular unit (NVU) and decreased Aβ 
clearance across the blood brain barrier (BBB) (Bell and Zlokovic, 2009).  The 
NVU at the BBB includes neurons and glia, vascular and perivascular brain cells 
(e.g. vascular SMC, endothelial cells and perivascular macrophages), which are 
responsible for cerebral homeostasis by regulating blood flow and molecular 
exchange across the BBB, and by providing immune surveillance and trophic 
support to the brain (Iadecola, 2010).  
 Both hypotheses try to answer several important questions regarding AD 
initiation and treatment: (1) whether vascular or cerebral (i.e., Aβ-related) pre-
clinical pathologies are the early markers of the disease process; (2) which 
markers should be targeted therapeutically before progressive clinical symptoms 
(i.e., cognitive decline) emerge, and (3) which preventive strategies should be 
implemented so that neurovascular integrity and brain health remain at the 
optimal level in old age.  
 The Down Syndrome Model/Chromosome Mis-segregation Hypothesis of 
AD (Potter, 1991; 2008) suggests that genomic instability and a slow 
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accumulation of aneuploid, including trisomy 21 cells through mitotic defects and 
aberrant cell cycle events in peripheral organs and in the brain of an individual 
over a lifetime could initiate or promote both familial (FAD; caused by mutations 
in presenilin 1 and 2 [PS1 and PS2] and APP genes) and sporadic form of 
Alzheimer’s.  The universal presence of AD-like pathology and 
neurodegeneration in Down syndrome (Epstein, 1990; Glenner and Wong, 
1984), the development of FAD in patients with a duplicated APP region on one 
chromosome 21 (McNaughton et al., 2010; Rovelet-Lecrux et al., 2006; Sleegers 
et al., 2006), and occurrence of ectopic cell cycle events and chromosome mis-
segregation in the cells and mice expressing FAD genes (e.g., Boeras et al., 
2008; Granic et al., 2010; Nagy et al., 1997; Potter, 2004; Vincent et al., 1996; 
Yang et al., 2006), and in fibroblasts, lymphocytes, buccal cells, and neurons of 
AD patients (e.g., Arendt et al., 2010; Geller and Potter, 1999; Iourov et al., 2009; 
Kingsbury et al., 2006; Migliore et al., 1999; Mosch et al., 2007; Thomas and 
Fenech, 2008; Trippi et al., 2001) reinforced the hypothesis that chromosomal 
instability and mosaic aneuploidy could be a ‘cytogenetic hallmark’ of AD 
neurodegeneration, initiated by either genetic mutations, APP overexpression, 
Aβ overproduction or by environmental insults (reviewed in Granic and Potter, 
2011).  Thus several molecules and processes associated with AD pathology 
may act as aneugens and contribute to chromosome mis-segregation and 
generation of aneuploid, apoptosis-prone neurons (Busciglio and Yankner, 1997) 
and neural progenitors.  Increase in surviving hyperploid and hypoploid brain 
cells might contribute to other commonly observed features of AD, such as 
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overexpression of inflammatory proteins, amyloidogenic processing of APP and 
defective microtubule function and protein trafficking between and within the cells 
(Potter, 2004).   
 
The Level of Central Aneuploidy in AD 
The advancements in DNA technologies and visualization of chromosomal 
aberrations in mitotically active and dormant cells allowed for the establishment 
of aneuploidy mosaicism in healthy and diseased tissues, including neuronal.  
However, the hypothesis of unscheduled cell cycle re-activation in quiescent 
neurons under pathological conditions of AD is not novel.  Analyzing with the less 
refined technique the brain tissue from Alzheimer’s patients, Ramon y Cajal and 
Bouman suggested in the early twentieth century that the senile plaques may 
arise from hyperproliferation and subsequent degeneration of diseased neurons 
that re-enter a de novo cell cycle trying to self-repair (Bouman, 1934; Ramon y 
Cajal, 1913).  It would take another three-quarter of the century for the evidence 
of the ectopic cell cycle events in fully differentiated neurons in AD brains to 
emerge (e.g., McShea et al., 1997; Nagy et al., 1997; Vincent et al., 1996; Smith 
and Lippa, 1995), which challenged the dogma of their post-mitotic nature.  
Several studies have shown that mature neurons are capable of re-entering the 
cell cycle in vitro and in vivo, and that, depending on the external cues, they are 
either committed to finishing the M phase and divide, or abort the cell cycle via 
apoptosis (Howard et al., 1993; reviewed McShea et al., 1999; Yang and Herrup, 
2007).  
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As discussed above, genomic instability in the normal adult and 
developing fetal human brain in the form of mosaic aneuploidy (~10% or 0.5% 
per chromosome, and 30-35% or 1.25-1.45% per chromosome, respectively) 
with the gains and losses of whole chromosomes is part of neuronal complexity 
and diversity (e.g., Iourov et al., 2009; Yurov et al., 2005; 2007; Arendt et al., 
2010), but could also play a pathogenic role if the level of aneuploidy exceeds 
the sustainable physiological threshold, and the mechanisms responsible to 
correct erroneous cells fail.  To date, the evidence drawn from animal models of 
AD and autopsy studies of human brains indicates that (1) reactivation of the cell 
cycle and DNA duplication (Yang et al., 2001; Zhu et al., 2008) in the vulnerable 
population of AD neurons may present a fundamental initiator of AD 
pathogenesis (e.g., Heintz, 1993; McShea et al., 1999; Nagy, 2005; Obrenovic et 
al., 2003; Varvel et al., 2008; Vincent et al., 1996; Yang et al., 2006) and occur 
before fibrilar Aβ deposition and cell death; and (2) AD brains harbor up to 35% 
of hyperploid, including trisomy 21 neurons, which are detectable at mild stages 
of AD before neuronal loss (Arendt et al., 2010; Iourov et al., 2009).  These 
cycling or aneuploid mature neurons may arise during prenatal and/or adult 
neurogenesis throughout an individual’s lifetime (Eriksson et al., 1998) and may 
either die or be functionally active.  
The above-mentioned study by Mosch et al. (2007) that used three 
independent methods to compare single-cell DNA content in normal and AD 
entorhinal cortices immunolabeled with the cell cycle markers, revealed about 
20% cyclin B1-positive neurons with hyperploid DNA content (i.e., >2n and <4n), 
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and about 12% neurons from early and 13% from advanced AD brains with 
trisomy 17 compared to 6% in the age-matched control group.  In addition, ~2% 
of cyclin B1-positive neurons had tetraploid DNA content (4n karyotype) 
compared to ~0.3-0.5% in the controls.  The authors concluded that hyperploid 
AD neurons undergo an incomplete DNA replication compared to a complete 
replication observed in cyclinB1-positve tetraploid cells, and that these cells, 
although committed to the cell cycle (i.e., progressing beyond the G1 restriction 
checkpoint; Bybee and Thomas, 1991), would rather die than finish the cell 
division.  The majority of neurons with a more than diploid content which were 
elevated in the early-stage of AD by 2-3 folds remained stable through the mild-
stage, but died off as the patients progressed to more severe dementia, 
accounting for about 90% of total cell loss (Arendt et al., 2010).  A shift from 
physiologically sustainable levels of ~10% of hyperploidy to pathological ~30-
35% in the preclinical AD might trigger selective clearance of vulnerable, 
genetically unstable neurons during AD development and progression.  Thus, 
mature neurons residing in the brain regions susceptible to AD pathology entered 
a lethal cell cycle, but could survive in a hyperploid or diseased state for years or 
decades (Morsch et al., 1999; Yang et al., 2001).  
A recent study by Iourov et al. (2009) assessed aneuploidy in AD brains 
using eight different FISH DNA probes and paints, and observed a 10-fold 
increased level of trisomy and monosomy 21 (10.7% versus 1.7% in controls, 
95% CI 6.5-14.7%) as the most predominant chromosome mis-segregation 
event, and less than 0.04% tetrasomic (i.e., a chromosomal duplication of a 
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single chromosome pair) and polyploid (4n) neuronal and glial cells.  To date, this 
is the latest and the most comprehensive analysis of neural genomic instability in 
AD utilizing the FISH assay.  Similarly, a study by Westra et al. (2009) that used 
a combination of DNA fluorescence-activated cell sorting (FACS), FISH for 
chromosomes 4, 6 and 21, and immunolabeling to analyze the level of tetraploidy 
(4n karyotype) verses tetrasomy (2n+2) for a specific chromosome in AD and 
normal brains determined that tetraploid cell are mostly non-neuronal, do not 
occur explicitly in AD, and are present at extremely low level (0.003%).  
The discrepancies among the described studies in the level and type of 
aneugenesis and genomic instability, and the emphasis on either tetraploidization 
(Arendt et al., 2010; Frade and Lόpez-Sánchez, 2010; Mosch et al., 2007; Yang 
et al., 2001; Yang and Herrup, 2007) or aneuploidization of the brain cells 
(Granic and Potter, 2011; Iourov et al., 2009; Iourov et al., 2011; Potter, 2004; 
2008) as an important hallmark of AD pathology could be explained by the 
differences in working hypotheses, methodology employed, and definition of 
hyperploid state.  Nonetheless, the accumulated evidence suggests that elevated 
chromosome mis-segregation and aneuploidy in cycling neurons in AD may 
represent a critical molecular event contributing to neurodegeneration (Potter, 
2004; Arendt et al., 2009; Iourov et al., 2011; Yang and Herrup, 2007; McShea et 
al., 1999).   
It is generally accepted that (1) cell cycle dysregulation and aberrant cell 
cycle re-entry in a subpopulation of susceptible neurons are early events in AD 
pathogenesis that can ultimately lead to cell death (cycle-related neuronal death 
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[CRND]; reviewed in Fiorelli and Padmanabhan, 2011); (2) how far into the cell 
cycle postmitotic AD neurons progress and whether they complete the cell 
division after DNA replication is unknown—an authentic mitotic event has yet to 
be recorded; and (3) neurons with abnormal DNA content (>2n) are present at an 
elevated level in AD brain regions prone to neuropathology and are capable of 
surviving throughout early to mid-stage of AD and contributing to the brain 
physiology.    
 
The Level of Peripheral Aneuploidy in AD 
Early cytogenetic studies have shown an increase in chromosomal abnormalities 
in human lymphocytes with advancing age in which sex chromosomes and 
chromosomes belonging to E, F and G group (i.e., short submetacentric and very 
short acrocentric chromosomes; Robinson, 1960) were more readily lost or 
gained than other autosomes (Jacobs et al., 1963; Galloway and Buckton, 1978).  
The aging process has been recognized as the strongest risk factor for dementia 
and AD; the risk of AD increases exponentially and doubles every 5-6 years after 
about age of 60 (Jorm et al., 1987; Kawas et al., 2000; Ziegler-Graham et al., 
2008).  The discovery that Down’s syndrome patients who live beyond the 4th 
decade of life invariably develop AD-like neuropathology (Glenner and Wong, 
1984; Olson and Shaw, 1969; Wisniewski et al., 1988), and the fact that APP 
gene resides on chromosome 21 (HSA21) (Goldgaber et al., 1987; Neve et al., 
1988; Tanzi et al., 1987), a small acrocentric chromosome, instigated the 
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research on nondisjunction in AD and on the common biological mechanisms 
between AD and DS (Potter, 1991; 2008; Geller and Potter, 1999). 
Initial cytogenetic studies investigating the rate and type of chromosomal 
aberrations in patients with dementia used a classic karyotype analysis and G-
banding on blood cultures, and yielded inconclusive (e.g., Nordensen et al., 
1980) or negative results (e.g., Buckton et al., 1987; Kormann-Bortolotto et al., 
1993; Mark and Brun, 1973; Moorhead and Heyman, 1983) due to a small 
sample size and technical limitations of the assay.  The advent of FISH (Ried, 
1998) allowed for analysis of chromosome mis-segregation in poorly dividing or 
non-dividing cells or cells with a low-level aneuploidy such as human 
lymphocytes, which in a mosaic living person are subjected to negative selection, 
and may be ‘masked’ by diploid cells in the tissue culture and thus may not 
represent the accurate level of chromosomal abnormality of an individual 
(discussed in Potter, 2004).   
Utilizing the advantages of FISH, Geller and Potter (1999) analyzed 
primary fibroblasts from AD patients carrying familial mutations in the PS1, PS2 
or APP gene and those of sporadic origin, and revealed twice the frequency of 
trisomy 21 (~5%) compared to age-matched controls (~2.5%), which was not 
associated with the age of the affected individual.  A parallel assessment of 
trisomy 18 nondisjunction revealed an increase in aneuploidy, indicating that the 
mitotic defects in AD likely affected other chromosomes.  Both trisomy 21 and 18 
are the most common trisomies in newborns linked to erroneous maternal 
meiosis I or II, respectively and to 5-15% of postzygotic (mitotic) nondisjunction 
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(reviewed in Nicolaidis and Petersen, 1998).  In both trisomies, errors in maternal 
meiosis I is associated with reduced genetic recombination between non-
disjoined chromosomes and an increased recombination in meiosis II errors 
(Lamb et al., 1996).  The susceptibility of chiasmata, the points of crossing over 
and genetic material exchange between to homologous chromosomes observed 
in meiosis, and the fact that HSA21 is the smallest, gene-poor autosome in 
humans (Gardiner and Davisson, 2000) might also explain a preferential 
occurrence of HSA21 nondisjunction in genetic disorders and in AD.  
Thomas and Fenech (2008) used FISH analysis and DNA probes for 
chromosome 21 and 17 to compare aneuploidy levels in buccal cells (BC) 
collected from young and older healthy adults, DS individuals, and clinically 
diagnosed AD patients.  Young controls harbored 5% of trisomy 17 and 21, 
whereas older adults had 13.8% trisomy 17 and 9.6% trisomy 21, confirming the 
previous results that aneuploidy levels increase with advancing age.  There was 
a 1.5-fold increase in trisomy 21 and a 1.2-fold increase in trisomy 17 in AD 
subjects compared to age-matched cognitively intact older adults.  DS individuals 
had 16% aneuploidy of chromosome 17 compared to 5% of young controls.  The 
use of BC in this study has several advantages: they are easy to collect and 
share the same origin as a neural tube epithelium from which nervous system is 
developed, and thus they may exhibit chromosomal defects similar to the brain 
tissues. 
Along with the studies described above, separate lines of investigation 
provided evidence that other mitotic defects and mitosis-specific proteins may be 
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present in the cells of AD patients (reviewed in Potter, 2004).  For example, the 
mitotic spindles in dividing AD cells exhibited abnormalities and susceptibility to 
premature centromere division (PCD) and micronucleation (MN) upon chemically 
induced (e.g., colchicines, griseofulvin) microtubule damage (e.g., Fitzgerald et 
al., 1975; Spremo-Potparević et al., 2004; Trippi et al., 2001; Potter et al., 1995).  
The PCD in which individual sister chromatids are separated by a clear gap and 
not connected at the centromeres, has been observed in lymphocytes and 
fibroblasts of AD patients and individuals prone to chromosome mis-segregation, 
and recently confirmed in neurons of individuals with sporadic AD (Spremo-
Potparević et al., 2008).    
 In summary, the universal presence of genomic instability and increased 
aneuploidy, including trisomy 21 in peripheral tissues (i.e., blood, skin, and 
mucosa) from patients with both familial and sporadic AD indicates that mitotic 
defects may not only be associated with FAD mutations but also with exogenous 
risk factors, and possibly other susceptibility AD genes.  A larger scale 
cytogenetic autopsy and biopsy study employing various FISH techniques at the 
single-cell level is needed to establish the type and level of genomic instability in 
AD and other neurodegenerative disorders.  
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The Evidence for the Down Syndrome/Chromosome Mis-segregation 
Hypothesis 
Down Syndrome: Consequence of Altered Gene Dosage 
As indicated previously, chromosomal instability and the resulting chromosomal 
aneuploidy in somatic and germ-line cells have been implicated in the etiology of 
genetic diseases and cancers in which the presence or absence of an entire 
chromosome(s) alters the expression of the genes and gene products resulting in 
a specific, abnormal phenotype (reviewed in Iarmarcovai et al., 2008; Ye et al., 
2007).  Down syndrome, a phenotypic result of trisomy 21, is the most common 
chromosomal instability in surviving humans.  Triplication of HSA21 is 
responsible for about 95% of DS cases (reviewed in Sherman et al., 2005), and 
arises as a direct result of meiotic error mostly of maternal origin (Ghosh et al., 
2008; Nicolaidis and Petersen, 1998; Warburton, 2005).  The remaining cases 
are due to mosaicism or translocations of parts of chromosome 21 with a hetero- 
or homologous acrocentric chromosome (i.e., 13, 14, 15, 22) (Kim and Sheffer, 
2002), and are usually associated with a less prominent DS phenotype (Devlin 
and Morrison, 2004a).  Overexpression of the critical genes in DS within the 
Down syndrome critical region (DSCR; 21q22; Korenberg et al., 1990) has been 
associated with several DS phenotypes, and instituted the research on genotype-
phenotype relationship.  Besides intellectual disability, DS individuals share over 
80 clinical traits including congenital heart disease, muscle hypotonia, leukemia, 
deficits in vision and hearing, seizures, immune system deficiency, accelerated 
aging and neurodegeneration of the Alzheimer’s type (Epstein, 1990; 
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Antonarakis and Epstein, 2004; Patterson, 2009).  There are two hypotheses that 
explain the relationship between the DS specific phenotype and triplication of 
HSA21.  Certain gene combinations might predispose DS individuals to a 
disease (e.g., Alzheimer’s) while other gene groupings might be protective (e.g., 
lower incidence of atherosclerosis and solid tumors; Draheim et al., 2010; Hasle 
et al., 2000) because of (1) gene dosage imbalance (Korenberg et al., 1990) or 
(2) increased gene expression and altered genetic homeostasis (Shapiro, 1983).  
For example, overexpression of APP gene may reflect the increased gene 
dosage of 50% leading to overproduction of Aβ, increased ratio of more 
amyloidogenic Aβ42 over Aβ40 (Teller et al., 1996) and neurodegeneration. 
 
Trisomy 21: Links between DS and AD  
Epidemiological evidence suggesting that chromosome mis-segregation and 
trisomy 21 mosaicism might be associated with AD pathogenesis originated from 
studies showing a significantly higher frequency of DS children in some families 
with familial AD (Heston et al., 1981; Heyman et al., 1983).  Another important 
result that provided support for the Trisomy 21 Model of AD came from a 
retrospective study of young mothers (aged <35) of Down syndrome children 
who showed a 5-fold increased risk of developing AD later in life compared to 
either older DS mothers or the general population (Schupf et al., 1994; 2001).  In 
the vein of the Trisomy 21 Model of AD, it could be postulated that the young DS 
mothers most likely had HSA21 mosaicism and were predisposed for genomic 
instability, which resulted in DS offspring and their own increased risk of AD later 
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in life.  Recently, Migliore et al. (2006; 2009) confirmed the susceptibility to 
aneuploidy and trisomy 21 nondisjunction in young mothers of DS children.  
Furthermore, case studies of patients with HSA21 mosaicism and no mental 
impairments of the DS type who developed AD by the age of 40, strongly 
suggest that a small percentage of chromosomal instability sufficed to result in 
early-onset AD (e.g., Ringman et al. 2008; Schapiro et al., 1989).   
Therefore, a slow accumulation of a low number of trisomy 21 and other 
aneuploid cells over the course of life may initiate and/or contribute to the 
pathogenesis of both genetic and sporadic form of AD.  Furthermore, a dose 
response effect could be suggested in which full trisomy 21 in DS individuals 
produces AD-like pathology by age 20 and by middle age in familial AD and even 
later in sporadic Alzheimer’s patients, who also belonged to the trisomy 21 
mosaic group with an increased frequency of DS children before the age of 35.  
The recent discovery that an extra copy of APP gene on one HSA21 is sufficient 
to cause early-onset AD (McNaughton et al., 2010; Rovelet-Lecrux et al., 2006; 
Sleegers et al., 2006) suggests that APP overexpression and consequent 
overproduction of Aβ peptide is the likely cause of AD in both DS and trisomy 21 
mosaic individuals. 
 
Experimental Evidence for DS Model/Chromosome Mis-segregation 
Hypothesis  
Several predictions under the Down Syndrome Model/Chromosome Mis-
segregation Hypothesis have been tested so far in the laboratory of Dr. 
33 
 
Huntington Potter and others: (1) AD patient should harbor mis-segregated, 
including trisomy 21 cells which could contribute to dementia onset and 
neurodegeneration but at slower pace than in DS due to modulating effect of 
normal cells in the body; (2) FAD mutations should occur in genes directly or 
indirectly involved mitosis; and (3) AD cells should exhibit defect in microtubules, 
mitotic spindle and mitosis-related proteins that could lead to aneuploidy and 
trisomy 21 mosaicism. 
 As mentioned previously, the cytogenetic studies confirmed the first 
prediction: the cells and tissues obtained from both familial and sporadic AD 
patients are mosaic for several chromosomes, including HSA21.  
Over the past two decades the lab of H. Potter investigated the role of 
mutant PS1, PS2 and APP genes and their proteolytic product, the Aβ peptide in 
the cell cycle, chromosome mis-segregation and induction of HSA21 aneuploidy.  
All assays, tissues and cells from FAD transgenic mice and cells harboring FAD 
genes or treated with Aβ peptide yielded comparable results: overexpression of 
presenilin or APP in vivo and in vitro or exposure to Aβ peptide induced genomic 
instability and trisomy 21 mosaicism through several defects in mitotic spindle, 
dysfunction of microtubules and inhibition of mitotic motors (Boeras et al., 2008; 
Borysov et al., 2011; Granic et al., 2010; Potter et al., 2008).    
 Additional experimental and epidemiological evidence has also suggested 
the involvement of presenilins and APP in mitosis: (1) PS1/2 proteins localized to 
the centromeres and nuclear envelope in dividing cells, and the kinetochores 
during interphase (Li et al., 1997; Honda et al.,2000); (2) the PS1 gene inhibited 
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the cell cycle (Janicki and Montero, 1999) and induced apoptosis in the cultured 
cells (Wolozin et al., 1996); (3) APP was found to get increasingly 
phosphorylated (Judge et al., 2011) and to localize to the centrosomes and 
nuclear membrane during mitosis (Nizzari et al., 2007; Zitnik et al., 2006); and (4) 
polymorphisms in the PS1 gene have been associated with an increased risk of 
AD (e.g., Wragg et al., 1996; Higuchi et al., 1996) and with an increase of DS 
offspring via a meiosis II defect (Lucarelli et al., 2004; Petersen et al., 2000) .  
The possible mechanisms by which PS and APP mutations may induce 
chromosome mis-segregation involves their inability to properly link the 
chromosomes to the nuclear envelope and to release them at the appropriate 
time during mitosis, which may lead to chromosome mis-segregation and other 
cell cycle defects.  Another possibility links PS1/PS2 and APP to the increased  
production of neurotoxic Aβ42 as a likely effector molecule responsible for the 
cell cycle dysfunction, including mitotic spindle abnormalities and chromosome 
mis-segregation (Boeras et al., 2008; Borysov et al., 2011, Granic et al., 2010).  
 To determine whether genomic instability observed in fibroblasts and 
lymphocytes from FAD and sporadic individuals could be mimicked in peripheral 
and brain tissues of AD mice, we investigated the level of total and chromosome-
specific aneuploidy in animals carrying PS1 and APP mutations.  For instance, 
quantitative FISH analysis with a mouse chromosome 16 BAC probe (Kulnane et 
al., 2002) of neurons isolated from APP-V177F mutant mice showed about 6.5% 
of trisomy 16 compared to 1.5% in nontransgenic littermates (Figure 4; Granic et 
al., 2010).  Similar levels of aneuploidy were observed in lymphocytes and brains 
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Figure 4. Induction of Trisomy 16 in Neurons of APP-V177F Mice  
(A-B) Quantitative FISH analysis with a mouse chromosome 16 BAC probe (orange) revealed significantly 
higher levels of trisomy 16 NeuN-positive (green, neurons) cells in transgenic mice compared to controls but 
no induction of tetrasomy in whole brain single-cell suspension (D).  
(C) No induction of trisomy 16 was observed in NeuN-negative cell.   
“Reprinted from Antoneta Granic, Jaya Padmanabhan, Michelle Norden, and Huntington Potter, “Alzheimer 
Aβ Peptide Induces Chromosome Mis-Segregation and Aneuploidy, Including Trisomy 21: Requirement for 
Tau and APP”, Molecular Biology of the Cell, Vol. 21, 511-520, February 15, 2010 with the permission of 
The American Society for Cell Biology.”  
 
of animals carrying either a mutant PS1 or APP human gene or in mutant PS1 
knock in mice (Boeras et al., 2008; Granic et al., 2010).   
To investigate whether FAD mutations or some other factors were 
responsible for the chromosomal instability observed in mouse models of AD, 
parallel cultures of human cells with a stable karyotype were transiently 
transfected with plasmids carrying either PS1 or APP mutant genes (e.g., M146L 
or Swedish mutation [K595N/M596L], respectively).  Overexpression of these 
genes induced about 2-3% of trisomy 21 and/or trisomy 12, and up to 30% of  
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total aneuploidy in metaphase cells (Granic et al., 2010; Boeras et al., 2008), 
indicating that an aneugenic effect of FAD mutations likely affected all 
chromosomes, and that chromosome mis-segregation was not restricted only to 
transfected cells.  We hypothesized that Aβ peptide itself found at increased 
levels in both familial and sporadic AD might be the effector molecule interfering 
with the cell cycle and chromosome segregation (Potter, 2008). 
Immunocytochemistry of PS1-expressing cells revealed several abnormalities in 
the mitotic spindles, with disarrayed microtubules, multiple centrosomes and 
lagging chromosomes as the most frequent spindle errors (Boeras et al., 2008).   
Following the initial observation that more cells became aneuploid than 
transfected, we examined the aneugenic effect of Aβ42 peptide in vitro.  Human 
epithelial cells treated with 1µM Aβ40 and Aβ42 for 48 hr develop more than 20% 
total aneuploidy and 2% of trisomy 21 and 12 compared to 6% total and less than 
1% chromosome 21 aneuploidy, respectively in the cells treated with various 
control peptides (e.g., Aβ42-1) (Figure 5, Granic et al., 2010).   
Further in vitro studies investigated the mechanism(s) by which Aβ exerts 
its aneugenic activity on dividing cells, especially those related to microtubule 
function, mitotic spindle integrity and tau.  It has been shown that Aβ requires 
downstream changes in tau protein and in microtubules to exert its toxic effect on 
neurons—Aβ induces tau phosphorylation (Small and Duff, 2008) and Aβ 
neurotoxicity depends on the presence of tau (Rappaport et al., 2002).  Our data 
indicated that (1) mouse splenocytes lacking one or both Tau genes developed 
up to 5% aneuploidy; (2) Aβ aneugenic activity depended on tau, suggesting that 
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Figure 5.  Aβ Peptides-induced Trisomy 21 and 12 In Vitro  
(A-C) Quantitative FISH analysis with a dual color probe (Abbott, Vysis) showed an increase in trisomy 21 
(SpectrumOrange) and trisomy 12 (SpectrumGreen) in Aβ-treated cells.  Adapted and used with permission 
from Granic et al., 2010, Molecular Biology of the Cell, The American Society for Cell Biology.  
 
the peptide interfered with the tau’s normal MT-stabilizing function; (3) Aβ 
induced similar mitotic spindle defects observed in the cell expressing PS1 
mutations, and inhibited three motor kinesins, the Eg5, KIF4A, and MCAK, 
required for proper spindle formation and chromosome mis-segregation (Borysov 
et al., 2011), and (4) a functional APP gene was necessary for aneugenic effect 
of Aβ.  Additionally, we determined that chelation of extracellular Ca2+ with 
BAPTA and thus inhibition of, for example, calpain, and inactivation of GSK-3β 
by LiCl, reduced Aβ-induced aneuploidy.  Previous studies have shown that both 
BAPTA and LiCl inhibit Aβ toxicity (Sofola et al., 2010; Kuwako et al., 2002).   
Future studies will determine if the interference with microtubule function  
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by Aβ contributes to defective neuronal plasticity, neurotoxicity, as well as 
impaired neurogenesis and generation of aneuploid neurons prone to Aβ 
overproduction and neurodegeneration.  Chromosomal instability, including 
trisomy 21 may be a cause and an effect of Aβ-induced microtubule dysfunction 
creating a feed-forward loop that stimulates AD progression.   
 
Aneuploidy in Other Neurodegenerative Diseases  
 
Ataxia-telangiectasia (AT) and frontotemporal dementia (FTD) are examples of 
neurodegenerative diseases in which mutations in genes involved in mitosis and 
the cell cycle regulation may be associated with chromosomal instability and 
neuronal death.  
AT is an autosomal recessive genetic disorder caused by mutation in a 
single gene, the ‘ataxia telangiectasia mutant’ (ATM) which encodes the ATM 
protein, a kinase responsible for the G1 cell cycle checkpoint, maintenance of 
genomic integrity and elimination of cells with damaged DNA (Abraham, 2001; 
McKinnon, 2004; Shiloh, 2003).  This single point mutation leads to a wide range 
of defects including neurodegeneration, cognitive impairment, immune 
dysfunction and high susceptibility to malignant tumors (McKinnon, 2004).  
Because of the loss of function in ATM, one of the main pathological hallmark of 
the disease is a significant increase in aneuploid cells, including neuronal cells 
early in disease progression both in murine models of AT ( ~38%; McConnell et 
al., 2004) and in humans (2-3 fold increase over normal human brain; Iourov et 
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al., 2009).  The data suggest that absence of ATM results in failed clearance of 
mis-segregated cells, which in turn instigates increased incident of lymphatic 
tumors, immunodeficiency because of accumulated oncogenic T and B cells, and 
defective neurogenesis and progressive neurodegeneration (Iourov et al., 
2009b).  
A recent study by Rossi et al. (2008) proposed another function for the 
protein tau—protection of genomic stability and chromosomal integrity.  
Cytogenetic analysis of lymphocytes and skin fibroblasts from individuals 
harboring a P301L mutation in Tau gene showed several chromosomal 
instabilities compared to non-demented controls (e.g., aneuploidy, chromosome 
and chromatid breaks, translocations and de-condensed chromosomes).  In the 
Potter laboratory, we have been investigating the role of microtubule defects in 
AD and FTD by determining the level of MT-based transport deficiency in mouse 
models of FTD and human brains evidenced by aneuploidy and reduced 
expression of neurotransmitters and neurotrophin receptors.  Preliminary data 
indicate an increased induction of trisomy 21 in human brains with FTD, and 
elevated levels of trisomy 16 in spleens and brains of mice harboring P301S 
mutation compared to non-transgenic controls.  
 
GENOMIC INSTABILITY IN CARDIOVASCULAR DISEASE  
 
Atherosclerosis is a leading cause of death in developed countries and a major 
component of cardiovascular disease (CVD).  The pathogenesis of 
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atherosclerosis is complex and involves multiple factors.  It has been generally 
accepted that three dominant pathways are implicated in atherogenesis: 
disturbed cholesterol homeostasis, inflammatory response, and oxidative 
damage.  Therefore, atherosclerosis has been described as an inflammatory 
disorder that is induced and progresses within a high cholesterol environment 
(Steinberg, 2002).  As with AD, several hypotheses have been proposed to 
elucidate the initiating agent or process responsible for atherogenesis.  
The Response to Injury Hypothesis postulates a tear in the endothelial 
lining of an artery caused by e.g., mechanical injury or oxidized low density 
lipoprotein (OX-LDL) (Ross, 1993; Carmena et al., 2004) as a first atherogenic 
step followed by overexpression of adhesion molecules, infiltration of 
inflammatory cells, an excessive migration and proliferation of smooth muscle 
cells, accumulation of cholesterol, fats, and cellular debris, and consequent 
plaque formation and calcification (Ross, 1993; Libby et al., 2002; Steinberg, 
2002).   
The Monoclonal Proliferation Theory posits a monoclonal expansion of 
SMC and chromosomal instability as an initiating mechanism for the 
development of atherosclerosis, similar to the development of aneuploid, benign 
tumors (Benditt and Benditt, 1975; Casalone et al., 1991; Fernandez et al., 2000; 
Lavezzi et al., 2005; Matturi et al. 1997; 2001; Murry et al., 1997; Vanni and 
Licheri, 1991).  Cytogenetic analysis of unstable atherosclerotic plaques revealed 
clonal proliferation of SMC in artery intima and the presence of several 
chromosomal instabilities, including trisomy and tetrasomy 7, trisomy 10, 18, and 
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20, monosomy 11, and loss of Y, suggesting the involvement of genomic 
alternations in atherosclerotic process.  
 
THEORETICAL FRAMEWORK   
 
Discovering the genetic origin of Aβ (Glenner and Wong, 1984) and the mapping 
of the APP on chromosome 21 (e.g., Goldgaber et al., 1987), allowed for new 
insights into pathogenic pathways of AD, and for the establishment of a unique 
link between genomic instability in DS and Alzheimer’s (Potter, 1991).  
Constitutive trisomy 21 has been associated with intellectual impairment, and 
development of Alzheimer’s like neuropathology by the 4th decade of life 
(Epstein, 1990).  Overexpression of APP due to altered gene dosage, may lead 
to overproduction of Aβ and neurodegeneration (Head and Lott, 2004).  Similarly, 
accumulated trisomy 21 and other aneuploid cells in AD patients both in the brain 
(e.g., Arendt et al., 2010; Mosch et al., 2007; Iourov et al., 2009) and peripheral 
tissues (Geller and Potter, 1999; Migliore et al., 1999; Thomas and Fenech, 
2008) over the course of life may present an initiating event in AD pathogenesis 
and/or promote neurodegeneration (Potter, 2008).  Likewise, the evidence from 
animal models of AD and autopsy studies of human brains suggests that 
reactivation of the cell cycle and DNA duplication (e.g., Yang et al., 2001) in the 
vulnerable population of AD neurons may present an important initiator of AD 
(Nagy, 2005; Vincent et al., 1996; Varvel et al., 2008; Yang and Herrup, 2007; 
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Yang et al., 2006) present before Aβ deposition and neuronal death, and could 
also lead to chromosome mis-segregation and aneuploidy. 
 A unifying hypothesis for Alzheimer’s and Down syndrome 
neurodegeneration has been proposed (Potter, 1991)—development of a mosaic 
population of aneuploid, including trisomy 21, cells and alternation in genomic 
homeostasis may lead to classic AD neuropathology observed in both diseases.  
The Trisomy 21 Hypothesis of familial and sporadic AD posits that slow 
development and accumulation of a small number of trisomy 21 cells over a 
lifetime could cause or help promote neurodegeneration (Potter, 1991; 2004; 
2008).  Trisomy 21 mosaicism could be the first step in AD pathogenesis, and 
might lead to: (1) neurodegeneration and apoptosis; (2) higher expression of a 
neurotoxic version of Aβ peptide; (3) induction of an inflammatory cascade; and 
(4) defects in microtubule function and protein trafficking between and within the 
neurons (Potter, 2008). 
Genomic imbalance has been observed in other diseases of the brain 
such as ataxia telangiectasia (Iourov et al., 2009; 2009b), schizophrenia (Yurov 
et al., 2008), autism (Yurov et al., 2007b), and it has been recently implicated as 
an early event in frontal temporal dementia (FTD) (Rossi et al., 2008).  Taken 
together, chromosome mis-segregation and aneuploidy in human brain may not 
only represent neural complexity, cellular diversity, and a universal genetic state 
of the human mind, but a mechanism for neurodegeneration if the level of 
imbalance reaches a pathogenic threshold. 
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Figure 6. Genomic Instability in AD and CVD as a Common Pathogenic Trait 
High cholesterol as a common risk factor for AD and CVD (atherosclerosis) may initiate aneugenesis and 
contribute to development of both diseases.  
 
 Cytogenetic analysis by FISH of the chromosome complement in 
atherosclerotic plaques showed clonal expansion of aneuploid smooth muscle 
cells in artery intima, with trisomy 7 and monosomy 11 as the most predominant 
chromosomal instability (Matturri et al., 1997; 2001).  Thus, the development of 
atherosclerotic lesions may be initiated or promoted by clonal expansion of 
aneuploid smooth muscle cells. 
In line with the Down Syndrome/ Chromosome Mis-segregation 
Hypothesis of AD and the Monoclonal Proliferation Theory of Atherosclerosis, it 
could be inferred that elevated blood cholesterol lipoproteins, common risk 
factors for AD and atherosclerosis, may act as atherogenic and aneugenic 
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agents, and that AD and CVD (atherosclerosis) may share chromosomal 
instability and development of aneuploidy as a unique cytogenetic and 
pathogenic trait (Figure 6).  
Therefore, the purpose of this dissertation was to investigate whether 
disrupted cholesterol homeostasis (e.g., elevated lipoproteins/cholesterol and 
modified intracellular cholesterol distribution) may contribute to genomic 
instability observed in AD and CVD using in vitro and in vivo models.  
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     CHAPTER TWO 
     BIOLOGICAL LINKS BETWEEN AD AND CVD 
 
Brain aging is characterized by the gradual and progressive biochemical and 
physiological changes in the structure and function of brain cells, its subcellular 
components, molecules and brain vasculature responsible for its optimal 
functioning and integrity (Shankar, 2010).  For example, alternation in dynamic 
communication between the cells of the neurovascular unit at the BBB may lead 
to decreased cerebral blood flow, impaired clearance of neurotoxic proteins, and 
increased brain vulnerability to the changes and insults from peripheral systems 
(Zlokovic, 2008; Iadecola, 2010).  Furthermore, abnormal metabolism of the key 
brain molecules like cholesterol and lipoproteins may promote several 
pathophysiological processes observed in age-associated brain disorders such 
as Alzheimer’s (e.g., reviewed in Canevari and Clark, 2007; Liu et al., 2010; 
Panza et al., 2009; Pfrieger, 2003; Poirier et al., 2003; Wolozin, 2004).   
 Accumulated evidence from epidemiology, genetics, pharmacology, and 
molecular, cell, and animal biology indicates that disturbance in central and 
peripheral cholesterol homeostasis may play a role in AD initiation and 
progression (Hartmann et al., 2007; Puglielli et al., 2003; Shobab et al., 2005; 
Wellington et al., 2004).  For instance, in line with the Vascular Hypothesis of AD 
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(de la Torre, 2004), epidemiological studies propose a link between AD, 
cardiovascular risk factors (e.g., high plasma cholesterol) and cardiovascular 
disease (CVD) (e.g., atherosclerosis and coronary heart disease) (e.g., Alonso et 
al. 2009; Anstey et al., 2008; Casserley and Topol, 2004; Dolan et al. 2010; 
Hofman et al., 1997; Laitinen et al., 2006; Li et al., 2005; Kivipelto et al., 2001; 
Solfrizzi et al., 2004; Solomon et al., 2007; 2008; Sparks et al., 1990; van Oijen 
et al., 2007).  Cerebral hypoperfusion and compromised neurovascular unit early 
in pathology of AD may lead to decreased clearance of Aβ and cerebral amyloid 
angiopathy (CAA), impaired cholesterol efflux across the BBB and atherosclerotic 
buildup in cerebral blood vessels (Bell and Zlokovic, 2009; Iadecola, 2010).  The 
presence and severity of atherosclerotic lesions in systemic and intracranial 
vasculature correlates with the extent of AD pathology (Beach et al., 2007; 
Casserley and Topol, 2004; Honig et al., 2005; Li et al., 2003; Sparks et al., 
1997).  Additionally, genetic and molecular studies identified ApoE as a major 
cholesterol transporter in the brain (Mahley, 1988) that serves as a ligand for the 
low density lipoprotein receptor (LDLR) family in neurons and glia, coordinating 
cholesterol intake and distribution (Andersen and Willow, 2006; Brown and 
Goldstein, 1976; 1986; May et al., 2007; Poirier, 2003).  Likewise, the inheritance 
of the ApoE ε4 allele has been recognized as the strongest genetic risk factor for 
sporadic AD (Roses, 1996; Strittmatter et al., 1993a).  ApoE, particularly apoE4 
directly interacts with Aβ and catalyzes its polymerization into neurotoxic 
assemblies (Ma et al., 1994; Wisniewski et al., 1994; Potter et al., 2001).  Results 
from several observational studies have also shown a reduced incidence of AD in 
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older adults taking both lipophilic or lipophobic statins (e.g., Fassbender et al., 
2001; Jick et al., 2000; Wolozin et al., 2000; reviewed in Kandiah and Feldman, 
2009; Wolozin, 2004b). 
  In line with the Amyloid Cascade Hypothesis (reviewed in Hardy, 2006), a 
number of cellular and animal studies have indicated a reciprocal relationship 
between cholesterol levels and APP processing and Aβ production.  The 
evidence includes the following: (1) cholesterol depletion or inhibition reduces 
cellular amyloid load and aggregation in vitro and in vivo (Fassbender et al., 
2001; Refolo et al., 2001; Schneider et al., 2006; Simons et al., 1998); (2) plasma 
membrane cholesterol levels correlate with, and presumably influence the activity 
and expression of APP secretases involved in Aβ generation (Bodovitz and Klein, 
1996; Ehehalt et al., 2003; Kojro et al., 2001; Xiong et al., 2009); (3) APP 
processing, γ-secretase and Aβ regulate cholesterol and other lipids (reviewed in 
Grösgen et al., 2010); (4) Aβ aggregates preferentially bind to cholesterol 
(Adulov et al., 1997; reviewed in Beel et al., 2010) and cause accumulation of 
cholesterol in senile plaques and neuronal terminals in cortex and hippocampus 
of human and mouse AD brains (Gylys et al., 2007; Mori et al., 2001; Panchal et 
al., 2010); and (5) animals, especially FAD transgenic mice, fed a high 
cholesterol diet increase Aβ production and develop greater amyloid burden, 
possibly by increasing the expression of ApoE to accommodate the extra 
cholesterol, and thus further catalyzing Aβ polymerization (Hooijmans et al., 
2007; Levin-Allerhand et al., 2002; Oksman et al., 2006; Refolo et al., 2001; Shie 
et al., 2002; Sparks et al., 1994).  Also, modification of membrane cholesterol 
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content and accumulation of lipids in cytosolic compartments, and deregulation of 
brain cholesterol metabolism has been implicated in other neurodegenerative 
disorders such as Niemann-Pick, Huntington’s and Parkinson’s disease 
(reviewed in Liu et al., 2009; Pfrieger, 2003).   
Despite the plethora of aforementioned evidence that points to an intrinsic 
role of cholesterol and CVD (atherosclerosis) in the etiology of AD, the nature of 
the mechanistic connection between them is not completely explained, and 
warrants further investigation.  This dissertation sought to explore a novel 
pathological trait that may underlie both AD and CVD—chromosome mis-
segregation and development of aneuploidy in which high cholesterol may act as 
an environmental aneugen.  To our knowledge, this would be the first study to 
investigate the effect of elevated lipoproteins/cholesterol on chromosomal 
integrity and the relevance thereof for AD and CVD.   
The first part of this chapter will define the general hypothesis and three 
specific research questions under the study, and the second part will focus on 
underlying scientific background relevant for each by delineating some important 
aspects of peripheral and central cholesterol homeostasis, and its role in AD 
pathology, neurodegeneration and atherosclerosis.  
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GENERAL HYPOTHESIS AND RESEARCH QUESTIONS  
 
This dissertation sought to investigate the general hypothesis that disturbed 
cholesterol homeostasis may lead to chromosome mis-segregation in vitro 
and in vivo and therefore contribute to genomic instability observed in AD 
and CVD.  Under this hypothesis, three specific research questions were 
examined (Figure 7):  
(1) Do elevated lipoproteins (i.e., oxidized low density lipoprotein [OX-
LDL], low density [LDL], and high density lipoprotein [HDL]) and 
cholesterol induce chromosome mis-segregation and aneuploidy through 
LDL receptor or APP-mediated pathways, and whether there is an 
association between altered intracellular cholesterol distribution and 
mitotic defects in vitro?  
(2) Does peripheral hypercholesterolemia in nontransgenic mice fed a 
high cholesterol diet affect chromosomal integrity in visceral and brain 
cells?  
(3) Is there a mechanistic link between calcium homeostasis (Mechanism 
I) and membrane dynamics (i.e., fluidity) (Mechanism II) and 
lipoproteins/cholesterol-induced cell cycle defects in vitro?  
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Figure 7. Research Questions under the General Hypothesis 
Disturbed cholesterol homeostasis may lead to chromosome mis-segregation and aneuploidy in vitro and in 
vivo, and this biological effect may initiate or contribute to AD pathogenesis similar to the development of 
cell cycle defects observed in cellular, mouse models of AD and patients with dementia (path 1).  Under the 
general hypothesis, this dissertation investigated following research questions (path 1 and 2): Do elevated 
lipids (in vitro and in vivo) and modifications in intracellular cholesterol lead to aneugenesis, and is this 
biological process LDLR-mediated or independent of cholesterol-APP/Aβ interaction (referenced above); Is 
there a mechanistic link between calcium homeostasis or plasma membrane dynamics and lipids-induced 
mitotic defects? 
 
CHOLESTEROL HOMEOSTASIS AND AD  
 
Since its isolation from gallstones in late 18th century, cholesterol’s biosynthesis, 
molecular structure and metabolism as well as its role in pathogenesis of 
cardiovascular, brain and several genetic diseases has been extensively 
investigated.  Cholesterol is a molecule essential for life, yet excess or deficiency 
and erroneous compartmentalization of cholesterol within the cells and body 
organs can be detrimental.  For instance, cholesterol is a main component of 
eukaryotic cell membranes (Bloch, 1991) where it regulates membrane fluidity, 
permeability and integrity, affects functioning of membrane-bound or membrane-
associated proteins, and facilitates transmembrane signal transduction (reviewed 
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in Maxfield and Tabas, 2005).  In the brain, among other functions, cholesterol is 
required for neurite formation, synaptogenesis, microtubule stability, and 
myelination of axons (Björkhem and Meaney, 2004; Koudinov and Koudinova, 
2001; Pfrieger, 2003).  Excess of cholesterol and otherwise disturbed cholesterol 
homeostasis has been implicated in the pathogenesis of several vascular, 
metabolic, hepatic and brain disorders.   
 A renewed interest in the role of high blood cholesterol and CVD in 
etiology of AD was spurred by several important discoveries, the main being the 
identification of ApoE as key cholesterol transporter in the brain (e.g., Brown and 
Goldstein, 1986), and the APOE ε4 allele as the strongest risk factor for sporadic 
AD (e.g., Strittmatter et al., 1993a).  Additionally, two groundbreaking studies by 
Sparks and colleagues reported abundant amyloid plaque deposits in 75% of the 
brains of cognitively intact older adults who died from coronary artery disease 
(CAD) compared to 12% of control brains of individuals with a healthy heart 
(Sparks et al., 1990), and an increase in Aβ immunoreactivity in the brains of 
rabbits fed a high cholesterol diet (Sparks et al., 1994).  A decreased prevalence 
of AD was also shown in older adults using statins (Wolozin et al., 2000), and 
reduced Aβ42 and Aβ40 production in neuronal culture and in a guinea pig 
model treated with lovastatin and simvastatin (Fassbender et al., 2001).  Despite 
the sound criticisms of the Amyloid Cascade Hypothesis which emphasized the 
inability to demonstrate causality (Neve and Robakis, 1998; Joseph et al., 2001), 
and provide effective treatments (de la Torre, 2004), a body of research that 
followed concentrated on the relationship between peripheral and central 
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cholesterol homeostasis and APP processing/Aβ production, and the 
involvement of the genes associated with cholesterol metabolism in susceptibility 
to AD (reviewed in Sagin and Sozmen, 2008).  In parallel, increasing evidence 
supporting a vascular etiology in AD (de la Torre, 2004) suggested the 
involvement of other APP-independent pathways in disease initiation and 
progression.  However, the complete understanding of biological mechanism in 
which combined influence of plasma cholesterol, related lipoproteins, protein 
carriers (e.g., ApoE), brain hypoperfusion, cerebrovascular Aβ and the brain 
cholesterol homeostasis contribute to neuropathology and cognitive dysfunction 
is yet to be attained.  
 
Cholesterol Metabolism, Function and Organization 
 
Cholesterol homeostasis is a tightly regulated process that involves cholesterol 
synthesis, transport, storage and removal.  In periphery, cholesterol originates 
from two sources: de novo synthesis in the liver and intestine and from diet.  The 
liver releases cholesterol into the circulation mainly in esterified form (i.e., 
cholesteryl esters) bound to ApoB, within LDL which is then taken up by 
peripheral cells via receptor-mediated (e.g., LDL receptor family) endocytosis.  In 
endosomal and lysosomal compartments, internalized cholesterol is rapidly freed 
from the lipoprotein particles and recycled back to the plasma membrane through 
either the endoplasmic reticulum (ER) or Golgi network (reviewed in Maxfield and 
van Meer, 2010; Soccio and Breslow, 2004).  The studies of Niemann-Pick  
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disease type C (NPC), which is characterized by abnormal accumulation of 
cholesterol and other lipids in late endosomes and lysosomes have shown that 
two proteins, the NPC1 and NPC2 are responsible for cholesterol egress from 
these organelles to the ER (Karten et al., 2009; Mukherjee and Maxfield, 1999; 
2004).  Deletion or mutations in either of these two non-homologous genes leads 
to altered trafficking of endogenous or LDL-derived cholesterol and its 
sequestration into cytoplasmic organelles.  Because of the delayed movement of 
internalized LDL-cholesterol to the ER and back to plasma membrane, the 
production of the endogenous cholesterol and LDL receptor is increased 
(Wojtanik and Liscum, 2003).   
The ER is the major regulatory site of cellular cholesterol homeostasis.  
Cholesterol biosynthesis requires more than 20 steps for which the key enzymes 
are localized in the ER, including the 3-hydroxy-3-methylglutaryl-CoA (HMG-
CoA) reductase, a rate-limiting enzyme and target of statins.  An elaborate sterol-
sensing mechanism (e.g., SREBP, the sterol regulated element binding protein 
and SCRAP, SREBP-cleavage activating protein; and INSIG) controls the 
cholesterol synthesis and expression of lipoprotein receptors (e.g., LDLR) based 
on the change in intracellular cholesterol levels.  The surplus of cholesterol is 
esterified in the ER by the Acyl-CoA acyltransferase (ACAT) and deposited in the 
cytoplasm as lipid droplets or transported via nonvesicular pathways from the ER 
to the plasma membrane through the ATP-binding cassette transporter family 
(ABC) located at the membrane surface.  Cholesterol efflux from the intra- to 
extracellular pools is achieved via HDL that serves as extracellular cholesterol 
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acceptor (with ApoA-I as a major apoprotein) taking cholesterol back to liver, 
where it is excreted in the form of bile salts.  Furthermore, unesterified 
cholesterol can be converted into oxysterols by cholesterol-metabolizing 
enzymes localized in the ER such as cholesterol 7α-hydroxylase (CYP7A) and 
cholesterol 24-hydroxylase (CYP46) and excreted from the cell via the ABC-
transporters.  Oxysterols also serve as ligands for the liver X receptor (LXR) 
which in turn regulates the genes for APOE and ABC (reviewed in Huttunen and 
Kovacs, 2007; summarized in Figure 8).   
 
 
Figure 8. Elements of Cholesterol Homeostasis  
Cholesterol homeostasis which includes cholesterol influx from the periphery, synthesis in the ER, storage 
(esterification), trafficking to the plasma membrane and efflux (hydroxylation and export to extracellular 
acceptors) is a tightly regulated process not fully explained.  Several key proteins associated with the 
endoplasmic reticulum regulate intracellular cholesterol levels.  Plasma membrane is enriched with 
cholesterol compartmentalized into lipid rafts, where APP and amyloidogenic APP-processing enzymes, β-
and γ-secretases reside.  Schematic diagram was adapted from Martins, et al. (2006), Mol. Psychiatry. 
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Thus, the ER as the central cholesterol sensing site regulates cholesterol 
synthesis, esterification into lipid bodies, trafficking to intracellular and plasma 
membranes and catabolism into oxysterols for excretion. 
 Cholesterol distribution between the organelles and intracellular 
membranes is heterogeneous, the highest being in the plasma membrane (~40% 
of lipid molecules; Maxfield and Wustner, 2002)—mostly packed into lipid raft 
microdomains (Brown and London, 2000; Crane and Tamm, 2004; Simons and 
Toomre, 2000), and the lowest in the ER (~1% of total cell cholesterol; Lange, 
1991).  Endocytic organelles and Golgi complex are also enriched in cholesterol 
(Hao et al., 2002), but how this asymmetric compartmentalization is achieved, 
and the mechanisms of cholesterol transport and movement within the cells is 
not completely revealed (reviewed in Ikonen, 2008; Prinz, 2007).  It is widely 
accepted that cholesterol content and organization within the membrane affects 
many cellular functions such as signal transduction and membrane trafficking 
(Maxfield and Tabas, 2005).  Cholesterol interacts with other membrane lipids 
and proteins, and because of its biophysical properties (e.g., rigid ring structure), 
it preferentially associates with hydrocarbon chains of saturated lipids causing 
increased lateral ordering and decreased membrane fluidity (Demel and De 
Kruyff, 1976; Mukherjee and Maxfield, 2004; Simons and Vaz, 2004).  According 
to the ‘fluid mosaic model’ of the plasma membrane, membrane lipids and 
proteins are organized into bilayer leaflets (Ikonen, 2008) in either highly-ordered 
(gel-like), liquid-ordered, or liquid-disordered (the most fluid) phases, which often 
coexist with different types of microdomains.  For example, the disordered lipid 
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phases are characterized by poorly-organized and loosely-packed acyl chains, 
which allow for easy diffusion of water and other molecules into the bilayer 
structure (Mukherjee and Maxfield, 2004; Simons and Vaz, 2004), and is usually 
cholesterol poor.  Cholesterol-rich plasma membrane, on the other hand, is 
consistent with the ordered lipid phase—because of its rigid ring structure, 
cholesterol has the ability to increase the order of more fluid membranes.  The 
lipid microdomains (e.g., lipid rafts) are involved in signal transduction and 
segregation of the membrane-anchored proteins based on their preference for 
different types of lipid ordering.   
Cholesterol, as an important regulator of plasma membrane organization, 
can be manipulated in culture, and the effect of changed biophysical membrane 
properties on proteins and other cellular functions can be readily studied.  In 
mammals, dietary intake of cholesterol and saturated/unsaturated fats are 
significant factors affecting membrane organization and therefore cell functioning 
(e.g., Aoun et al., 2011; McMurray et al., 2011; Raza, 2010; Wang and Schreurs, 
2010; Wassall and Stillwell, 2009). 
 In summary, intracellular cholesterol distribution and organization between 
different organelles and membranes in eukaryotic cells is heterogeneous in 
nature and characterized by differential lipid ordering which, if changed, may 
affect the functioning of various proteins and lead to a diseased state.  The 
mechanism by which cells maintain these differences, and keep in check the 
sterol sensing response over a narrow range of cholesterol concentration, and 
readily transport and distribute intracellular cholesterol is only partly understood.     
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Brain Cholesterol Homeostasis and AD Pathology 
 
Cholesterol is essential for normal brain development and function, including 
formation of synapses and synaptic plasticity, neurotransmission, signaling 
transduction, membrane biosynthesis and repair (Göritz et al., 2002; Koudinov 
and Koudinova, 2001; Pfrieger, 2003).  Brain cholesterol homeostasis is a 
complex, strictly regulated process not fully explained (Pfrieger and Ungerer, 
2011).  As in the periphery, this process includes cholesterol synthesis, shuttling, 
storage and turnover, which are mostly independent of hepatic cholesterol pools, 
and protected by the BBB (Björkhem and Meaney, 2004).  The tight junctions 
between cerebral endothelial cells that form the barrier prevent the brain to 
compete for cholesterol from circulation (Ballabh et al., 2004).  Alternations in 
cholesterol/lipoprotein metabolism and brain cholesterol homeostasis have been 
linked to several pathologic processes that, for example, lead to production of 
neurotoxic proteins and changes in plasma membrane integrity (reviewed in Liu 
et al., 2010).  To understand the complexity of the role that cholesterol may play 
in neurodegenerative diseases, one has to appreciate the unique aspects of 
brain cholesterol homeostasis, the proteins and transporters involved in its 
maintenance, and intermediary steps and enzymes interacting between 
peripheral and central cholesterol pools. 
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Figure 9. Brain Cholesterol Homeostasis 
Brain cholesterol homeostasis is accomplished by a tight cooperation between the two main cell types of 
CNS, astrocytes (left) and neurons (right).  Astrocytes provide mature neurons with cholesterol, which is 
synthetized in the ER from sterols and transported to Golgi apparatus and lipid rafts in the plasma 
membrane (PM).  Cholesterol with ApoE is exported to neurons via the ABC transporter family, internalized 
via receptor-mediated endocytosis (e.g., LDLR), and further shuttled through the endosomes, lysosomes 
and ER to the PM.  The excess cholesterol is converted by 24-hydrocylase (CYP46) to 24-
hydroxycholesterol (24-OH-Chol) which crosses the BBB.    
 
The brain is the most cholesterol-rich organ in the human body: it contains 25% 
of the total body cholesterol, but accounts only for 2% of total body weight 
(Dietschy and Turley, 2004).  Intracellular cholesterol is present mainly in the 
myelin sheaths and cell membranes (e.g., lipid rafts), where it is essential for 
membrane fluidity and elasticity, synaptogenesis, signal transmission, and 
functioning of membrane-associated proteins (Pfrieger, 2003).  Brain cholesterol 
is synthesized de novo by neurons, astrocytes, and oligodendrocytes, 
independently of peripheral production.  While oligodendrocytes supply 
cholesterol for myelin formation, it is believed that astrocytes, the major neuronal  
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supporting cells, produce cholesterol required to sustain the integrity of neuronal 
membranes and synapse (Björkhem and Meaney, 2004; Pfrieger and Ungerer, 
2011).  As the neurons mature, they reduce production of endogenous 
cholesterol and become dependent on effective cholesterol synthesis and 
transport from adjacent cells, primarily astrocytes (Figure 9; Liu et al., 2010).  
Slowed rate of cholesterol biosynthesis in adult neurons may reflect the overall 
reduced requirement for surplus cholesterol in the brain after maturation, and the 
need for optimal energy efficiency.  Furthermore, astrocytes not only synthesize, 
but also recycle extracellular cholesterol released from dying neurons (Jurevics 
and Morell, 1995). 
Cholesterol exchange and uptake between the brain cells is a multifaceted 
process not fully elucidated (reviewed in Liu et al., 2010; Pfrieger and Ungerer, 
2011).  As in peripheral cells, several key acceptors, receptors, transporters and 
enzymes involved in regulation of the brain cholesterol homeostasis have been 
recognized.  For example, both ApoE (the main carrier protein) and lipoprotein 
receptors are essential for cholesterol transport and clearance within the brain.  
The ATP-binding cassette transporter (ABCA1) is responsible for cholesterol flux 
from neurons to glia, preventing accumulation of excess cholesterol inside the 
cells (Dietschy and Turley, 2004).  The neurons also internalize cholesterol in 
several intercellular compartments (e.g., endosomes, lysosomes, and Golgi 
apparatus), where it is released from its lipoprotein complex in the form of free 
cholesterol, or transformed into cholesterol esters for storage.  Free intracellular 
cholesterol serves as a negative feedback loop to HMGR to reduce cholesterol 
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synthesis in the ER, while cholesterol esters have a role in dendritic and synaptic 
remodeling (Pfrieger, 2003; Poirier, 2003).  Because the brain has no mechanism 
for cholesterol degradation, excess cholesterol is transformed into 24S-
hydroxycholesterol (24OH) by oxidation (encoded by CYP46 gene), a brain-
specific lipophilic cholesterol metabolite that passes through the plasma 
membranes and crosses the BBB (Björkhem et al, 1998).  Another oxysterol, 27-
hydroxycholesterol (27OH) is produced in the periphery, and enters the brain at 
an estimated rate of 1% a day.  The exchange between the two oxysterols 
across the intact BBB has been proposed as a missing link between cerebral and 
plasma cholesterol pools, suggesting that the brain cholesterol homeostasis is 
not entirely independent of the periphery (Dietschy and Turley, 2004).  Moreover, 
vascular insults compromise the integrity of the BBB causing an increase in 
exchange of oxysterols between the brain and circulation (Xie et al., 2003).  
Any disturbance in the brain cholesterol homeostasis due to, for example, 
presence of interfering molecules such as Aβ; and diminished efficiency of 
transporting proteins (e.g., ApoE); or compromised BBB and injury to the 
neurovascular unit could contribute to neurodegeneration.  
Differential distribution of cholesterol in the cell membranes and 
intracellular cell compartments makes the analysis of total cholesterol in aged 
and diseased brain technically challenging.  Studies involving aged mouse and 
human brains have shown an increase of cholesterol in the membranes 
(Igbavboa et al, 1996; Schroeder, 1984) and decreased synthesis in 
hippocampus but stable levels of total cholesterol (Thelen et al., 2006).  
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However, there is a little consensus about the change in bulk brain cholesterol in 
AD (Panza et al., 2006).  Some studies reported reduced levels of cholesterol in 
the brain areas with extensive Aβ and tau pathology, especially in the patients 
with APOE ε4 allele (Wood et al., 2002), but increased cholesterol flux in early 
stages of AD (Dietschy and Turley, 2004).  Distribution of the membrane 
cholesterol changes with the progression of disease severity—the levels of 
cholesterol within the cell membrane increase, altering membrane fluidity.  
Higher membrane cholesterol content is associated with the increased Aβ-
induced toxicity both in neurons and astrocytes (Abramov et al, 2011).  Also, 
excess cholesterol accumulates in the form of ester droplets within senile 
plaques (Gómez-Ramos and Asunción Morán, 2007; Mori et al., 2001; Panchal 
et al, 2010) and in Aβ-positive neuronal terminals (Gylys et al., 2007), whereas 
tangle-bearing neurons in AD brains contain more free cholesterol compared to 
phospho-tau free cells (Distl et al., 2001).  These findings fit with the hypothesis 
that change in intracellular cholesterol and not in total cholesterol may be the 
major force behind AD progression that alters APP processing and Aβ dynamics 
(Eckert et al., 2000).  
Another measure of cholesterol turnover and neurodegeneration in AD 
may be the disruption in oxysterol homeostasis.  Several studies reported a 
change in oxysterol levels during disease progression.  At early stages of the 
disease, the amount of 24OH cholesterol increases in the brain and periphery, 
suggesting increased cholesterol turnover from destroyed synapses and dying 
neurons (e.g., Papassotiropoulos et al., 2002; Lütjohann et al., 2000).  In the later 
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stages, concentrations of 24OH fall, indicating lower brain cholesterol 
metabolism and the loss of neurons expressing CYP46 gene proportionally to the 
degree of brain atrophy.  The ratio between brain and circulatory oxysterols has 
been suggested as a biochemical biomarker for AD progression (Leoni et al., 
2004; Leoni and Caccia, 2011).  
Supposedly a bidirectional relationship between cholesterol and Aβ has 
been observed in cellular and animal studies that manipulated the levels of 
cholesterol by depletion or synthesis inhibition, or by dietary interventions.  At 
least a part of cell’s APP and APP-cleaving enzymes that generate 
amyloidogenic Aβ peptide, the β- and γ-secretases are localized in lipid rafts 
(Chen et al., 2006; Wahrle et al., 2002), whereas the non-amyloidogenic α-
secretase activity favors more fluid, non-lipid raft environment (Kojro et al., 2001; 
reviewed in Wolozin, 2004).  Alternations of the membrane lipid content may 
therefore shift the activity of the key enzymes involved in APP processing from 
harmful (Ehehalt et al., 2003; Xiong et al., 2008) to neuroprotective (Bodovitz and 
Klein, 1996; Kojro et al., 2001).  For example, cholesterol depletion/inhibition with 
different drugs (e.g., statins, cyclodextrins) reduced Aβ production and cellular 
amyloid load in cultured neurons and in brains of treated animals (e.g., Burns et 
al., 2006; Fassbender, et al., 2001; Refolo et al., 2001; Schneider et al., 2006; 
Simons et al., 1998), whereas increased membrane cholesterol in mature 
neurons led to Aβ-induced calpain (a calcium-dependent cysteine protease) 
activation and generation of neurotoxic tau fragments (Nicholson and Ferreira, 
2009; reviewed in Wray and Noble, 2009).  Small rodents, especially FAD 
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transgenic mice fed a high cholesterol diet increased production Aβ and develop 
greater amyloid burden (e.g., Hooijmans et al., 2007; Levin-Allerhand et al., 
2002; Oksman et al., 2006; Refolo et al., 2001; Shie et al., 2002; Sparks et al., 
1994) compared to animals on regular diet.   
It could be postulated that an altered ratio between the more 
amyloidogenic Aβ42 and less harmful Aβ40 affects membrane lipid content, and, 
in turn, membrane fluidity could affect activity of the enzymes involved in the 
amyloidogenic pathway, causing a vicious circle.  The data suggest that 
intracellular and not total cholesterol regulates APP processing and Aβ 
production (Burns et al, 2006), but the interconnection between all proteins 
involved in APP proteolysis and cholesterol homeostasis is not fully elucidated.  
Similarly, the mechanism linking the increase in extracerebral cholesterol content 
and intracerebral Aβ load is not completely clear, but it points to disrupted 
oxysterol homeostasis, vascular insults and compromised BBB (reviewed in 
Martins et al., 2006).   
In summary, disturbance in cholesterol homeostasis and specific changes 
in cholesterol distribution in plasma membrane may be involved in AD 
pathogenesis by: (1) overproduction of toxic Aβ that affects membrane 
properties; (2) altered plasma membrane fluidity and elasticity due to improper 
cholesterol trafficking or/and receptor mediated uptake; (3) increased calcium 
influx and calpain activity leading to generation of neurotoxic tau species; (4) 
change in cholesterol flux and recycling; and (5) inability to maintain cholesterol 
steady-state levels for synaptogenesis and repair. The research on cholesterol 
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involvement in neurodegenerative diseases and the role it plays in health of 
central nervous system is fairly new with a plethora of ‘brain secrets’ to be 
discovered. 
Hypercholesterolemia and AD Risk 
 
A positive association between high blood cholesterol and dementia has been 
reported in some but not all epidemiological studies (Panza et al., 2009).  The 
studies differed depending on: (1) the ‘time period at exposure’ (late vs. mid-life 
blood cholesterol); (2) the length of follow up; (3) number of cholesterol 
measurements; (4) dementia ascertainment method; (5) availability of ApoE ε4 
genotype; (6) choice of covariates; and (7) population under study.  All of the 
above may bias the results and account for inconsistencies.  Dementia has a 
long latency period and the concepts of time at exposure and follow up period 
may be of essence to detect a true relationship between exposure and disease. 
Proponents of a ‘life-course perspective’ seek to understand at which stage of life 
an exposure (total cholesterol) might have the most effect on the outcome 
(cognitive impairment), and if the effect of exposure is additive or synergistic 
(Fratiglioni et al., 2010).   
For example, some of the recent prospective studies reported positive, 
negative or no association between blood cholesterol and AD and/or vascular 
dementia (VaD).  The Seven Countries Study of 10,211 men and 40 years follow- 
up reported a positive association between total cholesterol (TC) and dementia  
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mortality (HR = 1.73, [95% CI 1.05-2.84]) in individuals with >250 mg/dl of blood 
cholesterol compared to men with <200 mg/dl (Alonso et al., 2009).  In the 
Honolulu Asia Aging Study of 1027 men, the serum TC declined significantly 15 
years before AD diagnosis, the strongest in those with ApoE ε4 allele (Stewart et 
al., 2007).  A recent meta-analysis of 12 prospective studies of AD and VaD 
(Anstey et al., 2008) that included about 23,800 subjects over, on average, 13 
years of follow-up revealed no association between late-life TC, LDL or HDL  and 
any type of dementia, but positive association between mid-life TC and AD and 
VaD which was not dependent on ApoE genotype.  Similarly, in the Kaiser 
Permanente Study with 21 years of follow-up, Solomon et al.  (2009) reported a 
positive association between high mid-life TC (>240 mg/dl) and AD and VaD (HR 
= 1.57, [95% CI 1.23-2.01; and HR = 1.26, [95% CI 0.82-1.9], respectively).   
Current research suggests that cholesterol and the risk of dementia may 
have a nonlinear association with age; at mid-life, high blood cholesterol may 
pose a risk for cognitive decline 30-40 years later, while higher cholesterol levels 
may be protective later in life (Duron and Hanon, 2008; Panza et al., 2006).  
Protective effects of higher cholesterol on cognition may be due to cholesterol 
involvement in neuronal plasticity (Koudinov and Koudinova, 2001), while the 
decrease in cholesterol from mid to late life may result from pathological process 
associated with neurodegeneration (Solomon et al., 2007). 
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The Role of Atherosclerosis in AD 
 
As mentioned previously, a number of epidemiological and pathological studies 
provided evidence for a pronounced vascular pathology in AD, and the 
importance of vascular risk factors and CVD in AD development (reviewed in de 
la Torre, 2004; 2010).  Autopsy studies revealed that white matter lesions, 
ischemic infarcts, lacunes, microvessel hemorrhages, CAA and atherosclerotic 
plaques as the most frequent types of vascular pathology in AD (Honig et al., 
2005; Jellinger, 2008), that contribute to steeper cognitive decline especially in 
the early stages of the disease (Esiri et al., 1999).  For instance, a comparative 
pathological study showed a higher incidence of vascular lesions in 48% of AD 
patients compared to 32.8% age-matched controls (Jellinger and Mitter-Ferstl, 
2003), whereas in the autopsy study of elderly Japanese-American males, these 
lesions were as common as classic AD markers (White et al., 2002).  
A number of epidemiological and autopsy studies provided important, yet 
inconsistent evidence regarding the etiologic role of systemic and central 
atherosclerosis in AD onset and development.  In a cross-sectional study, 
Hofman et al. (1997) showed that indicators of atherosclerosis in carotid arteries 
and large vessels of the legs were associated with an increased risk of AD and 
VaD especially in ApoE ε4 carriers (OR = 3.9 [95% CI 1.6-9.6], and OR = 19.8 
[95% CI 4.1-95.0], respectively).  In a recent autopsy study, atherosclerosis of 
coronary arteries associated strongly with the density of neuropathological 
lesions of AD in older adults with at least one ApoE ε4 allele (Beeri et al., 2006).  
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No association between coronary atherosclerosis and VaD was found.  In a large 
prospective study of 6,647 participants, two noninvasive measures of carotid 
atherosclerosis (i.e., the intima media thickness and carotid plaques) were 
associated with AD regardless of ApoE genotype (HR = 2.4 [95% CI 1.25-4.60], 
and HR = 2.53 [95% CI 1.21-5.32], respectively) after controlling for vascular 
covariates (van Oijen et al., 2007).  The Baltimore Longitudinal Study of Aging 
(BLSA) utilized a series of 200 brain and 175 full body autopsies from 
prospectively followed participants to examine the relationship between systemic 
and central atherosclerosis, AD pathology and the risk of dementia (Dolan et al., 
2010).  The results indicated that the presence of intracranial but not cardiac or 
aortic atherosclerosis significantly increased the odds for dementia (OR = 2.0 
[95% CI 1.4-2.9] per unit increase in atherosclerotic grade), independently of AD 
pathology and cerebral infarcts.  Quantitative analysis of atherosclerosis in 
systemic and central vessels showed no association between the degree of 
atherosclerotic burden and AD pathology, suggesting that there is an additional 
association between intracranial atherosclerosis and dementia that is not related 
to cerebral infarcts and AD lesions.  Furthermore, recent retrospective 
histopathological studies confirmed the association between the intracranial 
atherosclerosis in the circle of Willis of AD subjects compared to age-matched 
controls, and a strong correlation between the density of senile plaques and 
NFTs and the degree of the atherosclerotic narrowing independently of 
possession of ε4 allele (Beach et al., 2007; Honig et al., 2005; Roher et al., 
2003).  For example, in a study of 397 older adults with confirmed 
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neuropathological diagnoses, Beach et al. (2007) showed that the circle of Willis 
atherosclerosis score was a significant predictor of AD (OR = 1.31 [95% CI: 1.04-
1.69]) and VaD (OR = 2.50 [95% CI: 1.52-4.10]) but not for non-AD dementia for 
each unit of increase in atherosclerotic grade, independently of the ApoE ε4 
genotype.   
In line with the aforementioned evidence, several hypotheses have been 
proposed to explain the relationship between AD and CVD: (1) atherosclerosis 
may exacerbate AD pathogenesis and act synergistically with 
neurodegeneration; (2) atherosclerosis may present a parallel pathology that 
adds to cognitive burden independently of classic AD markers and susceptibility 
genes (e.g., ApoE ε4); and (3) both diseases may share a common biological 
mechanism linking the two pathologies (e.g., cell-cycle defects).  While larger 
scale prospective and autopsy studies are needed to address the validity of 
association between systemic and central atherosclerosis and AD risk, the 
proponents of the Vascular Hypothesis argue that scientific evidence supporting 
vascular origins of AD outweighs that supporting the Amyloid Hypothesis (de la 
Torre, 2004; Casserly and Topol, 2004).   
Thus, atherosclerosis and AD may be independent but converging 
diseases that share several common genetic and environmental risk factors (i.e., 
ApoE ε4 polymorphism, hypercholesterolemia, hypertension, diabetes, systemic 
inflammation, obesity, smoking, and high fat diet) [Casserly and Toppol, 2004].  A 
better understanding of one disease could aid in providing better therapies and 
prevention strategies for the other.  Because most of the vascular risk factors are 
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preventable, skillful and timely prevention and/or treatment of vascular disease 
preferably at middle age could help preserve both cardiovascular and cognitive 
health (de la Torre, 2004; 2010).  For instance, several non-invasive techniques 
have been developed to detect systemic vascular pathology such as the 
narrowing of carotid artery (e.g., carotid artery ultrasound [CAUS]) caused by 
intima-media thickness [C-IMT]; the velocity and direction of the blood flow from 
the heart to brain [e.g., pulse-wave Doppler scanning]; changes in the structure 
and function of the heart muscle [e.g., echocardiography]; and the extent of 
peripheral arterial disease (e.g., ankle-brachial index [ABI]).  All the above may 
be valuable screening tools that could aid in designing strategies to prevent 
ongoing or future cognitive decline (de la Torre, 2010).  Similarly, CVD-related 
clinical trials could routinely include measures of cognitive function to investigate 
the therapeutic potentials of anti-inflammatory, anti-angiogenic, and anti-
hypercholesterolemic agents on dementia development.  In sum, additional 
epidemiological and clinical studies looking at the benefits of either lifestyle 
changes or therapies for CVD (e.g., atherosclerosis) at middle age would provide 
valuable insights for prevention strategies aimed to stall cognitive decline later in 
life. 
 
CONCLUSIONS: DISRUPTED CHOLESTEROL HOMEOSTASIS AND AD 
 
Taken together, the cellular, animal and epidemiological studies referenced 
above implicate cholesterol as an important component of neurodegenerative  
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process in AD.  While hypercholesterolemia may contribute to AD pathology via 
systemic and cerebral atherosclerosis by causing diminished cerebral perfusion 
and neuronal energy crisis, other mechanisms may also take place.  First, altered 
cholesterol homeostasis within the brain and plasma membrane may promote Aβ 
production and increase both amyloid and tau-related pathologies.  Second, 
similar to atherogenesis in peripheral vessels, high cholesterol may disrupt 
communication between neurons and vascular cells within the neurovascular unit 
resulting in increased inflammation, impaired cerebral Aβ clearance and 
consequent CAA within vessel walls, endothelial injury and compromised BBB 
(e.g., Farks and Luiten, 2001; Bell and Zlokovic, 2009).  Third, a unique 
cytogenetic mechanism may underlie both AD and atherosclerosis contributing to 
pathogenesis—disrupted cholesterol homeostasis may interfere with the 
cytogenetic properties of mitotic cells (peripheral and central) by affecting the 
process of proper chromosome segregation.   
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          CHAPTER THREE 
EXPERIMENTAL PROCEDURES 
 
To assess the effect of lipoproteins and cholesterol on chromosome segregation 
in vitro and in vivo, this study utilized various human cell lines and primary cells 
derived from human and mouse peripheral tissues and brains, dietary 
intervention on wild-type mice, and karyotype and fluorescence in situ 
hybridization (FISH) analyses as the main methods for the quantification of 
chromosomal aberrations in a single cell.  This chapter describes in detail the cell 
lines, cell sources, reagents, experimental procedures, and data acquisition and 
analysis used to address the research questions under the general hypothesis 
(Figure 7).  
 
CELL LINES  
 
hTERT-HME1 Cell Line  
 
The hTERT-HME1 cell line (Clontech) is a primary human mammary epithelial 
cell line that permanently expresses the telomerase reverse transcriptase 
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(Clontech).  Stable expression of this enzyme preserves telomere length and 
allows the cells to divide indefinitely while retaining normal function, phenotype,  
and karyotype (Jiang et al., 1999; Morales et al., 1999).  The cell line was 
cultured in the mammary epithelium basal medium (MEBM, Lonza) 
supplemented with 52 µg/ml bovine pituitary extract (BPE), 0.5 µg/ml 
hydrocortisone, 10 ng/ml hEGF, 5 µg/ml insulin, 50 µg/ml gentamicine, and 50 
µg/ml amphotericine-B, and subcultured every 2-3 days. The cells were 
maintained for no more than 6 population doublings (PD) from the PDinitial.  
 
HASM Cell Line  
 
The Human Primary Aortic Smooth Muscle Cells (HASMC) (ScienCell Research 
Laboratories) were isolated from the human aorta and cryopreserved at 
secondary culture at the density > 5 x 104 cells per vial.  The cells were 
maintained in smooth muscle cell medium (SMCM; ScienCell Research 
Laboratories) consisting of 500 ml basal media, 2% fetal bovine serum (FBS), 5 
ml smooth muscle cell supplement, and 5 ml 1x penicillin/streptomycin (PS; 
5,000 I.U/ml each; Cellgro) solution according to manufacturer’s specifications.  
The cells were propagated when they were 90% confluent in 2 µg/ml poly-L- 
lysine (Sigma)-coated cell culture dishes, and the growth media was changed 
every other day. 
 
73 
 
Human Fibroblasts 
 
LDL receptor-deficient human skin fibroblasts harboring two mutations, C240-F 
and Y160-ter, that cause a severe form of familial hypercholesterolemia (FH), 
and human fibroblasts with a functional LDL receptor from an unaffected age and 
race matched donor were purchased from Coriell Cell Repositories.  Both cell 
lines were cultured following  company’s protocol  in Minimum Essential Medium 
(MEM; with Eagle-Earle salts and non-essential AA) (Gibco/Invitogen) 
supplemented with 2 mM L-glutamine (Gibco), 5 ml MEM essential AA 50x 
(Gibco), 2.5 ml MEM Vitamins 100x (Gibco) and 15% heat inactivated FBS 
(Cellgro).  
Four different human fibroblasts harboring a Niemann-Pick C1 (NPC1) 
mutation (Coriell, NIGMS Human Genetic Cell Repository) and four age-matched 
controls (Coriell, NIA Aging Cell Culture Repository) (Table 1) were maintained in  
Dulbecco’s modified MEM (with 2 mM L-glutamine; Gibco/Invitrogen), 
supplemented with 15% FBS (Atlanta Biological), and 5 ml of 1x PS solution 
(5,000 I.U/ml each; Cellgro).  All fibroblasts and HASMC were grown in 37˚C, 5% 
CO2 incubator and subcultured every 3-5 days. 
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Table 1. Characteristics of the Niemann-Pick Type C (NPC) and Control Samples 
 
NK = not known. Human fibroblasts were purchased from Corielle and brains from NICHD Brain and Tissue 
Bank for Developmental Disorders. Independent t-test revealed no age difference between NPC and control 
brain donors (data not shown).  
 
PRIMARY CELLS 
 
Generation and Maintenance of mNPC 
 
Neurosphere cultures containing mouse neuronal precursor cells, mNPC) were 
established from non-transgenic prenatal brains (E17-E18) following a modified 
protocol by Pacey et al. (2006) and maintained according to the procedure 
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developed by Marchenko and Flanagan (2007).  Specifically, timed-pregnant 
C57BL/6J mice (Jackson Labs) were anesthetized with sodium pentobarbital (50 
mg/kg) by intraperitoneal (i.p.) injection and the fetuses retrieved through the 
transabdominal incision.  Six to eight pups were removed from the amniotic sack, 
decapitated with a sterile blade and their brains cleaned of skulls, meningeal 
tissue and cerebella and pooled into a 60 mm culture dish in cold 1x PBS 
(Cellgro).  The remaining cortical tissues were enzymatically and mechanically 
processed to obtain a single-cell suspension and grown in the presence of 
mitogens (i.e., growth factors).  First, the cortices were minced and incubated in 
5 ml of pre-warmed 0.25% trypsin (Gibco/Invitrogen) for 4 min at room 
temperature followed by a gentle trituration with a fire polished Pasteur pipette.  
After a centrifugation at 1500 rpm for 5 min, the majority of the trypsin was 
removed with the supernatant and the rest neutralized in 5 ml of Trypsin 
Neutralization Buffer (Lonza) for 4 min at 37˚C.  The tissue aggregates were 
triturated with a fire-polished pipette for at least 10 times.  Following the second 
centrifugation (1500 rpm for 5 min), the cell pellet was further resuspended and 
triturated in 1 ml of mouse neural precursor cell media (mNPC media, described 
below) (Schwartz et al., 2003; Marchenko and Flanagan, 2007) with fire polished 
pipettes of two different pore sizes (each 60-70 times) to yield a single-cell 
suspension.  Lastly, after the viability and the cell concentration was established 
by Trypan Blue (Invitrogen) dye exclusion, the cells were plated in 24 multi-well 
tissue culture plates (Falcon) at a density of 50-100 cells/µl (Pacey et al., 2006) 
in 0.5 ml of mNPC media and grown in 37˚C, 5% CO2 incubator.  The mNPC 
76 
 
media consisted of DMEM:F12 growth media (Gibco) supplemented with 20% 
BIT-9500 (5x) serum substrate (Stem Cell Technologies), 1x PS (Cellgro), and 
the following growth factors at the concentration of 40 ng/ml: human epithelial 
growth factor (EGF), fibroblast growth factor (FGF)-basic, and platelet-derived 
growth factor (PDGF-AB) (PeproTech).  
After 5-7 days, developed neurosphere clones were dissociated in 2 ml of 
Cell Dissociation Buffer (Invitrogen) for 5 min at 37˚C, centrifuged, resuspended 
and triturated in 0.5 ml of NPC media, and plated in 6-well plates (Fisher 
 
 
Figure 10. Development of Mouse Neural Precursor Cells 
The cells were isolated from the mouse fetal cortices (E17-E18) and were mechanically and enzymatically 
processed to yield a single-cell suspension.  The development of neurospheres clones was achieved by 
culturing dissociated clusters in growth factors-containing media, which resulted in newly formed spheres. 
Adapted and re-drawn from Chojnacki et al. (2009).   
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Scientific).  Mature neurospheres (~100 µm in diameter, Pacey et al., 2006) were 
passaged once a week and grown in 25 cm2 tissue culture flasks (Falcon) in 
conditioned mNPC media (½ supernatant of old and ½ fresh growth media) to 
assure optimal cell growth. Similarly, only half of the media was changed every 
other day in between the passaging (Figure 10). 
 
Mouse Splenocytes and Brain Cells 
 
Mouse spleens and brains were harvested and processed to yield a single-cell 
suspension and prepared for karyotype and FISH analysis according to 
procedures described elsewhere (Boeras et al., 2008; Granic et al., 2010).  
Briefly, mouse spleens were removed, washed in sterile 1x PBS and triturated in 
RPMI 1640 medium (Gibco/Invitrogen) using the ends of two sterile Superfrost 
Plus slides (Fisher) to dissociate single cells.  The cell suspension was grown for 
44 hr in RPMI 1640 medium supplemented with 10% FBS, 2 mM L-Glutamine, 
5% PSA, 50 µM β-mercaptoethanol, and 5 µg/ml Concanavalin-A (Sigma) which 
was used as a mitogen.  
Mouse brains were cleaned of meninges and mechanically dissociated in 
ice-cold 1x PBS using 5 ml and 2 ml pipettes and fire polished Pasteur pipettes 
of three different pore sizes (10-15 times each).  The brain cells prepared as a 
single-cell suspension were centrifuged at 1500 rpm for 5 min, and then 
immediately resuspended and fixed in cold 3:1 anhydrous methanol (Fisher 
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Scientific):acetic acid (Fisher Scientific) (fixative) and incubated on ice for at least 
30 min prior to any downstream assays being performed.  
 
Human Brain Cells   
 
Frontal cortices from the patients with the Niemann-Pick type C disease (aged 
17.26 ± 11.07) and age, gender and race matched control brain tissues (age 
20.88 ± 8.64) were obtained from the NICHD Brain and Tissue Bank for 
Developmental Disorders at the University of Maryland (Baltimore, MD) (Table 
1).  To generate a single-cell suspension, we used a technique established 
previously in the laboratory of H. Potter with fresh and frozen mouse brains 
(Granic et al., 2010).  Briefly, 2 g of frozen brain tissue was triturated with fire 
polished Pasteur pipettes of different pore sizes in ice-cold 1x PBS.  The cells 
and cell aggregates were centrifuged at 1500 rpm, the supernatant removed, and 
the cell pellet resuspended and fixed in either ice-cold fixative (3:1 anhydrous 
methanol and acetic acid) and incubated on ice for at least half an hour, or in 4% 
paraformaldehyde (PFA, Electron Microscopy Science) in 1x PBS and incubated 
in 37˚C water bath for 30 min.  
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MICE 
 
APPKO Mice   
 
Six transgenic mice lacking an APP gene and their non-transgenic littermates 
were 3-4 months of age (Jackson Labs) and had C57BL/6J background strain.  
The genotype was confirmed using QPCR Bio-Rad iCycler (Bio-Rad).  Mice 
spleens were used for primary cell culture and lipoprotein/cholesterol treatments.  
 
Wild-type Mice 
 
Twelve one month old non-transgenic C57BL/6J mice (6 males and 6 females) 
(Jackson Lab) were caged in standard housing in pairs, and were fed ad libitum 
for 12 weeks with either regular rodent chow, low cholesterol or high cholesterol 
diet (Harlan Laboratories) with free access to fresh water.  Food intake and 
weight gain were monitored and recorded weekly for each mouse.  After 12 
weeks, the mice were anesthetized with i.p. injection of sodium pentobarbital (50 
mg/kg weight), and transcardially perfused with 0.9% saline before any internal 
organs of interest were removed.  Livers, spleens and brains were visually 
inspected for pathological changes.  All animals, including the two time-pregnant 
C57BL/6J mice were housed at the animal housing facility at the University of 
South Florida (USF) in a 12-hours light and dark cycle room at 22˚C.  All animal 
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studies were approved and conducted in accordance with the guidelines stated 
by the USF Institutional Animal Care and Use Committee.  
 
DIETS  
 
Regular mouse chow (2018 Teklad Global 18% Protein Rodent Diet, Harlan 
Laboratories) consisted of 5% crude plant-based oil (fat), 0% cholesterol, and 
supplied 3.3 Kcal/g of Digestible Energy (DE).  Low cholesterol diet (7001 Teklad 
4% Mouse/Rat Diet, Harlan) contained 4.2% crude oil, 0.02% cholesterol, and 
3.23 Kcal/g of DE.  The custom made high cholesterol diet (TD.95286, Harlan) 
consisted of 21% milk fat (fat), 1% of cholesterol, and provides 4.5 Kcal/g of DE.  
 
REAGENTS 
 
Lipoproteins 
 
Human oxidized LDL (protein concentration 2 mg/ml), human LDL (protein 
concentration 5 mg/ml) and human HDL (protein concentration 10 mg/ml) were 
purchased from Biomedical Technologies Inc.  The content of protein in each 
lipoprotein complex was assayed by the supplier using the Lowry method (Lowry 
et al., 1951), and the lipid concentration calculated according to chemical 
composition established by Fellin et al. (1974) and Barclay et al. (1972).  For  
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example, chemical composition of human LDL is 22% protein and 78% lipid 
which brought the lipid content of the sample to 17.7 mg/ml.  Water-soluble 
cholesterol (WsCh) was obtained from Sigma (31.8 mg of pure cholesterol in 0.6 
g total weight of solid, balanced in methyl-β-cyclodextrin) and resuspended in 
sterile water.  
 
Salts 
 
For the calcium ions chelation, two different Ca2+ blockers were used.  Chelator 
BAPTA (Calbiochem) served as an intracellular Ca2+ buffering reagent at the 
concentration of 1 mM.  Four carboxylic functioning groups in BAPTA molecule 
bind to two calcium ions.  EGTA chelator was added to the cells at the 
concentration of 1.5 mM.  The reagent is selective for Ca2+, and binds one cation 
per molecule (soluble in 1 M NaOH).  hTERT-HME1 cells are cultured in the 
medium that contains 294 mg/L of calcium (or 2.65 mM). 
 
OTHER REAGENTS, KITS, AND DNA PROBES 
 
Absolute (without benzene) ethyl alcohol (Sigma-Aldrich) was prepared as a 
sterile aqueous 1 M solution and aliquoted.  Filipin complex (Sigma) was 
dissolved in dimethyl sulfoxide (DMSO, Sigma) and stored at -20˚C in small 
aliquots protected from light.  Giemsa stain (Gibco/Invitrogen) was diluted freshly  
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in the 1x GURR buffer (GibcoBRL Life Technologies) to stain metaphase 
spreads according to standardized cytogenetic protocol.  Trypan blue (0.4%, BD 
Biosciences) exclusion assay was used to determine the viability of the hTERT 
cells grown in the closed chamber system with and without ethanol.  Mouse anti-
neuronal nuclei (NeuN) Alexa Fluor® antibody (Millipore) and VectaShield with 
4’,6-diamino-2-phenylindole (DAPI) (Vector Laboratories) was used to label  
neurons and nuclei, respectively.  Nick Translation Kit (Abbott Molecular Inc.) 
and SpectrumGreen™ or SpectrumOrange™ dUTPs (Abbot, Vysis) were used to 
generate BAC probe following an established protocol (Kulnane et al., 2002; 
Boeras et al., 2008).  Ethanol Assay Kit (BioVision) and BioTek Synergy HT 
micro-plate reader (BioTek Instruments) for colorimetric assay (optical density 
570 nm; OD570) and Gen5™ (BioTek Instruments) data analysis software were 
used to measure ethanol concentration in the media at the baseline, after 24 and 
48 hr of exposure following manufacturer’s instructions.  Oil-Red-O staining kit 
(American MasterTech) was used to detect fatty deposits in hepatocytes of mice 
fed a high cholesterol diet.  LSI® ETV6(TEL)/RUNX1(AML1) ES Dual Color 
Translocation Probe, LSI® IGH (14q32)/MALT1(18q21) Dual Color Dual Fusion 
Probe, and LSI® D7S522 (7q31) SpectrumOrange™/CEP® 7 SpectrumGreen™ 
were purchased from Abbott, Vysis.  
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IN VITRO INCUBATION WITH LIPOPROTEINS/CHOLESTEROL 
 
Two days prior to treatment/incubation, freshly passaged hTERT cells (1-3 x 105 
cells/2 ml) were plated in 100 mm tissue culture dishes (56 cm2/dish) with 
supplemented Mammary Epithelium Basal Medium (MEBM, Lonza) to assure 
60%-70% confluency on the day of the treatment.  The cells were incubated for 
48 hr at the concentration of 20 µg/ml of lipoproteins and 2 and 4 µg/ml of WsCh.  
Higher concentrations of WsCh were cytotoxic (data not shown).   
First, 7 parallel experiments were conducted to assess the effect of 
lipoproteins on chromosome segregation (i.e., karyotype analysis and 
chromosome specific aneuploidy) and 6 separate experiments to test the 
aneugenic effect of cholesterol.  Second, the same cell passages were used for 
the set of parallel experiments involving Ca2+ chelating reagents, BAPTA or 
EGTA.  The cells were pretreated with the 1 mM and 1.5 mM of chelators, 
respectively for 3 min before lipoproteins were added.  Prior to the harvest, the 
cells were treated with 33 ng/ml colcemid for 10 hr, fixed according to the 
standardized cytogenetic procedure, and prepared for metaphase chromosome 
and FISH analysis.  Third, two sets of triplicate experiments involving lipoproteins 
and ethanol co-incubations were conducted separately with the same low cell 
passage (described below). 
Similarly, two days before the treatment with lipids, freshly passaged 
HASMC were seeded onto pre-coated (2 µg/ml of poly-L-lysine, Sigma) single 
well glass chamber slides (8.6cm² growth surface/well) (BD Bioscience) at the 
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density of 105 cells per slide.  After 48 hr of lipids/cholesterol incubation, the cells 
were rinsed twice with 1x PBS without Ca and Mg (Cellgro) and immediately 
fixed with cold 3:1 anhydrous methanol and acetic acid fixative and put at -20°C 
for 30 min.  Fresh fix was added to the cells before storage at -20°C. 
Human fibroblasts with and without functional LDL receptor were seeded 
at a density of ~2 x 105 cells per single chamber slide pre-coated with 2µg/ml of 
poly-L-lysine.  The same procedure involving incubation with lipids and fixation 
was followed as with the HASMC. 
Mouse non-transgenic and APPKO spleen cells were incubated with the 
lipoproteins at the same concentration mentioned above for 48 hr, harvested and 
fixed for FISH analysis using a BAC probe for mouse chromosome 16 according 
to established protocol (Kulnane et al., 2002; Boeras et al., 2008).  
 
CLOSED CHAMBER FOR ETHANOL AND LIPIDS INCUBATION 
 
To assure an exact and consistent ethanol (EtOH) concentration in treated cells, 
a modified closed chamber system protocol by Adickes et al. (1988) was used 
(described below).  Prior to ethanol and lipoproteins co-treatments, several pilot 
experiments were conducted to examine the viability of hTERT-HME cells in the 
closed chamber, and to establish cytotoxicity of the two EtOH concentrations 
using the Trypan Blue dye exclusion assay and hemocytometry.  First, the effect 
of 25 and 50 mM of EtOH for 6, 12 and 24 hr on cell morphology, proliferation 
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and survival was assessed (data not shown).  Second, based on these results, 
triplicate experiments were conducted with 25 mM EtOH for 24 hours followed by 
lipoproteins/cholesterol and EtOH co-incubation for 48 hr.  
Specifically, a day before pretreatment with EtOH in the closed chamber 
(a 27 x 16.5 x 11 cm tightly sealed polystyrene container), hTERT cells were 
seeded in 6-well plates at the density of 6 x 104/well and grown in 37˚C, 5% CO2 
incubator.  Next, established cultures were incubated in 25 mM EtOH containing 
media for 24 hr and cultured in the sealed chamber alongside with an open dish 
(10 x 7 x 6 cm) filled with 300 ml 25 mM EtOH aqueous solution, which was 
changed daily to counteract alcohol evaporation.  The next day, lipoproteins (20 
µg/ml) and water soluble cholesterol (4 µg/ml) were added to the fresh culture 
media with EtOH, and the cells were grown for 48 hr.  A small aliquot of EtOH- 
containing media from two samples was collected at the baseline, 24 and 48 hr 
later to measure alcohol concentration using a colorimetric assay (Ethanol Assay 
Kit, BioVision).  Lastly, the cells were harvested and fixed for FISH analysis.  
 
METAPHASE CHROMOSME ANALYSIS 
 
After colcemid treatment, hTERT-HME1 cells were harvested according to the 
standard cytogenetic procedure described previously (Boeras et al., 2008).  
Briefly, the cells were hypotonically treated in 75 mM KCl for 15 min in a 37°C 
water bath, fixed in 3:1 anhydrous methanol: acetic acid fixative for a minimum of 
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30 min on ice, followed by two fixative washes and resuspension in fresh fix.  
Metaphase spreads were stained with Giemsa stain (Gibco/Invitrogen 
Corporation) diluted in the 1x GURR buffer (GibcoBRL Life Technologies) and 
the chromosomes counted (Figure 11A, B).  Genus 2.81® software was used for 
chromosome analysis (Applied Imaging).  At least 40-45 metaphases were 
analyzed per each sample. 
 
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) 
 
Fluorescence in situ hybridization (FISH) is a cytogenetic technique that allows 
one to detect the number of copies of a particular chromosome in both 
metaphase and interphase cells at the single-cell level (Ried, 1998; Tibiletti et al., 
1999; Speicher and Carter, 2005) with great sensitivity and specificity (Tibiletti, 
2004).  This method is especially suitable for poorly and non-dividing cells, or for 
cells with a very low level of aneuploidy (e.g., lymphocytes).  The basic principle 
of FISH consists in hybridization of fluorophore containing DNA probe with a 
unique genomic sequence to its complimentary DNA in cytological samples 
prepared on slides (Figure 11C).  Annealed probe and target-DNA is then 
visualized in situ using fluorescent microscope filters that should match the 
wavelength of the selected fluorophore for proper detection and analysis 
(reviewed in Jiang and Katz, 2002; Tibiletti, 2007).  In the present studies, for 
human samples commercially available single or dual-labeled locus specific 
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chromosome probes (Abbott, Vysis) were used, and for mouse samples, a ~300 
kb unique mouse DNA sequence cloned into the bacterial artificial chromosome 
(BAC) cloning vector and labeled by Nick translation (Zhu et al., 1994) was 
utilized.  
Prior to hybridization, all slides were aged at room temperature followed 
by hybridization procedures recommended by Abbott, Vysis and by protocols 
described elsewhere (Boeras et al., 2008; Granic et al., 2010; Kulnane et al., 
2002).  Briefly, aged slides were placed in 37˚C 2x SSC buffer for 45 min and 
dehydrated in serial ethanol washes (70%, 80%, and 90% for 2 minutes each), 
and targeted with a DNA probe mixture (7 µl hybridization buffer, 1 µl 
fluoroprobe, and 2 µl DNase-free water).  Interphase FISH of all 
lipoprotein/cholesterol and reagents-treated human cell lines and primary cells 
was performed with either the LSI® ETV6(TEL)/RUNX1/(AML1) ES Dual Color 
Translocation Probe, LSI® D7S522 (7q31) SpectrumOrange ™/CEP® 7 
SpectrumGreen™ or LSI IGH/MALT1 Dual Color Dual Fusion probe (Abbott, 
Vysis) in a HyBrite hybridization chamber (Vysis) according to manufacturer’s 
specifications for a selected probe for at least 16 hr at 37˚C.  A dual color 
detection protocol allows one to simultaneously assess two chromosomes under 
appropriate dual-band pass fluorescence microscope filters.  The next day, slides 
were washed with 0.4x SSC and 2x SSC containing NP-40 detergent to remove 
nonspecifically-bound probe, and mounted with DAPI II (Abbott, Vysis) or 
Vectashield with DAPI (Vector Laboratories) counterstain.    
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Figure 11.  Metaphase Chromosome Spreads and FISH Procedure  
(A-B) Human aneuploid metaphase (A) (>46 chromosomes) and mouse (B) euploid metaphases (40 
chromosomes) were prepared following standardized cytogenetic protocol (Barnicot and Huxley, 1961) and 
stained with Giemsa.   
(C) In the FISH procedure, DNA probe is labeled with fluorophore-containing nucleotides followed by the co-
denaturing of the target and probe DNA and annealing of the complimentary DNA sequences. 
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A bacterial artificial chromosome (BAC) containing a mouse chromosome 
16-specific sequence (a gift from Dr. Bruce Lamb at Case Western Reserve of 
University) was labeled by Nick translation and fluorophore-containing dUTP as 
described previously (Kulnane et al., 2002; Boeras et al., 2008; Granic et al., 
2010).  Briefly, 1 mM of either SpectrumGreen™ dUTP (2’-Deoxyuridine, 5’-
Triphosphate; Abbott, Vysis) or SpectrumOrange™ dUTP (Enzio Life Sciences) 
was used to label 1 µg of BAC DNA in Nick translation enzymatic 
reaction/incubation (Nick Translation kit, Abbott) at 15˚C for 8-16 hr.  Precipitated 
and pre-incubated (37˚C overnight) BAC probe was co-denatured with mouse 
spleen or brain cells at 74˚C for 4 min and hybridized at 37˚C in HyBrite chamber 
for either 22 or 48 hours, respectively, followed by two or three consecutive 
washes in SSC detergent-containing buffers of various stringencies (0.4x SSC, 
2x SSC, and 4x SSC) and counterstained with DAPI II (Abbott, Vysis) or 
Vectashield (Vector) nuclear DNA stain.  
 
FISH FOLLOWED BY IMMUNOCYTOCHEMISTRY 
 
Studying the effect of PS1 mutation and overexpression on the cell cycle and 
chromosome mis-segregation in mouse models of FAD, this laboratory 
previously used a modification of the protocol by Liesi et al (2001) to develop 
primary mouse neuronal cultures followed by FISH analysis, therefore depending 
on availability of live animals and successful isolation of neuronal cells.  Other  
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researchers that examined the levels and distribution of aneuploidy in normal and 
AD brains in humans and mice utilized either brain slices and 
immunofluorescence staining and cytometry to measure the DNA content in 
single neurons (e.g., Arendt et al., 2010), and mechanically isolated nuclei from 
different brain regions and FISH (e.g., Iourov et al., 2009), or FACS analysis of 
PFA-fixed brain cells labeled with a neuronal specific marker followed by FISH 
assay (e.g., Westra et al., 2008).   
To circumvent the technical complexity of each method (e.g., a single-cell   
DNA quantification on the brain slices requires specialized instruments and 
multistep immunocytochemistry protocol), the lab developed a relatively simple 
technique which combines FISH and immunostaining performed in two 
consecutive steps on a single slide (Granic et al., 2010).  To assess neuronal 
versus glial cell aneuploidy in the cells derived from either fresh or frozen brain 
tissue utilizing only fluorescence microscopy, mechanically dissociated single 
cells (nuclei) were first subjected to FISH assay with a single or dual labeled 
DNA probe followed by immunocytochemistry using a conjugated primary 
antibody against the neuronal nuclear antigen, NeuN labeled with AlexaFluor 488 
or with other fluorophore.  With this method, both neurons and glial cells from any 
brain region could be assessed for aneuploidy for any chromosome of interest.   
Thus, a single-cell suspension of NPC and control frontal cortices (Table 
1) were hybridized with a DNA probe for chromosome 21, and immediately after 
FISH, incubated in 1x PBS for 10 min, blocked in 10% goat serum/0.1% Triton X-
100 PBS solution for 1 hr followed by overnight incubation in conjugated Ms X 
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Neuronal Nuclei AlexaFluor 488 (Millipore) 1:100 antibody prepared in 1% 
BSA/0.1% TritonX-100 1x PBS.  After final washes in 1x PBS, the cells were 
stained with DAPI II counterstain and coverslipped. 
 
IMMUNOCYTOCHEMISTRY, FILIPIN AND OIL-RED-O STAINING 
 
Filipin is a cholesterol-specific fluorescent dye (Norman et al., 1972) used to  
quantify plasma membrane and intracellular free cholesterol and to demonstrate 
a correlation between decreases in membrane cholesterol and increased 
membrane fluidity (Coxey et al. 1993).  To co-stain NPC brain cells with neuronal 
marker and filipin, a modification of the protocol described by Millard et al. (2000) 
was used.  A single-cell suspension of 4 NPC and 5 control frontal cortices 
(Table 1) were fixed in 4% PFA in 1x PBS for 30 min at 37˚C.  The cells were 
dropped onto pre-wetted slides (Fisher) that were marked around the edges with 
the ImmEdge pen (Vector Laboratories) to create a single chamber, and allowed 
to age overnight.  After the three consecutive washes with 1x PBS for 10 min, the 
slides were stained/permeabilized with 50 µg/ml filipin in PBS/10% normal goat 
serum overnight at 4˚C, and then incubated in conjugated Ms X Neuronal Nuclei 
AlexaFluor 488 (Millipore) 1:100 antibody prepared in filipin/1x PBS/10%goat 
serum for 60 min in 37˚C hybridization oven on a shaker. Following final washes 
in 1x PBS, the cells were mounted with Fluoro-gel with Tris Buffer (Electron 
Microscopy Sciences) and coverslipped.  
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 Oil-Red-O stain is used to detect intracellular neutral lipids in hepatocytes 
and adipogenic cultures (e.g., De Gottardi et al., 2007), and for detection of 
hepatic steatosis in liver cryosections (e.g., Zhao et al., 2011). Visual 
accumulation of cytosolic lipids in more than 5% of hepatocytes in human liver is 
considered as diagnostic of steatosis (Klein et al., 2005) as a consequence of an 
increased efflux of free fatty acids and triglycerides formation (Bradbury, 2006).  
A single-cell suspension of 4% PFA/1x PBS-fixed livers were dropped onto slides 
and stained with the Oil-Red-O staining kit following manufacturer’s procedures 
(American MasterTech).  Hematoxylin stained single cells (blue) and cell 
aggregates were evaluated under phase microscopy for the presence of lipid 
droplets (red).  
 
IMAGE AQUISITION AND ANALYSIS 
 
FISH Visualization and Scoring 
 
Hybridization signals were visualized using a Nikon Eclipse E1000 fluorescence 
microscope with a 4912 CCIR high performance COHU CCD Camera and Genus 
2.81® software (Applied Imaging) or a Zeiss Imager.M1 microscope with a CV-
M4+CL high resolution camera and Axiovision 4.6 software (Zeiss).  The 
corresponding optical filters and their spectral bandwidths were: DAPI (peak 
excitation/emission (ex/em) 350 and 470 nm), Fluorescein Isothiocyanate (FITC)  
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(ex/em 490/525 nm), and Tetramethyl Rhodamine Isothiocyanate (TRITC) 
(ex/em 557/576 nm) for the Nikon Eclipse scope, and Zeiss filter sets 49 
DAPI/Hoechst 33258 (ex/em 365/445[450] nm), 38 HE eGFP/FITC/Alexa488 
(ex/em 470[40]/525[550] nm) and 43 HE Cy3/DsRed/Rhodamine (ex/em 
550[525]/605[670] nm) from Chroma.  
Only intact nuclei (DAPI) and compact and bright signals were scored for 
aneuploidy separately for each probe/fluorophore following the Abbott/Vysis 
(http://www.abbottmolecular.com/contactus/fishtechsupport/techtipsandinfo/fish- 
lab-quality-control.html) guidelines.  For example, overlapping cells were not 
analyzed and closely adjacent spots or spots connected with a fluorescent strand 
were evaluated as a split signal and counted as one chromosome.   
During the course of our studies, this laboratory experienced high 
hybridization efficiency (> 98%) with both commercially available (Vysis) and 
homemade BAC probes (data not shown) on cell lines and primary cells as a 
source of target-DNA.  The evaluation of chromosomal abnormalities in the 
samples lacking more than 10% of fluorescent spots is not recommended 
because it leads to underestimation of trisomies and overestimation of 
monosomies and miscalculation of aneuploidy (Tibiletti, 2007).  A similar problem 
arises when the nuclei are processed from paraffin sections (slices) or isolated 
from paraffin-embedded tissue blocks if the architecture of analyzed cells is not 
correctly assessed (Tibiletti, 2007).  To avoid any biases in scoring of euploid 
and aneuploid cells in the study samples, only non-overlapping single nuclei 
derived from a single-cell suspension were evaluated.  A portion of the 
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hybridization area was routinely recounted for reliability.  On average, between 
700 and 1,000 interphases per each sample/treatment were scored for 
aneuploidy, and about 400 NeuN-positive and NeuN-negative NPC brain cells 
were analyzed for DNA hybridization spots. 
 
Filipin Semi-quantitative Analysis 
 
First 50 NeuN-positive NPC and control brain cells were semi-quantitatively 
assessed for the most intense filipin stain and cholesterol localization and 
categorized into three following groups: membrane staining, intracellular staining 
and both.  For filipin visualization and image acquisition, a Zeiss Imager.M1 
microscope with a CV-M4+CL high-resolution camera and 49 DAPI/Hoechst 
33258 filter set (Chroma) was used, along with the Axiovision 4.6 software 
(Zeiss).  Also, a Zeiss Imager.M1 and phase contrast was used to assess the 
presence of Oil-Red-O staining in mouse hepatocytes.   
 
STATISTICAL ANALYSIS 
 
To establish whether lipoprotein/cholesterol induce chromosome mis-segregation 
in various human and mouse cells (i.e., hTERT-HME, HASMC, human 
fibroblasts, mouse splenocytes, and mouse neural precursors), a Paired 
Student’s t-test was used to compare the aneuploidy levels (mean ± SEM) 
between treated cells and controls.  Similarly, to answer the question if a 
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functional LDLR or APP gene is required to observe aneugenic effect of lipids in 
vitro, a Paired t-test was employed to contrast the levels of aneuploidy in 
lipoproteins-treated fibroblast harboring malfunctional LDLR compared to 
controls, and in lipid-treated mouse splenocytes lacking APP gene compared to 
untreated cells (Research Question 1).   
To investigate the role of intracellular cholesterol homeostasis in 
chromosome mis-segregation in a neurodegenerative disease model, an 
Independent t-test was used to compare the aneuploidy levels between the 
NPC1 fibroblasts and the NPC brain cells and corresponding age, gender and 
race matched controls.  The same statistical analysis was utilized to contrast 
filipin staining between the NeuN-positive NPC cells and normal neurons 
(Research Question 1).   
To establish the effect of a dietary-induced hypercholesterolemia on 
chromosome segregation in peripheral tissues in a mouse model, a Paired t-test 
was used to compare the levels of aneuploidy in spleens of the mice (littermates) 
fed a high cholesterol to mice consuming regular diet, and the mice fed a low 
cholesterol diet to mice on regular chow (Research Question 2).   
To explore the mechanism of aneuploidy induction in vitro, and to 
establish whether Ca2+ chelation and plasma membrane fluidization by ethanol 
may attenuate lipoproteins/cholesterol-induced aneuploidy, a Paired Student t-
test was used to compare aneuploidy levels between the lipids-treated cells with 
and without chelator, and the cells co-incubated with lipids and ethanol compared 
to appropriate controls (Research Question 3).   
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Three to 7 treatments with lipids for each cell line, and triplicate 
experiments with the chelator and ethanol were conducted and scored for 
aneuploidy.  Four to 5 primary NPC cells sources and controls (Table 1) and at 
least 6-12 mice were analyzed for each graph.  All data were presented as mean 
± SEM of treatments and controls with p < 0.05 considered as statistically 
significant.  
 
SUMMARY 
 
To summarize, the following materials and methods were used to answer the 
research questions.  For the Research Question 1 (Do lipids induce aneugenesis 
in vitro and is the induction dependent on a functional LDL receptor and APP 
gene?), hTERT-HME1, HASM cells, human fibroblasts with and without 
functional LDLR, mouse APPKO splenocytes and neural precursors, human 
NPC1 fibroblasts and brain cells where treated either with lipoproteins/cholesterol 
and/or assessed for aneuploidy utilizing the FISH assay, and for the intracellular 
cholesterol distribution using filipin staining.  For the Research Question 2 (Does 
diet-induced hypercholesterolemia affect chromosome mis-segregation in 
visceral and brain tissues of wild-type mice?), young nontransgenic animals were 
fed three different diets, and the spleen and brain cells analyzed for chromosome 
16 aneuploidy using a BAC probe and FISH.  For the Research Question 3 (Is 
there a mechanistic link between calcium homeostasis (Mechanism I) and 
plasma membrane dynamics (Mechanism II) and lipid-induced chromosome mis-
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segregation in vitro?), hTERT cells were treated with lipoproteins in the presence 
or absence of calcium chelators (BAPTA and EGTA) and EtOH, respectively, and 
analyzed for aneuploidy using FISH.  
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 CHAPTER FOUR 
       RESULTS  
 
To investigate  the role of lipoproteins and cholesterol in chromosome 
segregation in vitro and in vivo, and to establish the effect of disrupted 
cholesterol homeostasis on the cell cycle, we used: (1) human and mouse 
primary cells with a functional LDL receptor; (2) mouse primary cells lacking APP 
gene; (3) human primary cells with defective LDLR and  Niemann-Pick Type C1 
(NPC1) genes responsible for lipoprotein uptake and intracellular cholesterol 
trafficking, respectively; (4) young wild-type mice fed high (1.05%) and low 
(0.02%) cholesterol diet for 12 weeks to induce hypercholesterolemia; and (5) 
metaphase chromosome analysis and FISH to examine the levels of total and 
chromosome specific aneuploidy, respectively.  Specifically, we assessed the 
level and distribution of trisomy and tetrasomy of human chromosomes 7, 12, 14, 
18, 21, and mouse chromosome 16 in various peripheral and brain cells.  Mis-
segregation of these chromosomes has been implicated in AD (e.g., Boeras et 
al., 2008; Geller and Potter, 1999; Granic et al., 2010; Migliore et al., 1999; 
Thomas and Fenech, 2008) and in development of atherosclerotic lesions (e.g., 
Casalone et al., 1991; Fernandez et al., 2000; Matturri et al., 1997; 2001).  
Lastly, (6) we examined the mechanisms by which lipoproteins and cholesterol  
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may cause chromosome mis-segregation, and asked whether (a) alternation in 
extracellular Ca2+ homeostasis by either EGTA or BAPTA, and (b) a change in 
membrane fluidity and elasticity by ethanol, may decrease 
lipoproteins/cholesterol-induced chromosome mis-segregation in the cell culture. 
 This chapter describes individual research questions, scientific rationale 
and study results in three sections: (1) lipoproteins/cholesterol-induced 
chromosome mis-segregation in vitro (Research Question 1); (2) diet-induced 
peripheral genomic instability in vivo (Research Question 2), (3) mechanistic link 
between calcium homeostasis and plasma membrane fluidity and lipids-induced 
aneuploidy in vitro (Research Question 3). 
 
LIPOPROTEINS/CHOLESTEROL-INDUCED ANEUPLOIDY IN VITRO 
 
hTERT-HME1 Cells Treated with Lipoproteins Developed Aneuploidy within 
48 Hours 
 
Recently, this laboratory has shown that overexpression or mutation in the PS1 
or APP genes causes chromosome aneuploidy, including trisomy 21 in cellular 
and animal models of AD (Boeras et al., 2008; Granic et al., 2010) partly via Aβ 
peptide by disrupting the microtubule integrity and the function of mitotic spindle 
motors (Borysov et al., 2011).  To broaden the knowledge that cell cycle defects 
and accumulation of aneuploid/hyperploid cells, including neurons may contribute  
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to neurodegeneration and dementia (e.g., Arendt et al., 2010; Iourov et al., 2009; 
Obrenovich et al., 2003; Potter, 2004), this dissertation sought to investigate the 
aneugenic effect of other effector molecules implicated in pathology of AD and 
AD-related risk factors (i.e., atherosclerosis), such as LDL and OX-LDL.  To 
answer the question whether lipoproteins at physiologically elevated levels 
induce mitotic defects and chromosome mis-segregation in dividing cells with low 
aneuploidy background and a functional LDL receptor, human primary epithelial 
cells with a stable karyotype (i.e., permanently expressing a telomerase reverse 
transcriptase gene; Jiang et al., 1999; Morales et al., 1999), the hTERT-HME1 
cells were exposed to OX-LDL, LDL and HDL for 48 hr at the concentration of 20 
µg/ml and assessed for aneuploidy by metaphase chromosome analysis and 
FISH.  First, seven parallel cultures of hTERT-HME1 cells were incubated with 
lipoproteins, then arrested at metaphase by colcemid and assessed for 
aneuploidy (metaphase spreads both of < and > of 46 chromosomes).  The 
results showed a significant increase in chromosome mis-segregation, especially 
in OX-LDL and LDL-treated cells compared to controls (p = 0.0001, and p = 
0.005, respectively; Paired t-test; Figure 12A).  LDL-cholesterol induced 
significantly more mis-segregated cells compared to less aneugenic HDL (p = 
0.005) and OX-LDL (p = 0.01).  Second, the induction of chromosome specific 
aneuploidy was analyzed by quantitative FISH analysis (Figure 12B-G), and 
revealed the induction of: (1) trisomy 21 (p = 0.02) and 12 by OX-LDL (p = 0.02; 
Paired t-test) and a borderline significant induction of trisomy 21 and 12 by LDL  
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Figure 12. Chromosome Aneuploidy, Including Trisomy and Tetrasomy 21, 12 and 
7 Induced in Lipoproteins-treated hTERT-HME1 Cells  
(A) hTERT-HME1 cells were treated with 20 µg/ml of OX-LDL, LDL and HDL for 48 hr and arrested in 
metaphase by incubation in 33 ng/ml of colcemid for 10-12 hr. Hypotonic treatment in 0.075 M KCl was 
followed by a cell fixation in 3:1 methanol:acetic acid.  Fixed cells were Giemsa stained for karyotype 
analysis.  All lipid-treated cells harbored significantly higher levels of aneuploidy compared to controls, 
especially those treated with LDL-cholesterol.    
(B-G) FISH analysis of the same lipoproteins-treated cells revealed OX-LDL-induced trisomy 21 (B) and 
trisomy 12 (C), and OX-LDL and LDL-induced tetrasomy 21 (E), tetrasomy 12 (F), and tetrasomy 7 (G).                                                          
                                  continued>  
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LSI® ETV6(TEL)/RUNX1(AML1) ES Dual Color Translocation Probe (SpectrumOrange™    
21/SpectrumGreen™ 12) was used to detect complimentary DNA sequence on chromosome 21 and 12 in 
interphase cells (D), whereas LSI® D7S522 (7q31) SpectrumOrange™/CEP 7 SpectrumGreen™ probe was 
used to detect LDL-induced tetrasomy 7 (G).  Atherogenic OX-LDL induced significantly higher levels of 
trisomy 21 and 12 compared to HDL-cholesterol. No induction of trisomy 7 in any lipid-treated sample was 
observed (data not shown).  
(H) Karyotype analysis of an aliquot of the cells from the same treatments showed low number of polyploidy 
cells, suggesting that the tetrasomies observed were due to chromosome mis-segregation of chromosomes 
21, 12 and 7, and not a result of chromosome duplication without cell division. 
A Paired t-test was used to compare aneuploidy levels (percentages) between lipids-treated and control 
cells with p < 0.05 considered to be statistically significant.  
 
(not significant; Figure 12B-D); and (2) tetrasomy 21, 12, and 7 induced by OX-
LDL and/or LDL (p = 0.03, Paired t-test; Figure 12D-G).  Compared to HDL, OX- 
LDL-cholesterol induced significantly more trisomic 21 and 12 cells within 48 hr 
(p = 0.03 and p = 0.01, respectively; paired t-test).  
Taken together, the data suggest that OX-LDL and LDL-induced 
tetrasomy in interphase cells happed possibly due to either cell reduplication with 
incomplete cell division or due to chromosome mis-segregation for a particular 
chromosome.  The presence of tetraploid neurons has been observed in AD 
brains of humans and mice, and explained by some researchers as due to 
aberrant cell cycle activation and DNA duplication without the cell cycle 
completion (e.g., Arendt et al., 2009; Obrenovich et al., 2003; Yang et al., 2001; 
2006; Yang and Herrup, 2007; Zhu et al., 2008).  In order to determine why there 
is more than diploid content of DNA in interphases of lipid-treated hTERT cells, a 
total number of metaphase hyperploid/polyploid and diploid cells were scored in 
the portion of the slide initially analyzed for karyotypes.  There was no elevation 
of polyploid (>4n) within diploid (2n) cells in OX-LDL and LDL-treated samples 
indicating that the increases in interphase tetrasomies were most likely due to 
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chromosome mis-segregation for the particular chromosome of interest (p = 0.4 
and p = 0.3, respectively; Figure 12H). 
 
LDL Induced Trisomy 7 in HASM Cells 
 
Cytogenetic analyses of atherosclerotic plaques from diseased human arteries 
and isolated primary smooth muscle cells (SMC) from these plaques have shown 
a variety of chromosomal instabilities, including trisomy and tetrasomy 7, 
monosomy 11, trisomy 10, 18, 20, and loss of the Y chromosome (Casalone et 
al., 1991; Fernandez et al., 2000; Lavezzi et al., 2005; Matturri et al., 1997; 
2001).  According to the Monoclonal Proliferation Theory of atherogenesis, 
individual SMCs occasionally undergo a somatic mutation and chromosomal 
alternations resulting in increased proliferative activity and consequent clonal 
expansion to yield atherosclerotic lesions (Benditt and Benditt, 1975; Casalone et 
al., 1991; Murry et al., 1997; Vanni and Licheri, 1991) similar to development of 
aneuploid benign tumors.  Therefore, the effect of lipoproteins (OX-LDL, LDL and 
HDL) on chromosome segregation in primary human aortic smooth muscle cells 
(HASMC) was assessed, and the cells treated with lipoproteins (20 μg/ml) for 48 
hr, fixed, and analyzed by FISH with fluorescent DNA probe for chromosome 7. 
Quantitative FISH analysis showed a statistically significant 3-fold increase in 
trisomy 7 (p = 0.0007, Paired t-test; Figure 13A, B) in LDL-treated cells, and a 
borderline significant increase in tetrasomy 7 over the background (6.2% over 
3.4%, respectively; data not shown).  Compared to HDL, atherogenic and 
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aneugenic LDL-cholesterol induced significantly more trisomy 7 (p = 0.01, Paired 
t-test) within 48 hr.  
 
 
Figure 13. LDL-induced Trisomy 7 in HASM Cells   
(A) Quantitative FISH analysis of HASM cells showed an increase in trisomy 7 when incubated with 20 µg/ml 
of LDL for 48 hours.  Atherogenic LDL-cholesterol induced significantly more trisomy 7 compared to HDL-
treated cells. A Paired t-test was used to compare aneuploidy induction between treated and untreated cells, 
and between LDL and HDL-treated cells. 
(B) LSI® D7S522 SpectrumOrange™ probe was used to detect a region on chromosome 7 in interphase 
cells. 
 
LDL-induced Trisomy 7 may be Dependent on a Functional LDL Receptor 
 
To establish whether lipoprotein-induced chromosome mis-segregation may be 
mediated through the LDLR and thus dependent on intracellular signaling, 
human primary cells from the patients diagnosed with familial 
hypercholesterolemia (FH) were obtained, and the aneuploidy levels were 
compared to control cells with a functional LDLR after exposing them to various 
lipids under the same conditions.  
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LDL receptor belongs to a large family of structurally and functionally 
homologous cell-surface receptors, the LDLR receptor family (Brown and 
Goldstein, 1976; 1986; Herz and Bock, 2002; Hussain et al., 1999) which are 
involved in diverse cellular functions implicated in AD pathogenesis (Jaeger and 
Pietrzik, 2008; Andersen and Willow, 2006), from cholesterol metabolism and 
Apolipoprotein E (ApoE) binding (Herz and Beffert, 2000) to APP trafficking and 
processing (Abisambra et al., 2010; Marzolo and Bu, 2009).  The LDLR is a 
ubiquitously expressed transmembrane protein that mediates clearance of 
cholesterol rich LDL particles circulating in the blood and facilitates LDL 
internalization into cells (Brown and Goldstein, 1976; 1986; Goldstein and Brown, 
1976; 1987), and is, therefore, essential for cholesterol homeostasis.  To date, 
there are more than 1066 unique LDLR genetic alternations that lead to FH 
(Leigh et al., 2008) causing three to four times higher levels of LDL cholesterol 
than normal (Khachadurian, 1964) and premature CVD events, including severe 
atherosclerosis (reviewed in Fahed and Nemer, 2011).   
To investigate whether lipoprotein-induced chromosome mis-segregation 
requires a functional LDLR, FH primary human fibroblasts (Coriell repository 
number GM01915) harboring two mutations in the LDLR gene and normal 
human fibroblasts (NHF, repository number GM01661) were treated with 20 
µg/ml of lipoproteins for 48 hr and assessed for aneuploidy.  Quantitative FISH 
analysis revealed that LDL treated NHF develop significantly higher levels of 
trisomy 7 compared to FH fibroblasts exposed to the same concentration of LDL 
(p = 0.03, Paired t-test; Figure 14A, B).  Compared to HDL-cholesterol, 
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atherogenic LDL induced more aneuploidy cells which reached a borderline 
significance (p = 0.07).  The data indicates that a functional LDLR is necessary to 
observe LDL-induced chromosome mis-segregation and aneuploidy generation 
in vitro.   
 
 
Figure 14. LDL-induced Trisomy 7 in Primary Human Fibroblasts may be LDLR 
Dependent 
(A) Normal human fibroblasts (NHF, light gray bars) developed significantly higher levels of trisomy 7 when 
treated with 20 µg/ml of LDL within 48 hr compared to LDL receptor deficient human fibroblasts obtained 
from the patient diagnosed with familial hypercholesterolemia (FH, black bars).  Compared to HDL-treated 
NHF, LDL-cholesterol induced a 2-fold increase in trisomy 7 that reached a borderline significance (p = 0.07, 
Paired t-test). The data suggest that a functional LDLR may be required for aneugenic effect of LDL in vitro.  
(B) FISH analysis and LSI® D7S522 SpectrumOrange™ probe was used to detect chromosome 7 in 
interphase cells. 
 
Lipoprotein-induced Aneuploidy is Independent of APP 
 
As discussed previously, accumulated evidence from experimental, animal and 
human studies points to the role of cholesterol in APP processing and Aβ 
generation and clearance (e.g., Eckert et al., 2000; Panza et al., 2009; Pfrieger,  
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2003; Schneider et al., 2006; Solomon et al., 2008).  High lipoprotein/cholesterol 
within the plasma membrane promotes (Ehehalt et al., 2003; Hooijmans et al., 
2007; Refolo et al., 2001; Sparks et al., 1994; Xiong et al., 2008), and low 
cholesterol reduces, the production of Aβ (Fassbender, et al., 2001; Refolo et al., 
2001; Simons et al., 1998), partly by changing the activity of the key membrane-
bound secretases involved in APP proteolysis (e.g., Bodovitz and Klein, 1996;  
Kojro et al., 2001; Schneider et al., 2006; Wahrle et al., 2002) within lipid rafts 
microdomains (Lee et al., 1998; Parkin et al., 1999; Refolo et al., 1991; Simons 
and Toomre, 2000). Furthermore, Aβ and presenilin (PS1/2) affect 
lipid/cholesterol metabolism (Cutler et al., 2004; Grimm et al., 2005) and 
cholesterol content of the plasma membranes, influencing in turn their fluidity and 
function (Grimm et al., 2006).   
As mentioned previously, this lab reported that familial AD-causing (FAD) 
mutations in the PS1 and APP gene and their pathogenic product, the Aβ peptide 
induced aneuploidy in transgenic mice and transfected cells in culture (Boeras et 
al., 2008; Granic et al., 2010) by disrupting the formation and stability of mitotic 
spindle and by interfering with normal microtubule function (Borysov et al., 2011).  
Moreover, Aβ-induced aneuploidy is dependent on a functional Tau gene and 
tau-stabilized microtubules, and on interaction with endogenous APP (Granic et 
al., 2010).  Similarly, Aβ-induced cytotoxicity requires a full-length APP possibly 
as a cell-surface receptor to aid endocytosis and generation of intracellular or for 
the uptake of extracellular Aβ (Lorenzo et al., 2000; Shaked et al., 2006).  
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 To test the hypothesis that observed lipoprotein/cholesterol induced 
chromosome mis-segregation in vitro may be independent of APP, APP 
processing and consequent Aβ production, primary splenocytes from APPKO 
mice and nontransgenic littermates were isolated and exposed to lipoproteins for 
48 hr.  The cells were fixed and hybridized with the mouse chromosome 16 BAC 
 
 
 
Figure 15. Primary Mouse Splenocytes Lacking the APP Gene Expression Develop 
Aneuploidy Upon Lipoproteins Treatment 
(A) In situ DNA FISH with a BAC plasmid containing mouse chromosome 16 labeled with the 
SpectrumOrange™ dUTP was used to detect the levels of aneuploidy in lipoprotein-treated primary 
splenocytes derived from non-transgenic (NON) and APP gene deficient mice (APPKO).   
(B) Quantitative FISH analysis revealed comparable levels of trisomy 16 in both cell types upon incubation 
with 20 µg/ml of OX-LDL and LDL within 48 hours.  The data suggest that aneugenic activity of lipoproteins 
may be independent of a functional APP gene and thus probably independent of Aβ. Paired t-test was used 
to compare the levels of aneuploidy in lipid-treated and untreated cells.  
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probe (Kulnane et al., 2002) labeled with SpectrumOrange™ dUTPs by Nick 
translation (Enzio Life Sciences) and scored for aneuploidy (Figure 15A).  OX-
LDL and LDL induced significant increases in trisomy 16 in both cells types 
compared to controls (p = 0.04 and p = 0.02 in OX-LDL-treated normal and 
APPKO splenocytes, and p = 0.03 and p = 0.05 in LDL-treated cells, 
respectively, Paired t-test; Figure 4B), suggesting that aneugenic effect of 
lipoproteins may be independent of APP expression and Aβ production.  Thus, 
endogenous APP may not be required for lipoproteins-induced aneuploidy, 
though it is needed for aneugenic activity of Aβ (Granic et al., 2010), Aβ-induced 
tau phosphorylation (Pigno et al., 2001; Small and Duff, 2008) and Aβ cytotoxicity 
(Rapoport et al., 2002; Roberson et al., 2007).  
 
Water-soluble Cholesterol Induced Aneuploidy In Vitro 
 
Cholesterol is the most abundant lipid in eukaryotic cell membranes (Bloch, 
1991) and is compartmentalized into microdomains (e.g., lipid rafts; Brown and 
London, 2000; Crane and Tamm, 2004; Pike, 2003), where it is required for 
essential cellular functions and membrane structure, such as signaling 
transduction and plasma membrane dynamics (Mukherjee and Maxfield, 2004; 
Simons and Toomre, 2000; Weber et al., 2006).  It is well established that 
membrane cholesterol content affects membrane stiffness and fluidity (Demel 
and De Kruyff, 1976), which can be changed by either cholesterol enrichment or 
depletion, respectively (e.g., Abramov et al., 2011; Mukherjee and 
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Chattopadhyay, 2005; Weber et al., 2006).  Also, cyclodextrins as cholesterol 
acceptors (e.g., methyl-β-cyclodextrin, MβCD) have been effectively used to 
manipulate intracellular cholesterol levels (Christian et al., 1997; Yancey, et al., 
1996) and to aid the delivery of hydrophobic cholesterol into the plasma 
membrane and cytosolic compartments (Härtel et al., 1998; Ohvo et al., 1997).     
To examine the effect of MβCD-delivered exogenous cholesterol on 
chromosome segregation in vitro, water-soluble cholesterol (WsCh), a 
MβCD:cholesterol complex, and karyotype and FISH analysis was used to 
assess the levels of overall  and chromosome specific aneuploidy.  First, hTERT- 
HME cells were incubated with either 4 μg/ml or 2 μg/ml of WsCh for 48 hr, and 
the metaphases analyzed for chromosome mis-segregation.  The cells treated 
with 4 μg/ml of cholesterol showed a 2-fold increase in total aneuploidy 
compared to untreated cells (p = 0.01, Paired t-test) but no induction of 
chromosome mis-segregation at the concentration of 2 μg/ml of WsCh was 
observed (not significant; Figure 16A).  Second, FISH analysis for a specific 
chromosome revealed a significant increase in trisomy 21 and trisomy 12 in 4 
μg/ml WsCh treated cells (p = 0.01 and p = 0.03, respectively, Paired t-test; 
Figure 16B) and no induction of  tetrasomy 21 or  12 (data not shown). Taken 
together, the data suggest that aneugenic effect of cholesterol is likely to affect 
all chromosomes, and that this biological effect may be related to the changed 
membrane fluidity in which cholesterol-enriched, more rigid membranes of the 
nuclear envelope fail to properly attach chromosomes during mitosis, leading to 
generation of aneuploid cells. 
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Figure 16. Cholesterol: MβCD Complex-induced Aneuploidy in hTERT Cells 
(A) Karyotype analysis of hTERT cells treated with 4 µg/ml water-soluble cholesterol (WsCh) showed the 
induction of aneuploidy within 48 hr.  Cell death was observed at the concentration of 10 and 20 µg/ml (data 
not shown).  A Paired t-test was used to evaluate the difference in aneuploidy between treated and 
untreated cells.  
(B) Quantitative FISH analysis with dual-labeled DNA probe revealed an increase in trisomy 21 and trisomy 
12 but no induction of tetrasomy 21 or 12 (data not shown). The data suggests that exogenously derived 
cholesterol balanced in MβCD is disturbing an important aspect of mitotic machinery probably by changing 
plasma membrane fluidity, which in turn may affect chromosome segregation in general. 
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Water-soluble Cholesterol Induced Trisomy 16 in mNPCs 
 
Recently, this lab reported that Aβ-induced cell cycle abnormalities and 
chromosome mis-segregation (Granic et al., 2010) may involve selective 
inhibition of mitotic spindle motors and microtubule defects (Borysov et al., 2011), 
which would especially be detrimental during neurogenesis and regeneration 
upon neuronal injury (Ming and Song, 2005; Zhao et al., 2008), resulting in 
malfunctional, apoptosis-prone neural progenitors and neurons.  Trisomy 21 cells 
that accumulate in the brains of AD patients (e.g., Iourov et al., 2009) and in FAD 
transgenic mice (Boeras et al., 2008; Granic et al., 2010), over-express APP and 
Aβ the imbalance of which may contribute to disease onset and progression, as 
evident  in individuals harboring trisomy 21 mosaicism (Migliore et al., 2006; 
Schupf et al., 1994) or an APP gene duplication (McNaughton et al., 2010; 
Rovelet-Lecrux et al., 2006; Sleegers et al., 2006).  Like Aβ, cholesterol-induced 
mitotic defects in neural progenitors may lead to the development of aneuploid, 
genetically-imbalanced neuronal and glial cells susceptible to apoptosis and 
degeneration in vivo. 
To test this hypothesis and to investigate the effect of cholesterol on the 
development of aneuploidy, including trisomy 21 in mouse neural precursor cells 
(mNPCs), neurospheres derived and cultured from prenatal brains of 
nontransgenic mice (described in Chapter Three) were utilized, and subjected to 
FISH with a fluorescently labeled BAC probe for chromosome 16 (Kulnane et al., 
2002), a mouse analog for human chromosome 21.  Parallel mNPCs cultures 
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were incubated with 4 µg/ml of WsCh for 7 days (equivalent to two cell divisions), 
and fresh cholesterol-containing media replenished every other day to allow for 
expansion of the spheres, a sign of mNPCs proliferation (Pacey et al., 2006).  
More than 4% trisomy 16 was detected in untreated cells (Figure 17A), which 
represents a constitutional genomic imbalance that has been previously reported  
 
 
Figure 17. Cholesterol-induced Trisomy 16 in Mouse Neural Precursor Cells 
(mNPC) 
(A) Fluorescently labeled BAC DNA probe containing a sequence of mouse chromosome 16 was used to 
detect aneuploidy levels in mouse neural precursor cells (mNPC) derived from prenatal brains of wild-type 
mice (E17-18).  Established neurospheres were treated with 4 µg/ml of WsCh for 7 days.  
(B) Quantitative FISH analysis showed a 2-fold increase in trisomy 16 in WsCh-treated cells compared to 
controls (Paired t-test).  mNPC harbor up to 4.6% endogenous aneuploidy reported previously in developing 
mouse and human brains (Peterson et al., 2008; Rehen et al., 2001; 2005).   
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in developing and adult healthy human and mouse brains (Peterson et al., 2008; 
Rehen et al., 2001; 2005; Westra et al., 2008; Yang et al., 2003; Yurov et al., 
2007).  Therefore, to detect measurable levels of cholesterol-induced aneuploidy 
over the background, mouse NPCs were incubated with the aneugenic 
concentration of cholesterol for longer time, and revealed 2-fold increases in 
trisomy 16 compared to untreated cells (p = 0.01, Paired t-test; Figure 17B). 
 
Differential Distribution of Cholesterol and Trisomy 21 in NPC1 Neurons, 
Glia, and Fibroblasts 
 
To investigate the role of disrupted central and peripheral cholesterol 
homeostasis in chromosome segregation in a human neurodegenerative disease 
model, primary cells derived from the patients diagnosed with Niemann-Pick 
Type C (NPC) disease (Table 1 in Chapter Three) were utilized.  All patients 
donors were clinically diagnosed with NPC, and the presence of disorder 
assessed with either filipin staining or the cholesterol esterification assay (Park et 
al., 2003), and by DNA analysis to confirm the mutation in NPC1 gene.  
Mutations and deletions in the NPC1 and NPC2 genes cause impaired trafficking 
of unesterified cholesterol (both LDLR-internalized and endogenously 
synthesized) and other lipids (e.g., glycosphingolipids) that accumulate in late 
endosomes and lysosomes and fail to travel to the plasma membrane and ER 
(reviewed in Karten et al., 2009; Mukherjee and Maxfield, 2004; Peake and 
Vance, 2010).  Like with exogenously delivered cholesterol that changes plasma 
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membrane stiffness, the ‘lipid traffic jam’ (Mukherjee and Maxfield, 1999) and 
differential redistribution of intracellular cholesterol in NPC1/2 cells, including 
neurons and glia away from plasma membrane (Karten et al., 2002; 2003; 
Mukherjee and Maxfield, 2002) may affect membrane fluidity and elasticity 
(Mukherjee and Maxfield, 1999), and proper chromosome segregation during 
mitosis, which may lead to the development of aneuploid cells susceptible to 
other cellular insults (e.g., oxidative stress) and apoptosis (Brusciglio and 
Yankner, 1997).  Thus, intracellular cholesterol imbalance as a pathological 
process that causes neurodegeneration in NPC disease may affect plasma 
membrane structure of dividing cells and neural precursors, making them prone 
to mitotic errors.    
To test the association between cholesterol redistribution and genomic 
instability in NPC disease, following assays were used: (1) immunofluorescence 
labeling and fluorescence microscopy to compare the localization of unesterified 
cholesterol between the neurons in NPC and age-matched normal brains; and 
(2) FISH analysis to detect the level of chromosome mis-segregation in NPC 
neurons, glia, and fibroblasts.  First, to visualize cholesterol distribution in 
neurons from the sample (Table 1), a single-cell suspension derived from frontal 
cortices of NPC cases and controls was fixed in PFA and co-stained with 
neuronal marker (Neu-N Alexa Fluor® 488 antibody) and filipin (Figure 18A) as 
described (Millard et al., 2000), and quantified into three distinct categories 
based on filipin stain intensity (i.e., plasma membrane, intracellular and both).  
Pronounced filipin-positive staining in endocytic organelles as indicative of 
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intracellular cholesterol sequestration has been reported previously in cellular 
(Jin et al., 2004; Millard et al., 2005), mouse models (Hawes et al., 2010; Kodam 
et al., 2010; Treiber-Held et al., 2003) of NPC, and in fibroblasts and neurons 
from NPC patients (Karten et al., 2002; reviewed in Morris and Carstea, 1998; 
Vanier, 2010).  Semi-quantitative analysis of cholesterol localization of the first 50 
NeuN/filipin-positive cells revealed significantly more cholesterol staining in 
intracellular compartments of NPC neurons (18%) compared to controls (2%, p = 
0.02, Independent t-test) in which cholesterol was associated mostly with the 
plasma membrane (85% verses 37%) (p = 0.02, Independent t-test; Figure 18B). 
Second, a separate single-cell suspension of NPC and control brain cells 
was fixed in methanol:acetic acid fixative and hybridized with the chromosome 21 
probe or dual-color DNA probes for chromosome 21 and 12 (Figure 18C), and 
chromosome 18 and 14 followed by immunocytochemistry with the NeuN 
antibody to distinguish between neuronal and glial cell.  Quantitative FISH 
analysis of Neu-N-negative and Neu-N-positive cells showed 4 to 6-fold 
increases in trisomy 21 in both neurons and glia with the NPC mutation, 
respectively compared to the cells from control brains (p = 0.02 and p = 0.0003, 
Independent t-test; Figure 7C middle and right panel and Figure 18D).  However, 
there was no increase in aneuploidy of chromosomes 12, 14 and 18 in the mixed 
brain cells population in NPC cases compared to controls (0.55% vs. 0.24%, p = 
0.11; 1.61% vs. 1.46%, p = 0.41; and 0.75% vs. 0.78%, p = 0.45, respectively).  
Third, primary fibroblasts from the patients harboring NPC1 mutations and 
fibroblasts from controls were subjected to FISH analysis with DNA probes for  
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Figure 18. Neurons, Glia, and Fibroblasts Derived from Niemann-Pick Type C1 
(NPC1) Patients Harbored Aneuploidy and Altered Cholesterol Distribution 
(A) NPC and control brain cells were co-stained with the NeuN antibody (green) and filipin (blue) to detect                                                                  
                                                                                                                                                       continued> 
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the localization of the intracellular cholesterol in neurons. 
(B) Semi-quantitative analysis and comparison of cholesterol distribution between NPC and control neurons 
revealed mostly perinuclear/cytoplasmic filipin staining in NPC and membrane staining in control cells. 
(C) NPC1 fibroblasts were analyzed by FISH with the DNA probe for chromosome 21 (red) and 12 (green), 
and counterstained with DAPI (blue) (first left panel). NPC brain cells from frontal cortices were subjected to 
FISH analysis with DNA probe for chromosome 21 (red) followed by co-staining with NeuN antibody (green) 
and DAPI (blue) nuclear stain, which revealed mostly disomic NeuN-positive (neurons) and NeuN-negative 
(glia) cells (middle panels) but significantly higher levels of trisomy 21 in NPC neurons (right panel) and glia 
compared to controls. 
(D) FISH analysis of NeuN-positive and NeuN-negative cells derived from patients harboring NPC mutations 
showed an increase in trisomy 21 cells compared to age-matched normal brain cells.  
(E) Likewise, human fibroblasts from NPC1 individuals showed an increase in trisomy 21 compared to age-
matched controls.  Independent t-test was used to compare cholesterol localization and the levels of trisomy 
21 between cases and controls.  
 
chromosome 21 and 12 and compared for chromosome mis-segregation.  We 
observed a 4-fold increase in trisomy 21 in NPC1 cells (p = 0.03, Independent t-
test; Figure 18C left panel and Figure 18E) and an induction of aneuploidy 12 
that did not reach statistical significance compared to normal fibroblasts (2.1% 
vs. 0.4%, p = 0.12).  
 
LIPOPROTEINS/CHOLESTEROL-INDUCED ANEUPLOIDY IN VIVO 
 
Low and High Cholesterol Diets Induced Trisomy 16 in Splenocytes 
 
An increasing body of evidence from observational and experimental studies 
suggests that the disruption in systemic cholesterol homeostasis plays a role in 
AD onset and progression (reviewed in Canevari and Clark, 2007; Panza et al., 
2009; Puglielli et al., 2003; Wolozin, 2004).  For example, recent epidemiological 
studies suggested a positive association between hypercholesterolemia at midlife  
and the risk of AD decades later (Anstey et al., 2008; Kivipelto et al., 2001;  
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2002a;  Solomon et al., 2007; 2009), and an increased risk of dementia/AD 
among individuals consuming high cholesterol and/or saturated fats diet 
(Engelhart et al., 2002; Kalmijn et al., 1997; Laitinen et al., 2006; Luchsinger and 
Mayeux, 2004; Morris et al., 2003; Parrot and Greenwood, 2007).  Likewise, 
murine and other animal models, including FAD transgenic mice fed a high 
cholesterol diet (1-1.3% w/w) developed pronounced amyloid burden and 
increased Aβ production (both central and peripheral), cerebrovascular 
disturbance, inflammation and steeper cognitive decline and learning impairment 
compared to animals on regular diets (Galloway et al., 2007; 2008; Hooijmans et 
al., 2007; 2009; Li et al., 2003; Levin-Allerhand et al., 2002; Oksman et al, 2006; 
Refolo et al., 2000; Shie et al., 2002; Sparks et al., 1994; Thirumangalakudi et 
al., 2008; Tibola et al., 2010) within 5-12 weeks.  Wild-type mice on long-term 
cholesterol enriched regimens (e.g., Typical Western, Atherogenic, Thomas-
Hartroft Diet) developed dyslipidemia (i.e., high total plasma cholesterol), altered 
VLDL, LDL and HDL metabolism, cerebrovascular disturbances, 
neuroinflammation, increased hepatic steatosis, atherosclerosis, and aerobic 
and/or cognitive dysfunction (Li et al., 2003; Maxwell et al., 2009; Paigen et al., 
1990; Sullivan et al., 1997; Thirumangalakudi et al., 2008).  Furthermore, 
inhibition of endogenous cholesterol synthesis with statins has been associated 
with a reduced risk of AD and decreased amyloid deposits in several human 
(Dufouil et al., 2005; Haag et al., 2009; Jick et al., 2000; Li et al., 2007; Sparks et 
al., 2005; Wolozin et al., 2000) and animal studies (Fassbender et al., 2001; 
Refolo et al., 2000).  The mechanistic link between increased extracerebral 
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cholesterol content and intracerebral Aβ load is not fully understood (Puglielli et 
al., 2003), but it points to disrupted oxysterol homeostasis (Papassotiropoulos et 
al., 2002; Xie et al., 2003), vascular insults (reviewed in Bell and Zlokovic, 2009; 
Casserly and Topol, 2004; de la Torre, 2010; Iadecola, 2010) and compromised 
blood-brain-barrier (Takeshi et al., 2010; Zlokovic et al., 2008).    
In the following in vivo experiment, it was investigated whether diet-
induced hypercholesterolemia in atherosclerosis-susceptible wild-type mice, the 
C57BL/6J strain (Li et al., 2003; Paigen et al., 1990) has an effect on 
chromosome-segregation in peripheral (splenocytes) and brain cells.  Twelve 
one month old nontransgenic mice (6 males and 6 females), the offspring from 
the same breeding pair were randomly assigned to three dietary regiments (two 
mouse pairs per group) for 12 weeks: (1)  a regular rodent diet (18% protein, 5% 
crude fat from oil and 0% cholesterol w/w; Harlan Laboratories); (2) a low (25% 
protein, 4.2% crude fat and 0.02% cholesterol w/w, Harlan Laboratories); and (3) 
a high cholesterol diet (17% protein, 21% milk fat, and 1% cholesterol w/w, total 
cholesterol of 1.05%, Harlan Laboratories).  The characteristics of the mice 
throughout the study are summarized in Table 2.   
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Table 2. Characteristics of the Mice Fed Three Different Diets for 12 Weeks  
 
Compared to other diets, mice fed a low cholesterol diet consumed more food per mouse pair/week (p < 
0.001, Paired t-test).  Also, in each dietary group except for a low cholesterol diet, female pairs consumed 
more food/g/mouse pair/week (p < 0.05). Correspondingly, mice fed a low and high cholesterol diet digested 
significantly more DE compared to mice fed a regular diet (p < 0.001; Paired t-test).  All female pairs except 
in a low cholesterol diet group consumed more DE than male pairs (p < 0.05). Thus, mice fed high 
cholesterol diet gained significantly more weight within 60 days compared to mice on a regular and low 
cholesterol diet (p < 0.05, Paired t-test).  
Digestible Energy (DE) is the total amount of energy in the diet minus the energy in indigestible portion of 
the food.  
All values are presented as M ± SD.  Paired Student t-test was used to compare the differences in food and 
caloric intake and weight gain between dietary groups. *p<0.05, **p<0.01, ***p<0.001 
 
Compared to other diets, the mice fed a low cholesterol diet consumed more 
food per mouse pair/week (p < 0.001, Paired t-test), and the mice on either a low 
and high cholesterol diet digested significantly more Digestible Energy per week 
compared to the mice fed a regular chow (p < 0.001, Paired t-test).  Because of 
the difference in caloric value between the diets, the mice on a high cholesterol 
diet gained on average 2 ½ times more weight than the mice fed either a regular 
chow or low cholesterol diet within 60 days of intervention (p < 0.05; Paired t-
test).  All four mice in the high cholesterol group developed hepatic steatosis, a 
sign of dyslipidemia while mice in the two other dietary groups showed no 
indication of fatty deposits in the livers (observational data).  Oil-Red-O staining 
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of isolated hepatocytes revealed pronounced Oil-Red-O staining in mice fed a 
high cholesterol diet compared to mice consuming regular chow (Figure 19A) 
Primary splenocytes cultures were grown according to established 
protocol (Boeras et al., 2008) for 44 hours in Con A containing media, fixed and 
prepared for FISH analysis with fluorescently labeled BAC probe for 
chromosome 16. Brains were processed to yield a single-cell suspension as 
described elsewhere and analyzed for aneuploidy (Granic et al., 2010).  FISH 
analysis of spleen cells from mice fed a low  and high  cholesterol diet showed a 
significant increase in trisomy 16 compared to splenocytes of mice fed a regular 
diet (p = 0.005 and p = 0.02, respectively, Paired t-test; Figure 19B), and no 
induction of aneuploidy  in the brain cells  (data not shown).  While there are no 
animal studies to date demonstrating that diet-induced hypercholesterolemia in 
nontransgenic mice affects brain cholesterol homeostasis, the data suggest that 
development of aneuploidy cells in peripheral (visceral) tissues of animals fed 
high cholesterol may be an initiating event that precedes the induction and 
accumulation of aneuploidy in the brain resulting from, for example, 
compromised BBB (Zlokovic, 2008).  Lipoproteins and Aβ complexes from the 
periphery may pass across weakened BBB as demonstrated by co-localization of 
plasma ApoB and Aβ close to the cerebral vasculature (Takechi et al., 2010) and 
thus contribute to genomic instability in the brain. 
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Figure 19.  Young Wild-type Mice Fed Low (0.02%) and High (1.05%) Cholesterol 
Diets for 12 Weeks Developed Higher Levels of Trisomy 16 in Spleen Cells 
Compared to Mice Fed Regular Diet 
(A) Mouse hepatocytes (hematoxylin; light gray in micrograph) were stained with Oil-Red-O stain (dark gray 
in micrograph) to detect accumulation of lipid droplets, a sign of liver steatosis and consequence of 
dyslipidemia.  
(B) Quantitative FISH analysis of primary splenocytes revealed a 2 to 3-fold induction of trisomy 16 in a low 
and high cholesterol diet fed mice compared to the animals on a regular diet (Paired t-test).  No induction of 
aneuploidy in the brain cells was observed in either low or high cholesterol diet fed mice (data not shown). 
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MECHANISM OF LIPIDS-INDUCED CHROMOSOME MIS-SEGREGATION 
 
Alterations in Extracellular Ca2+ may Attenuate OX-LDL and LDL-induced 
Aneuploidy In Vitro 
 
It has been postulated that perturbed calcium homeostasis plays an important 
role during aging and in AD pathogenesis (Eckert et al., 1994; Khachaturian, 
1994; LaFerla, 2002).  Aβ peptide neurotoxicity is partly explained by Ca2+ 
dysregulation in synapses early in AD (Green and LaFerla, 2008).  Increased 
production of a longer, more toxic version of Aβ peptide, Aβ42, by mutations in 
PS1 and PS2 gene leads to overload of intracellular calcium stores and deficits in 
Ca2+ refilling mechanism, and reductions in γ-secretase/PS1-dependent Ca2+ 
levels in the ER (Mattson and Chan, 2003).  Recently, it has been shown that 
oligomeric Aβ incorporates into neuronal membranes forming ‘amyloid channels’ 
that contribute to Ca2+ disturbances prior to the accumulation of Aβ deposits and 
classic senile plaque burden (Kawahara et al., 2011).  Furthermore, calcium 
augments Aβ formation and tau phosphorylation (reviewed in LaFerla, 2002; Yu 
et al., 2009), and it is required for Aβ-induced inactivation and cleavage of tau 
(Park and Ferreira, 2005), as well as for the proper function of kinesin-like MT 
motors important for spindle formation and mitosis (Vinogradova et al., 2009; 
Wang and Schwarz, 2009).  In the study of Aβ-induced aneuploidy, this 
laboratory has shown that chelation of extracellular Ca2+ with BAPTA prevented 
chromosome mis-segregation in vitro (Granic et al., 2010), possibly by 
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inactivation of calpain-mediated tau cleavage and consequent destabilization of 
microtubules.  
To elucidate the role of Ca2+ in lipoproteins/cholesterol-induced 
aneuploidy and to investigate whether the blockage of Ca2+ influx may normalize 
chromosome mis-segregation, several experiments with hTERT-HME cells using 
two different chelating reagents, EGTA and BAPTA were conducted.  First, the 
cells were pre-treated with 1.5 mM of EGTA for 3 minutes before the incubation 
with 20 µg/ml of lipoproteins for 48 hr, then fixed by standard cytogenetic 
procedures and analyzed by FISH.  Karyotype and FISH analysis revealed a 
slight increase in total aneuploidy and lower mitotic index in EGTA-treated cells, 
but similar levels of trisomy 21 and 12 compared to controls (data not shown).  
Contrasting the aneuploidy levels of the cells treated with EGTA and lipoproteins 
to cells incubated only with lipids, we observed a 3-fold decrease in OX-LDL 
induced trisomy 21 (p = 0.04, Paired t-test; Figure 20A), tetrasomy 21 (p = 0.01, 
Paired t-test), and tetrasomy 12 (p = 0.03, Paired t-test; Figure 20B).  Second, to 
confirm these results, the hTERT-HME1 cells were pre-incubated with 1 mM of 
extracellular Ca2+ chelator BAPTA for 3 minutes, and treated with lipids for 48 hr.  
The results showed a statistically significant BAPTA-dependent reduction in OX-
LDL-induced trisomy 21 (p = 0.02; Paired t-test), trisomy 12 (p = 0.01; Paired t-
test; Figure 20C) and a borderline decrease in trisomy 21 in LDL-treated samples 
(p = 0.065; Paired t-test; Figure 20C). 
 
126 
 
 
Figure 20. Alternations in Extracellular Ca2+ with Chelators may Attenuate OX-LDL-
induced Aneuploidy In Vitro  
(A-C) Quantitative FISH analysis with dual-labeled DNA probe for chromosomes 21 and 12 showed a 
significant reduction in trisomy 21 (A), tetrasomy 21 (light gray bars, B) and tetrasomy 12 (black bars, B) in 
hTERT cells pretreated with 1.5 mM of Ca2+ chelator EGTA compared to the cells treated only with OX-LDL. 
                                                                                                                                                    continued> 
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(C) Also, cells pretreated with 1 mM BAPTA had significantly lower levels of OX-LDL-induced trisomy 21 
(light gray bars, C) and trisomy 12 (black bars, C) compared to the cells grown without chelator.  Paired t-
test was use to compare aneuploidy levels between the lipids-treated cells with and without chelators.  
 
 
Changing Membrane Fluidity by Ethanol Decreased Lipids-induced 
Chromosome Mis-segregation In Vitro 
 
The membrane fluidizing property of ethanol (EtOH) and its effect on the 
biophysiology of different mammalian cell including neuronal membranes, has 
been recognized (Alling, 1983; Goldstein, 1983; Rubin and Rottenberg, 1982) 
and actively investigated (e.g., Bae et al. 2005; Marques et al., 2011; Serget et 
al., 2004).  The membrane disordering effect of acute and chronic ethanol 
exposure has been attributed to several processes, including (1) perturbation of 
acyl chains’ ordering within the membrane (Holte and Gawrisch, 1997; Marques 
et al., 2011); (2) altered binding to the lipid-water surface (Barry and Garwrisch, 
1994); (3) changed membrane cholesterol content compared to other lipids 
(Yamada and Lieber, 1984), and (4) oxidative stress induced by ethanol 
metabolism (Sergent et al., 2004).  As mentioned before, both lipoprotein- and 
MβCD-delivered cholesterol increase the membrane cholesterol content in vitro 
(Abramov et al. 2011), decreasing membrane fluidity and elasticity (Demel and 
De Kruyff, 1976).  It could be hypothesized that the cells with 
lipoprotein/cholesterol-enriched membranes may be prone to mitotic errors, and 
that this biological effect may be counteracted by membrane-fluidizing actions of 
ethanol.   
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To determine whether enhancing membrane fluidity with ethanol prior to 
lipoproteins/cholesterol treatment may reduce aneugenic effect of lipids, the 
hTERT cells were pretreated with 25 mM of EtOH for 24 hr and further co-
incubated with lipids in EtOH-containing media.  The rationales for using this 
concentration of EtOH were: (1) 25 mM or 0.115% correspond to the blood-
alcohol  levels of moderate drinkers (1-3drinks a day, 15-45 g), which has been 
associated with a decrease in CVD (Rimm et al., 1999) and AD (Luchsinger et 
al., 2004) risk; 2) increased cholesterol efflux and cholesterol transport but 
unchanged cholesterol synthesis have been observed in human astrocytes in 
vitro at the concentration of 25 mM of EtOH in the presence and absence of 
cholesterol acceptors (Guizzetti et al., 2007); (3) preincubation of hepatic cells 
with 0.5% EtOH did not have an effect on LDLR or LDL (Dashti et al., 1996); (4) 
25mM EtOH fluidized the exofacial leaflet of the synaptic membranes (Schroeder 
et al., 1988; Wood et al., 1989); and (5) pilot experiments showed low cytotoxicity 
and up to ~95% of cell viability within 48 hr of EtOH exposure and non-significant 
induction of aneuploidy (data not shown).  To avoid evaporation and assure 
consistent concentration of EtOH in the culture (Eysseric et al., 1997), a modified 
closed chamber system was used (i.e. ‘compensating system’, described below; 
Adickes et al., 1988; Rodriguez et al., 1992) with EtOH replenished every 24 hr.  
A colorimetric assay (OD570; Ethanol Assay Kit, BioVision) was used to measure 
the ethanol concentrations in two random EtOH-containing samples at the 
baseline, 24 and 48 hr later and calculated according to manufacturer’s 
specifications (mean ± standard deviation of three dilutions; M ± SD; 22.32 ± 
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0.36, 20.39 ± 0.58, and 18.29 ± 0.59 mM, respectively).  A slight decrease in 
EtOH levels within 24 hr of each time point was not statistically significant (Paired 
t-test, data not shown).  
Quantitative FISH analysis with dual-labeled translocation DNA probe of 
lipoproteins/EtOH-treated cells showed a significant decrease in OX-LDL and 
LDL-induced trisomy 21 (p = 0.015, Paired t-test; Figure 21A), and OX-LDL and 
LDL-induced trisomy 12 (p = 0.012, Paired t-test; Figure 21B), suggesting that 
fluidization of the membranes by EtOH may stabilize chromosome segregation 
upon lipid treatment.  In this experiment, a statistically significant LDL-induced 
aneuploidy for chromosomes 21 and 12 was observed (p = 0.02 and p = 0.03, 
respectively, Paired t-test), which separately reached a borderline significance in 
previous experiments (Figure 12B, C), a variation that may be contributed to the 
clonal change in hTERT aneuploidy background (Granic and Potter, unpublished 
data) and to a difference in LDL-cholesterol composition between different 
lipoprotein batches.   
It has been reported previously that ethanol can affect cell proliferation 
(Guizzetti et al., 1997; Luo and Miller, 1998) by affecting the length of G1 and S 
phase (Hicks et al., 2010), and by delaying the progression though M phase of 
the cell cycle (Mashimo et al., 1999).  Also, recent in vitro studies showed 
ethanol-induced chromosomal instability and chromosomal damage in human 
cell lines, including neurons (Benassi-Evans and Fenech, 2011, Kayani and 
Parry, 2010; Lamarche et al., 2004).  Here, a non-significant increase in trisomy 
21 (Figure 21A), tetraploidy 21 and 12 in 25 mM EtOH-treated cells was 
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observed within 72 hours, and no reduction in OX-LDL and LDL-induced 
tetraploidy in EtOH pre-incubated samples (data not shown).  An opposing effect 
of lipoproteins and ethanol on chromosomal stability in vitro could be postulated 
in which EtOH-induced fluidization of the membrane may attenuate or normalize 
its rigidity caused by exogenous lipoproteins/cholesterol delivery and increased 
membrane lipid content.  
 
 
Figure 21. Altering Membrane Fluidity with Ethanol Decreased Lipoproteins-
induced Aneuploidy In Vitro  
(A-B) Quantitative FISH analysis of hTERT cells pre-treated with 25 mM of ethanol (EtOH) for 24 hr and co-
incubated with lipoproteins and EtOH for next 48 hr revealed a decrease in OX-LDL and LDL-induced  
                                                                                                                                                continued> 
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trisomy 21 (A) and trisomy 12 (B) (Paired t-test).  No change in tetraploidy 21 or 12 was observed (data not 
shown).  This experiment was conducted in the closed chamber system to counteract EtOH evaporation and 
to assure consistent EtOH concentration. Colorimetric assay (OD570) was used to measure EtOH levels in 
two random samples at the baseline, 24, and 48 hr later.  A slight decrease in EtOH concentration within 48 
hr was observed, but stayed at 82% of the baseline. 
 
 
 To summarize, this study reported several novel findings investigating the 
cytogenic link between CVD and AD: (1) atherogenic lipoproteins (i.e., LDL, OX-
LDL) and cholesterol induced chromosome mis-segregation, including trisomy 
and tetrasomy 12 and 21, and trisomy 7 in primary human and mouse cells in 
vitro, and apparently require a functional LDL receptor but not the presence of 
APP gene to exert their aneugenic effect; (2) disturbance in intracellular 
cholesterol homeostasis and obstructed cholesterol trafficking to the plasma 
membrane may be associated with an increase in trisomy 21 in NPC1 fibroblasts, 
neurons and glial cells; (3) long-term exposure to dietary cholesterol may induce 
chromosome mis-segregation in peripheral tissues of young wild-type mice; and 
(4) alternation in either extracellular Ca2+ homeostasis or plasma membrane 
fluidity may decrease lipoproteins/cholesterol-induced aneuploidy in vitro. 
132 
 
 
 
      CHAPTER FIVE 
        DISCUSSION  
 
The main premise of this dissertation was that atherogenic 
lipoproteins/cholesterol disrupt genomic stability in vitro and in vivo and thereby 
contribute to the etiology of Alzheimer’s disease.  Several important ideas and 
discoveries prompted the research described here, including that (1) the cell 
cycle defects and chromosome mis-segregation as a pathological trait of 
Alzheimer’s disease are associated with overexpression or mutations in FAD 
genes, PS1/2 and APP, and its proteolytic product, the amyloid-beta peptide, 
which acts as a mitotic spindle toxin leading to accumulation of aneuploid and 
hyperploid, apoptosis prone neurons and neural progenitors (e.g., Arendt et al., 
2010; Boeras et al., 2008;  Borysov et al., 2010; Granic et al., 2010; Iourov et al., 
2009; Obrenovic et al., 2003; Potter, 1991, 2008); (2) atherosclerotic plaques are 
characterized by a monoclonal expansion of smooth muscle cells in arterial walls 
under high LDL (OX-LDL)-cholesterol stimuli (e.g., Matturri et al., 1997; 2001), 
which trigger chromosomal aberrations; (3) disturbed cholesterol homeostasis as 
a risk factor for AD is associated with enhanced amyloidogenesis and 
atherogenesis in the brain and blood vessels, changed plasma membrane 
dynamics, and compromised integrity of the BBB (e.g., Casserly and Topol, 
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2004; Dolan et al., 2010; Solomon et al., 2007; Xiong et al., 2009; Zlokovic, 
2008), leading to decreased clearance of neurotoxins, inflammation and neuronal 
death.  Despite a body of molecular, cellular and epidemiological evidence 
pointing to the central role of lipoproteins/cholesterol in AD initiation and 
progression, the mechanistic connections between cardiovascular and brain 
disease risk factors (e.g., hypercholesterolemia) are only partly understood. One 
challenge has been that there is a separation and limited exchange between 
peripheral and central cholesterol pools, suggestive of independent pathological 
pathways.   
Cholesterol is a molecule essential for life, involved for example in brain 
development and function—yet excess, shortage or erroneous distribution of 
extracellular or intracellular cholesterol could be detrimental and lead to 
neurodegeneration.  Investigating further the event of chromosomal instability as 
a ‘cytogenetic hallmark’ of AD and the involvement of other dementia-associated 
molecules in aneugenesis, this study revealed that the cell lines with a functional 
LDL receptor developed mitotic defects and aneuploidy of several chromosomes, 
including HSA21 upon treatment with elevated levels of lipoproteins (OX-LDL 
and LDL) and cholesterol, the common risk factors for AD and CVD 
(atherosclerosis), independently of Aβ-mediated genomic instability.  The cells 
exposed to cardioprotective HDL-cholesterol (Assmann and Gotto, 2004) were 
less prone to genomic errors.  Furthermore, disrupted intracellular cholesterol 
homeostasis in Niemann-Pick skin and brain cells was associated with HSA21 
mosaicism, possibly due to the changed distribution of the cellular cholesterol 
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between the cytosolic compartments and plasma membrane.  In the animal 
model of diet-induced hypercholesterolemia, atherosclerosis susceptible wild-
type mice fed a high cholesterol diet soon developed aneuploidy in peripheral 
cells.  Attenuation of the extracellular calcium levels and therefore the 
inactivation of, for example calpain-mediated tau cleavage, decreased the lipid-
induced chromosome mis-segregation in cultured cells.  Also, changing the 
plasma membrane property with ethanol prior to and during lipoproteins and 
cyclodextrin-derived cholesterol incubation reduced aneugenesis by 2-3-fold in 
vitro.  Taken together, the data suggest a common pathological trait and a unique 
cytogenetic mechanistic link between AD and atherosclerosis in which elevated 
cholesterol acts as environmental aneugen.   
This chapter will explore (1) the relevance of lipid-mediated aneuploidy in 
AD with regards to the recent findings involving membrane cholesterol-Aβ-tau 
and calcium homeostasis connections (2) the possible role of plasma membrane 
fluidity in cholesterol-induced genomic instability; (3) the limitations of employed 
experimental designs; (4) future experiments to further address the research 
questions; and (5) diagnostic and therapeutic implications of the chromosome 
mis-segregation in AD and CVD. 
 
LIPOPROTEINS/CHOLESTEROL-INDUCED ANEUPLOIDY IN VITRO 
 
Several human cell lines (mostly derived from primary cultures) used in this study 
developed a rapid chromosome mis-segregation and aneuploidy of 
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chromosomes 7, 12 and 21 upon treatment with atherogenic lipoproteins, OX-
LDL and LDL, compared to HDL-treated cells or untreated controls (Figures 12B-
G; 13A; 14A).  The studies of atherogenesis have shown that smaller and denser 
LDL particles are prone to oxidation and easily penetrate into subendothelial 
arterial space, initiating the atherosclerotic process (Berliner and Haberland, 
1991; reviewed in Ross, 1993; Tsimikas and Miller, 2011).  The data presented 
here suggest another biological role of atherogenic lipoproteins—induction of cell 
cycle defects and aneuploidy that is likely to affect other chromosomes besides 
7,12, and 21.   
Mis-segregation of chromosomes 7, 12 and 21 has been reported in 
previous studies in the brains and peripheral tissues of AD patients (e.g., Geller 
and Potter, 1999; Iourov et al., 2009), as well as in the mouse and cellular 
models of AD (e.g., Boeras et al., 2008), and in atherosclerotic plaques (e.g., 
Matturri et al., 1997; 2001).  To date, it is not known whether or how the 
relationship between the AD candidate genes and mis-segregation of carrier 
chromosomes, and thus altered gene (gene product) expression, bears on the 
etiology of AD.  Whereas aneuploidy of HSA21 fits well with the Down Syndrome 
Model of AD (Potter, 1991), altered genomic homeostasis (i.e., APP 
overexpression) and the Amyloid Cascade Hypothesis (e.g., overproduction of 
Aβ) (Hardy, 2006), other chromosomes susceptible to mitotic errors may carry 
the genes involved in other pathways significant to AD, such as cholesterol 
metabolism and de novo lipogenesis.  For example, recent genome scan and 
association studies reported at least three late-onset AD candidate genes located 
136 
 
on chromosome 12 (e.g., Scott et al., 2000); of which oxidized LDL (lectine-like) 
receptor 1(OLR1), a gene implicated in lipid metabolism, has been proposed as a 
risk factor for AD in some French and American families (Lambert et al., 2003), 
and has been associated with increased Aβ40 levels and pronounced CAA in 
frontal cortices of AD patients (Shi et al., 2006).  Moreover, OLR1 has been 
linked to tumorigenesis (Hirsch et al., 2010), upregulation of NF-κB and its target 
oncogenes responsible for inhibition of apoptosis (Khaidakov et al., 2011) and to 
development of atherosclerotic lesions (Chen et al., 2000), suggesting a 
mechanistic overlap between atherogenic and oncogenic pathways.  
A future study utilizing SKY or mFISH techniques could determine, for 
example, the frequency and type of chromosomal aberrations for each 
chromosome in mitotically active cells upon lipoprotein treatments, and establish 
whether, under certain aneugenic stimuli, some chromosomes are lost or gained 
more than others.    
It is well established that ApoE and LDL receptors are key players in the 
etiology of AD (e.g., reviewed in Gopalraj et al., 2005; Jaeger and Pietrzik, 2008; 
Kim et al., 2009) and are involved in ‘lipid’ and ‘amyloid cascade’ pathways.  Both 
candidate genes reside on chromosome 19 (19q13.2 and 19p13.2, respectively) 
(Francke et al., 1984; Lin-Lee et al., 1985; Smit et al., 1988) within the A-T rich 
and gene poor chromosome bands as revealed by G-banding (Rønne, 1990; 
Ushiki et al., 2002), but the loss or gain of this chromosome has not been 
reported in relation to AD.  Early molecular studies in the laboratory of H. Potter 
that investigated the role of ApoE allelic variants in Aβ polymerization (Ma et al., 
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1994; 1996) and their possible involvement is the cell cycle defects in AD, 
determined that apoprotein alone had no aneugenic properties in vitro, but rather 
the lipid cholesterol bound to it could be the candidate effector molecule that 
triggered erroneous chromosome segregation (Lee and Potter, 1995; 
unpublished data).  This dissertation confirmed the initial hypothesis.  However, it 
is not known whether the absence of ApoE or presence of its different allelic 
variants (i.e., ε2, ε3, and ε4; Strittmater et al., 1993a) would result in a more or 
less pronounced aneugenic karyotype upon lipoprotein treatment.  Similarly, 
whether AD transgenic mouse models harboring mutant APP or PS1 genes in 
combination with different APOE alleles develop variable aneuploidy profiles may 
be worthwhile to investigate.   
As mentioned above, ApoE, a major cholesterol transporting molecule in 
the brain and a ligand for LDLR in neurons and glia, is produced de novo by 
astrocytes (reviewed in de Chaves and Narayanaswami, 2008), and performs 
several functions that are isoform-specific.  ApoE coordinates cholesterol intake 
and redistribution during development or after neuronal injury (May et al., 2007; 
Poirier, 2003); it associates with Aβ, promoting its aggregation in an isoform-
specific manner (e.g.,Ma et al., 1994;  Wisniewski et al., 1994), and is involved in 
inflammation, tau aggregation, signaling transduction, and brain cells survival 
(Gee and Keller, 2005; Kim et al., 2008).  To date, APOE ε4 gene is the most 
investigated and best established risk factor for late-onset of AD.  There is no 
consensus among the researchers about the relationship between cholesterol 
homeostasis, ApoE and AD (Kivipelto et al., 2002a).  One of the hypotheses 
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reviewed by de Chaves and Narayanaswami (2008) emphasizes the isoform-
specific effect of ApoE in AD pathogenesis.  Animal and cellular studies revealed 
several pathology-promoting features of APOE ε4 gene, which include: (1) less 
efficient cholesterol delivery to neurons for regeneration and repair; (2) impaired 
antioxidant mechanism; (3) promotion of tau and Aβ aggregation; (4) reduced Aβ 
clearance; (5) dysregulation of neuronal signaling; (6) altered LDL receptor 
binding; (7) greater susceptibility to proteolytic degradation and aggregation; (8) 
and lesser cellular cholesterol release (reviewed in de Caves and 
Narayanaswami, 2008).  It is believed that compared to ε4, other isoforms of the 
APOE gene are neuroprotective (Ma et al., 1994; Wisniewski et al 1994; Rebeck 
et al., 2002), and are less involved in AD-promoting pathways.  Taken together, it 
could be hypothesized that the carriers of APOE ε4 genotype in combination with 
unfavorable AD genes and environmental risk factors may be more at risk for AD 
and neurodegeneration than non-carriers, but whether they are more susceptible 
to chromosome instability is currently not determined.    
 
The role of APP and LDLR in Lipid-induced Aneuploidy 
 
This study provided in vitro evidence that aneugenic effect of lipoproteins may be 
independent of APP expression and Aβ production, and that both aneugens may 
act separately, at least in their early steps.  On the other hand, a functional LDL 
receptor was required for aneugenic activity of LDL.   
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Accumulated evidence from molecular and animal studies indicates that 
cholesterol is involved in APP processing and Aβ generation (e.g., Eckert et al., 
2000; Refolo et al., 2001; Solomon et al., 2009), partly by affecting the activity of 
membrane-associated APP-secretases (e.g., Ehehalt et al., 2003; Kojro et al., 
2001).  Aβ toxicity includes the interference with a proper mitotic spindle function 
(Borysov et al., 2011) and consequent aneuploidy that is dependent on a 
functional Tau gene and on the presence of endogenous APP (Granic et al., 
2010).  To determine whether lipids and Aβ-induced chromosome mis-
segregation are mechanically related, mouse spleen cells lacking the APP gene 
were exposed to lipoproteins, and the aneuploidy levels compared to lipid-treated 
cells with a functional gene (Figure 15B) under the same experimental 
conditions.  Comparable levels of OX-LDL and LDL-induced trisomy 16 (up to 
~5.5%) were observed in both cell lines, suggesting that neither endogenous 
APP or Aβ, nor Aβ-induced Tau phosphorylation was required for lipoprotein-
induced aneuploidy.   
To confirm these results in other cell models, the following experiments 
could be conducted.  To determine the role of APP in lipid-induced aneugenesis 
in the brain cells, neural precursor cells (Pacey et al., 2006) derived from young 
APPKO mice with the established genotype could be treated with isolated lipids 
prepared with ApoE as a protein carrier.  Human monocyte-derived 
macrophages exposed to OX-LDL exhibit increased production of lipid-free ApoE 
(Cader et al., 1997), which could be immunoprecipitated from the culture 
supernatant, and, coupled with purified lipids, extracted and isolated by the 
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method described by Bligh and Dayer (1959) to generate ApoE containing LDL 
particles.  In addition, siRNA gene silencing technology (Elbashir et al., 2001) 
could be employed to transiently block the expression of APP in a human cell line 
followed by the treatment with lipoproteins.  
As discussed previously, the LDL receptor family has been implicated in 
several processes relevant to AD pathogenesis, which include isoform-specific 
ApoE binding (Hertz and Beffert, 2000), APP trafficking and processing 
(Abisambra et al., 2010; Marzolo and Bu, 2010), decreased amyloid deposition 
and increased Aβ clearance upon overexpression (Kim et al., 2009), and 
synaptic plasticity (Herz, 2009).  In the periphery, the main function of LDLR is to 
mediate the removal of cholesterol from the bloodstream (Brown and Goldstein, 
1986), and to reduce the risk of atherogenesis and coronary heart disease 
(CHD).  The number of LDL receptors in liver, and thus the efficiency of LDL 
removal are regulated by the cholesterol content in hepatocytes (Goldstein and 
Brown, 1987).  The data reported here suggest another potential role of LDLR—
mediation of LDL-induced aneuploidy in vitro (Figure 14A).  Future studies could 
determine the relationship between downregulation and upregulation of LDL 
receptor and lipid-induced aneuploidy in vitro by manipulating the expression of 
the receptor prior to LDL-cholesterol treatment.    
Genetic defects in the LDLR gene result in impaired clearance of 
lipoproteins from the circulation and severe atherosclerosis and the risk of CHD.  
Mutations in LDLR are classified into several classes based on the 
characteristics of the mutant receptor (e.g., class 1 mutations lead to absence of 
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the protein; class 2 (50% of the mutations) affect the intracellular transport of the 
receptor; in class 3, mutant receptors can reach the cell membrane but are 
defective in binding to lipoprotein; class 4 mutations prevent the ligand-receptor 
internalization) (Gent and Braakman, 2004).  The class of the mutant FH cell line 
used in this study is not known, but it could be hypothesized that similar results 
would be obtained with cell lines harboring a different class of LDLR mutation.  
Alternatively, gene silencing technology could be used to completely block the 
receptor in hTERT-HME1 cells prior to lipid treatment to confirm the results 
obtained with the primary fibroblasts.   
In summary, it could be suggested that the presence of LDLR and 
absence of APP play a complex, interdependent role in lipoprotein-induced 
chromosome mis-segregation in vitro, which could be further explored by utilizing 
different cell models and methods.   
 
HIGH CHOLESTEROL DIET-INDUCED ANEUPLOIDY  
 
Epidemiological evidence suggests an association between high consumption of 
cholesterol and saturated fats and dementia (e.g., Engelhart et al., 2002; Kalmij 
et al., 1997; Luchsinger  and Mayeux, 2004; Morris et al., 2003; Solfrizzi et al., 
2005).  Similarly, familial AD (FAD) and nontransgenic animals on a long-term 
high cholesterol regimen develop dyslipidemia, neuroinflammation, increased 
amyloid burden, atherosclerosis, hepatic steatosis, and cognitive dysfunction 
(e.g., Levin-Allerhand et al., 2002; Li et al., 2003; Maxwell et al., 2008; Oksman 
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et al., 2006; Refolo et al., 2000) compared to animals on regular diets.  
Compromised BBB and vascular insults (Iadecola, 2010; Zlokovic, 2008) due to 
altered peripheral cholesterol homeostasis may affect the integrity of the central 
cholesterol metabolism and exacerbate AD pathology.   
 In this study, diet-induced hypercholesterolemia in nontransgenic young 
mice (1 month) was associated with mitotic defects and the accumulation of 
aneuploid cell in the periphery (splenocytes) (Figure 19) at a higher levels than in 
mice fed a low cholesterol diet or regular (non-animal fat containing) chow, 
suggesting that change in systemic cholesterol homeostasis may compromise 
genomic stability in dividing cells.  As discussed previously, patients diagnosed 
with sporadic AD harbor aneuploidy in various peripheral cells (lymphocytes, skin 
fibroblasts, buccal cells; Geller and Potter, 1999; Migliore et al., 1999; Thomas 
and Fenech, 2008), which could be contributed to several environmental 
aneugens and not related to Aβ-mediated chromosome mis-segregation.   
 Analysis of brain extracts of the mice fed different cholesterol diets in this 
study with ELISA (enzyme-linked immunosorbent assay) and immunoblotting for 
Aβ40 and Aβ42 levels, and for the expression of APP, phospho-tau and ApoE, 
respectively yielded inconclusive results (data not shown).  However, no 
difference in Aβ42 levels between the dietary groups was detected (ranged from 
22.3 to 23.4 pg/ml, p > 0.2), and similar performance on the task of spatial 
memory and learning utilizing a modified version of the Morris water maze 
(Nunez, 2008) over 12 consecutive trials (data not shown).  The diets in this 
study were not energy adjusted, and the caloric intake and weight gain between 
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the groups was statistically significant (Table 2), which influenced animals’ 
behavior and performance  during cognitive testing (e.g., mice with more adipose 
tissue floated better and were less stressed; observational data), but may also 
have affected the aneuploidy result.  Future study with the middle aged animals 
(5-6 months) should be conducted with cholesterol and regular diets of similar 
digestible energy and controlled intake, and mice cognitive performance 
assessed with other hippocampus-based memory test such as object recognition 
(Clark et al., 2000).       
 
POSSIBLE MECHANISMS OF ANEUPLOIDY INDUCTION 
 
The Role of Cholesterol in Biological Membrane  
 
Lipids are essential for membrane integrity, structure and function.  The plasma 
membrane is organized into two main domains, the exofacial (outer) and 
cytofacial (inner) leaflet, which differ in cholesterol and phospholipids content, 
ordering (cohesion and packing of e.g., acyl chains), fluidity, electric charge, 
location of microdomains (e.g., lipid rafts and calveolae), and the functioning of 
associated enzymes, receptors and proteins (Ikonen, 2008; Wood et al., 2002).  
Lateral and transbilayer distribution of the cholesterol within the plasma 
membrane is believed to be essential for several membrane functions such as: 
(1) permeability of ions and maintenance of solute concentrations on each side of 
the membrane; (2) anchoring and diffusion of the proteins; (3) vesicle formation; 
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and (4) organization of signaling transduction (Maxfield and Tabas, 2005).  
Membrane lipid domains and asymmetry in lipid distribution are not stationary 
and could be affected by aging (Schroeder, 1988), chemical treatments (e.g., 
ethanol, MβCD; Christian et al., 1997; Rubin and Rottenberg, 1982), and 
neuropathological conditions such as Alzheimer’s, Niemann-Pick, and Tangier 
disease (Eckert et al., 2000; Lee et al., 1998;  Koike et al., 1998; Mori et al., 
2001; Mukherjee and Maxfield, 1999; Orsό et al., 2000; Wood et al., 2002).  
Manipulation of the cholesterol content in the leaflets results in changed 
membrane fluidity which, for example, in the nervous system may affect the 
functioning of the membrane-bound neuronal receptors and modulate the binding 
of ligand molecules.  Several techniques have been developed to detect the 
difference and change in leaflet fluidity, including cationic and anionic 
fluorescently labeled probes (Schroeder, 1985) such as Laurdan fluorescence 
(Parasassi et al., 1990) or fluorescence quenching (Schroeder, 1985).  For 
example, a spectrofluorometer measures the intensity of the fluorescence 
polarization of Laurdan as a function of the change in the dipole moment of the 
fluorophore after excitation (Mukherjee and Chattopadhyay, 2005). 
 The experiments of this dissertation have shown that human cells treated 
with the MβCD:cholesterol complex, which serves as an acceptor of hydrophobic 
cholesterol and aids its delivery into the plasma membrane by inserting it into a 
central nonpolar cavity (Härtel et al., 1998), develop aneuploidy within 48 hours 
(Figures 16A, B; 17B).  This biological effect could be a consequence of the 
rigidifying effect of cholesterol in which cholesterol-enriched, more ordered 
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membranes fail to properly align and attach MT-bound chromosomes prior to 
anaphase, resulting in aneuploid progeny.  To determine whether changed 
membrane fluidity could be a mechanistic link between cholesterol exposure and 
chromosome mis-segregation, the change in membrane ordering prior and after 
cholesterol treatment could be measured by generalized polarization (GE) of 
Laurdan fluorescent probe (Parasassi et al., 1990).   
Early studies by Schroeder et al. (1988) and Wood et al. (1989) utilizing 
fluorescent quenching to measure the synaptic membrane fluidity upon treatment 
with 25mM of ethanol determined that the disordering (fluidizing) effect of this 
molecule affected primarily the exofacial leaflet.  The mechanism by which 
ethanol changes membrane fluidity has been ascribed to several processes, one 
being the change in the order and packing of acyl chains, which in rigid 
membranes are elongated and tight.  Upon ethanol exposure, the chains become 
disordered and loose, which allows for water and other small molecule to easily 
enter the bilayer space (Marques et al., 2011; Mukherjee and Maxfield, 2004).  It 
could be hypothesized that membrane rigidifying effect of cholesterol could be 
counteracted by membrane fluidizing action of ethanol, which should result in 
attenuation of lipid-induced aneuploidy (Figure 21A, B).  Whether lower 
concentrations and different pre-incubation times also have membrane-fluidizing 
effects, and whether lipoprotein-induced aneuploidy could be counteracted by 
ethanol in the dose-response manner over different time points is worthwhile to 
investigate, especially in cells directly involved in the atherosclerotic process.  A 
moderate red-wine consumption has been associated with the reduced incidence 
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of CVD in consumers of a typical French diet high in saturated fats and 
cholesterol (‘French Paradox’) (reviewed Lippi et al., 2010).  Alcohol and 
polyphenols (e.g., resveratrol) in red wine may act synergistically and increase 
the cholesterol efflux from blood vessel walls, decrease oxidative stress and lipid 
peroxidation, and prevent downstream atherosclerotic events such as foam-cell 
formation, but may also change membrane fluidity and reduce the aneugenic 
effect of dietary cholesterol as another mechanism of atherogenesis.   
 
The Role of Calcium in Aβ and LDL-Induced Aneuploidy 
 
Findings from this and a recent study (Granic et al., 2010) suggest that both LDL-
cholesterol and Aβ-induced chromosome mis-segregation could be attenuated by 
chelation of extracellular calcium (Figure 20A-E).  Whereas Aβ-mediated 
aneuploidy depends on functional APP and Tau genes, lipid-induced 
aneugenesis is independent of APP, but requires a functional LDL receptor.  Tau 
is essential for Aβ-induced neurotoxicity (Rapoport et al., 2002), and the calcium-
dependent protease calpain is activated by Aβ and generates neurotoxic tau 
fragments leading to neurodegeneration (Park and Ferreira, 2005).  Increased 
membrane cholesterol regulates the calcium influx (Bialecki et al., 1991), and 
increases the susceptibility of mature neurons to Aβ-induced calpain activation 
and production of 17kDa neurotoxic tau fragment.  A recent study by Abramov et 
al. (2011) showed that a higher cholesterol content in the plasma membrane 
increased Aβ-induced calcium signaling and apoptosis in both astrocytes and 
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neurons.  Whereas Nicolson and Ferreira (2009) were the first to propose a role 
for plasma cholesterol in a tau-Aβ-calcium mediated neurotoxicity pathway, the 
data presented here indicate that restoring calcium homeostasis and therefore, 
de-activating calpain-mediated tau cleavage and destabilization of microtubules 
may attenuate LDL-cholesterol induced chromosome mis-segregation in vitro 
(Figure 22).   
 
 
Figure 22. Possible Pathways Involving Calcium Homeostasis, Aβ and LDL-
cholesterol-induced Aneuploidy in Pathogenesis of AD 
Multiple interrelated pathways may be involved in the complex etiology of familial (FAD) and sporadic AD 
(SAD). Both Aβ and LDL induce chromosome mis-segregation in vitro within 48 hr.  Removal of extracellular 
calcium decreased both Aβ and LDL-mediated aneuploidy.  Elevated cholesterol changes plasma 
membrane fluidity (Weber et al., 2006) and increases Aβ-induced calcium signaling (Abramov et al., 2011), 
which in turn may increase the susceptibility of neurons to Aβ-dependent calpain activation, tau cleavage 
into neurotoxic fragments and apoptosis (Nicholson and Ferreira, 2009).  Calcium chelation may attenuate 
both Aβ and LDL-induced mitotic defects by restoring calcium homeostasis and de-activate calpain, and, 
consequently, preventing tau cleavage and destabilization of microtubules.   
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IMPLICATIONS OF CHROMOSOME MIS-SEGREGATION IN AD AND CVD 
FOR DIAGNOSIS AND THERAPY 
 
The mechanistic implication of the results presented in this dissertation is that 
disruption in cholesterol homeostasis may contribute to Alzheimer’s disease 
pathogenesis by inducing genomic instability and chromosome mis-segregation, 
and thus contributing to disease progression.  AD as the most common type of 
dementia in old age, currently affects 35.6 million people in either genetic 
(familial) or sporadic form, and that prevalence is expected to quadruple 
worldwide by the mid of the 21st century (Ferri et al., 2005).  Whereas genetic or 
early-onset AD accounts for only 5% of all cases (Cummings, 2004), 95% of 
sporadic or late-onset AD is attributed to the interaction of a number of factors 
such as advancing age, environmental insults, and to several risk-enhancing 
genetic polymorphisms (Bertram and Tanzi, 2004).  Likewise, CVD 
(atherosclerosis) is the most prevalent disorder and the number one killer in 
developed countries (Daviglus et al., 2006). 
The search for more effective diagnoses and therapy for AD and CVD 
should take into account mitotic defects in peripheral and central tissues of 
individuals at risk, especially those whose genetic predispositions and lifestyle 
factors (e.g., high-fat diet) increases the odds of developing both diseases.  
Chromosome analysis and detection of low levels of aneuploid cells utilizing 
FISH or spectral karyotyping in skin fibroblasts or buccal cells in patients at risk 
for cardiovascular events during the pre-clinical phase of dementia could be a 
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potential diagnostic tool.  Another implication of the data presented above that 
cholesterol-induced genomic instability in AD may be the initiating event in 
disease pathogenesis also suggests new approaches to prevention and 
treatments (Potter, 2004).  For example, elevated total and LDL-cholesterol as 
risk factors for AD and atherosclerosis in midlife should be treated early both as 
an atherogenic and aneugenic agent.  Molecules that would restore the mitotic 
defects and strengthen the fidelity of mitotic machinery could be searched for and 
used as a prophylactic measure.  Furthermore, other aneugenic environmental 
agents aside from high cholesterol that cause chromosome instability could be 
identified and countered with drugs that restore genomic homeostasis.  
Alternatively, a more difficult but still effective approach to therapy would be to 
identify and remove mis-segregated cells from the body by utilizing their unique 
cell biology and/or gene profile.  
To summarize, the results from this dissertation and several other 
laboratories over the past twenty years have shown that AD patients are 
susceptible to genomic instability, accumulating elevated levels of aneuploid 
including trisomy 21 cells throughout the body compared to age matched healthy 
controls.  Whether the patients suffering from CVD (atherosclerosis) are at higher 
risk for AD because of disturbed genomic homeostasis may be important to 
investigate.  The precise mechanism by which abnormal cells arise in the 
periphery (e.g., skin and arterial walls) and especially in the brain during the life 
of an individual and how or whether they contribute to disease initiation and 
progression warrant future investigation.  The better understanding of these 
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novel findings has the potential to contribute to the development of future 
diagnoses and therapies for AD and CVD. 
 
CONCLUDING REMARKS 
 
This dissertation presented several novel findings, the main being that 
Alzheimer’s disease and CVD (atherosclerosis) may be mechanistically related 
through a cytogenetic pathway.  While dysfunction of cholesterol homeostasis 
may contribute to AD pathology via systemic and cerebral atherosclerosis 
causing cerebral hypoperfusion, disrupted communication between neurons and 
vascular cells at the BBB, inflammation, impaired cerebral Aβ clearance and 
consequent CAA, and compromised BBB (Vascular Hypothesis), other 
mechanisms may also be involved.  Altered cholesterol homeostasis within the 
brain and plasma membrane may promote or inhibit amyloid production and 
clearance (Amyloid Cascade Hypothesis) leading to neurodegeneration.  Finally, 
this dissertation presents evidence that a unique common cytogenetic 
mechanism may underlie both AD and CVD (atherosclerosis).  Specifically, 
disturbed cholesterol homeostasis may interfere with the cytogenetic property of 
mitotic cells in the periphery and brain by changing their ability to properly 
segregate their chromosomes, similar to development of mis-segregated, 
including HSA21 aneuploid cells in blood, skin, mucosa and brain of AD patients 
(Chromosome Mis-segregation Hypothesis), further perpetuating the pathology. 
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 Another novel finding of this dissertation suggests an association between 
disturbed intracellular cholesterol homeostasis and differential distribution of 
lipids between cell compartments and aneuploidy, as observed in the NPC1 
cells.  The mechanism by which impaired cholesterol trafficking and storage 
leads to accumulation of neurofibrillary tangles and neurodegeneration in the 
brains of NPC1 patients is obscure (Karten et al., 2009), but understanding the 
correlation between the aneugenesis and dysfunction in cholesterol homeostasis 
may provide new insights into the pathogenic pathways of both AD and NPC.  
 This study had several limitations including: (1) mis-segregation of only a 
few of chromosomes was tested and the extent of chromosome-specific 
aneuploidy is not known; (2) the role of the more or less neuroprotective APOE 
variants in genomic instability and aneugenesis in conjunction with lipids is 
undetermined; (3) the extent of lipoprotein-induced aneuploidy in the brain cells 
has not been investigated; (4) mice on a high cholesterol diet gained significantly 
more weight compared to the mice in other dietary groups, which may have 
biased the results; and (5) the known fluidizing effect of ethanol in vitro has been 
hypothesized as a possible mechanism for the reduction in aneuploidy in the 
cells co-incubated with lipids and alcohol—however, the membrane fluidity has 
not been measured. 
In summary, the fact that several age-related diseases (e.g., Alzheimer’s, 
cancer, atherosclerosis, and FTD) share a common cytogenic trait—genomic 
instability and chromosome mis-segregation—opens new avenues for the 
research and therapeutic approaches. 
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                    GLOSSARY 
 
 
acrocentric chromosome: a chromosome with a very short p (small) arm and 
centromere (a region of the chromosome where sister chromatids are in close 
contact) positioned towards its end.  Observed in human chromosomes 13, 14, 
15, 21, and 22.  
 
anaphase: the stage of mitosis when sister chromatids are separated by mitotic 
spindle.  
 
aneugen: process, agent or molecule that induces improper segregation of the 
chromosomes during the cell division. 
 
aneuploidy: a numerical abnormality of chromosomes compared to normal 
genome (e.g., normal human somatic cells contains 46 chromosomes or 22 pair 
of autosomes and one pair of sex chromosomes). 
 
apoptosis: programmed cell death.  
 
BAC (bacterial artificial chromosome): an artificially constructed cloning 
plasmid in which a DNA sequence of interest could be inserted and transformed 
into bacteria to generate identical clones resistant to a specific antibiotic.  
 
calpain: a calcium-dependent protein expressed ubiquitously in mammalian 
cells.  
 
cerebral amyloid angiopathy (CAA): accumulation of amyloid-β protein in blood 
vessels of the central nervous system. 
 
cerebral hypoperfusion: decrease blood flow in cerebral vasculature especially 
in microvessels.  
 
chelator: an organic compound that serves as a ligand to other molecules via 
formation of a single central atom bond.   
 
chiasma (pl. chiasmata): a X-shaped chromosomal structure and the site of 
cross-over (a reciprocal exchange of DNA) between homologous chromosomes 
during meiosis. 
 
chromogenic in situ hybridization (CISH): an alternative cytogenetic method 
to FISH that employs enzymatic reactions and the brightfield microscopy to 
153 
 
assess gene alternations, aneuploidy and other chromosomal aberrations in 
formalin fixed or paraffin-embedded tissue slices.  
 
clonal proliferation: division of identical cells derived from the same original 
cell.  
 
cholesteryl esters: highly hydrophobic esterified form of cholesterol. 
 
circle of Willis: a circle of arteries that supply the blood to the brain.  
 
colcemid: microtubule toxin, a drug that inactivates spindle formation and arrests 
the cells in metaphase. 
 
cyclodextrines: a family of organic compounds composed of several sugar 
molecules in a ring structure able to form stable aqueous complexes with other 
molecules.  
 
cytokinesis: a process of division of the mother cell into two daughters. 
 
cytosol: intracellular fluid-filled space of the cell divided into compartments by 
membranes.  
 
diploid: containing two copies or homologs of each chromosome (one inherited 
from one parent and one from the other).  Most somatic cells are diploid.  
 
dynein: a microtubule (MT) motor protein complex that transports various 
cellular cargo along MT toward its minus-end and centrosomes.  
 
efflux: any exit of ions or molecules from the cell into extracellular space. 
 
endocytosis: a process of ingestion of molecules in which plasma membrane 
folds inwards to form an intracellular vesicle.  
 
endoplasmic reticulum (ER): an organelle in eukaryotic cell composed of 
interconnected network of membranes responsible for transport, production, 
metabolism and regulation of different proteins, lipids, ions and other molecules. 
 
endosome: membrane-associated vesicle inside the cell that transports 
molecules for further processing to other organelles or back to the plasma 
membrane.  
 
euploid: containing normal chromosome compliments for the species (opposite 
of aneuploid).  
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fluorescence-activated cell sorting (FACS): a technique that uses modified 
flow cytometer (an instrument that counts and differentiates different types of 
cells based on intensity of fluorescent dye) to sort cell into different containers. 
 
fluorescence in situ hybridization (FISH): a cytogenetic technique in which a 
specific DNA sequence labeled with a fluorescent dye binds to complimentary 
DNA of a target cell of specimen.  
 
fluorophore (chromophore): a compound that bound to other molecule causes 
fluorescence (e.g., DAPI, fluorescein isothiocyanate, SpectrumOrange).  
 
G-banding: a classic cytogenetic technique in which metaphase chromosomes 
are enzymatically treated (trypsin) and stained with the Giemsa stain to obtain 
unique chromosomal bands (light and dark). 
 
Golgi network (apparatus): a membrane structure in the cell responsible for 
processing and packing of the proteins before secretion. 
 
hepatic steatosis: fatty liver, accumulation of neutral lipids in hepatocytes. 
 
hyperploid: containing more than diploid chromosome compliment.  
 
hypoploid: containing less than diploid chromosome compliment.  
 
influx: flux of ions and molecules into the cell or subcellular organelles.  
 
in vitro: (Latin ‘within glass’) studies in cellular biology done in the cells isolated 
from tissues and organs. 
 
in vivo: studies done in an intact living organisms.  
 
karyotype: a set of condensed chromosomes in metaphase stained or otherwise 
prepared in order to detect the unique features of each chromosome pair.  
 
kinase: proteins that transfer phospho groups onto other molecules and thus 
regulate different cellular processes.  
 
kinetochore: a protein complex located at the centromere (a region of the 
chromosome), where the microtubules are attached during mitosis.  
 
ligand: (Latin ‘binding’) a biomolecule that forms a bond (e.g., ionic bonds) with 
other substance or molecule to perform certain biological function. 
 
loss of heterozygosity: loss of function of one allele of the gene in which the 
other one is already non-active.  
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lysosome: (Greek lysis [to separate] and soma [body]) an organelle in the cell 
filled with digestive enzymes that break down proteins, sugars, nucleic acids and 
cellular debris. 
 
meiosis: a specialized nuclear division in formation of the gametes in which 
each cell contains haploid nuclei with a single homolog of each chromosome 
(e.g., 23 chromosomes in humans).  
 
microtubule (MT): a straw-like hollow structure composed of tubulin subunits 
that supports cell cytoskeleton in interphase and forms mitotic spindle during 
mitosis.  
 
mitochondria: cell energy plant that converts complex sugars into energy 
packets, the adenosine triphosphate (ATP) via glycolysis or Kreb’s cycle.  
 
mitosis: a process of division in which the duplicated chromosomes are 
separated via mitotic spindle.  
 
mitogen: an agent that stimulates the proliferation of the cells.  
 
mosaicism: the presence of the euploid and aneuploid cell population in one 
organ or organism.  
 
nuclear envelope (NE): the inner cellular membrane that surrounds and protects 
nucleus from various insults and damage. 
 
PCR (polymerase chain reaction): a molecular biology technique used to 
amplify a specific DNA sequences and fragments.  
 
retrograde immunocytochemistry: a combination of protein staining and 
tracing technique used to identify, for example, neuronal projections.   
 
separase: a protein that initiates the separation of sister chromatids. 
 
sister chromatids: a duplicated set of chromosomes.  
 
spectral karyotyping (SKY): a cytogenetic technique that allows for 
visualization of all chromosomes in metaphase by using different fluorescent 
probe for each.  
 
telomerase: a specialized enzyme that synthetizes the repetitive sequence of 
DNA at the end of the chromosomes, the telomeres that maintain their integrity 
and regulate the number of cell divisions.  
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tetraploid: containing four copies (or homologs) of each chromosome as a result 
of failed cytokinesis.  
 
Xenopus cell extract: cells prepared from frog oocytes.  
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